0001140215 REED:CustomerTwoMember us-gaap:SalesRevenueNetMember 2020-01-01 2020-12-31

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K

 

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended December 31 2020, 2021

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _______ to _______

 

Commission File Number: 001-32501

 

REED’S, INC.

(Exact name of registrant as specified in its charter)

 

Delaware 35-2177773
(State of incorporation) (I.R.S. Employer Identification No.)

201 Merritt 7, Norwalk, CT 06851
(Address of principal executive offices) (Zip Code)

 

(800) 997-3337

 

(Registrant’s telephone number, including area code)

 

 

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock REED The NASDAQ Stock Market LLC

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes ☐ No

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer Smaller reporting company
  Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

 

The aggregate market value of the voting and non-voting common equity held by non-affiliates (excluding voting shares held by officers and directors) as of June 30, 20202021 was $55,025,15476,114.

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date. There were a total of 86,403,321112,842,146 shares of Common Stock outstanding as of March 22, 2021.2022.

 

 

 

 

 

 

TABLE OF CONTENTS

 

PART I51
  
Item 1. Business51
  
Item 1A. Risk Factors139
  
Item 1B. Unresolved Staff Comments3127
  
Item 2. Properties3127
  
Item 3. Legal Proceedings3127
  
Item 4. Mine Safety Disclosures3127
  
PART II3228
  
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities3228
  
Item 6. Selected Financial Data[Reserved]3328
  
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations3328
  
Item 7A. Quantitative and Qualitative Disclosures About Market Risk4034
  
Item 8. Financial Statements and Supplementary Data41F-1
  
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure4235
  
Item 9A. Controls and Procedures4235
  
Item 9B. Other Information4235
Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections35
PART III36
  
PART IIIItem 10. Directors, Executive Officers and Corporate Governance4336
  
Item 10. Directors,11. Executive Officers and Corporate GovernanceCompensation4339
  
Item 11. Executive Compensation47
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters5142
  
Item 13. Certain Relationships and Related Transactions, and Director Independence5244
  
Item 14. Principal Accountant Fees and Services5446
  
PART IV5548
  
Item 15. Exhibits, Financial Statement Schedules5548
  
Item 16. Form 10-K Summary5548

 

2i

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS AND INFORMATION

 

This Annual Report on Form 10-K (“Annual Report”), the other reports, statements, and information that we have previously filed or that we may subsequently file with the Securities and Exchange Commission (“SEC”) and public announcements that we have previously made or may subsequently make include, may include, incorporate by reference or may incorporate by reference certain statements that may be deemed to be forward-looking statements. The forward-looking statements included or incorporated by reference in this Annual Report and those reports, statements, information and announcements address activities, events or developments that Reed’s, Inc. (hereinafter referred to as “we,” “us,” “our” or “Reed’s”) expects or anticipates will or may occur in the future. Any statements in this document about expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements. These statements are often, but not always, made through the use of words or phrases such as “may,” “should,” “could,” “predict,” “potential,” “believe,” “will likely result,” “expect,” “will continue,” “anticipate,” “seek,” “estimate,” “intend,” “plan,” “projection,” “would” and “outlook” and similar expressions. Accordingly, these statements involve estimates, assumptions and uncertainties, which could cause actual results to differ materially from those expressed in them. Any forward-looking statements are qualified in their entirety by reference to the factors discussed throughout this document. All forward-looking statements concerning economic conditions, rates of growth, rates of income or values as may be included in this document are based on information available to us on the dates noted, and we assume no obligation to update any such forward-looking statements.

 

The risk factors referred to in this Annual Report beginning on page 149 could cause actual results or outcomes to differ materially from those expressed in any forward-looking statements made by us, and you should not place undue reliance on any such forward-looking statements. Any forward-looking statement speaks only as of the date on which it is made, and we do not undertake any obligation to update any forward-looking statement or statements to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of unanticipated events. New factors emerge from time to time, and it is not possible for us to predict which will arise. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.

 

Management cautions that these statements are qualified by their terms and/or important factors, many of which are outside of our control, involve a number of risks, uncertainties and other factors that could cause actual results and events to differ materially from the statements made, including, but not limited to, the following risk factors:

 

● The availability and cost of capital to finance working capital and our operating plans,

● Maintaining the listing of our common stock on the Nasdaq Capital Market or other national securities exchange. We will be subject to delisting if we do not meet the Nasdaq bid price rule by August 15, 2022,

● Our ability to generate sufficient cash flow to support marketing and product development plans and general operating activities,

 

● Decreased demand for our products resulting from changes in consumer preferences,

 

● Competitive products and pricing pressures and our ability to gain or maintain our share of sales in the marketplace,

 

● The introduction of new products,

 

● Our being subject to a broad range of evolving federal, state and local laws and regulations including those regarding the labeling and safety of food products, establishing ingredient designations and standards of identity for certain foods, environmental protections, as well as worker health and safety. Changes in these laws and regulations could have a material effect on the way in which we produce and market our products and could result in increased costs,

 

● Changes in the cost and availability of raw materials and the ability to maintain our supply arrangements and relationships and procure timely and/or adequate production of all or any of our products,

 

3

● Our ability to penetrate new markets and maintain or expand existing markets,

 

● Maintaining existing relationships and expanding the distributor network of our products,

ii

 

● Decline in global financial markets and economic downturn resulting from the coronavirus COVID-19 global pandemic,

 

● Business interruptions resulting from the coronavirus COVID-19 global pandemic,

 

● Our ability to remediate weaknesses we identifiedmay identify in our disclosure controls and procedures and our internal control over financial reporting in future periods in a timely enough manner to eliminate the risks posed by such material weaknesses, in future periods,

● Maintaining the listing of our common stock on the Nasdaq Capital Market or other national securities exchange,

 

● The marketing efforts of distributors of our products, most of whom also distribute products that are competitive with our products,

 

● Decisions by distributors, grocery chains, specialty chain stores, club stores and other customers to discontinue carrying all or any of our products that they are carrying at any time,

 

● The availability and cost of capital to finance our working capital needs and growth plans,

● The effectiveness of our advertising, marketing and promotional programs,

 

● Changes in product category consumption,

 

● Economic and political changes,

 

● Consumer acceptance of new products, including taste test comparisons, and

 

● Possible recalls of our products, and

● Whether or not we will be entitled to forgiveness of our Paycheck Protection Program loan.products.

 

Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements.

 

4iii

 

PART I

 

Item 1. Business

Overview

 

Reed’s, Inc.Inc,, a Delaware corporation (“Reed’s”, the “Company,” “we,” or “us” throughout this report) owns a leading portfolio of handcrafted, all-naturalnatural beverages that is sold in over 40,00045,000 outlets nationwide (includingnationwide. These outlets include the natural and specialty food channel, grocery stores, mass merchants, drug stores, convenience stores, club stores and on-premise locations including bars and restaurants).restaurants. Reed’s two core brands are Reed’s, which includes Reed’s Craft Ginger Beer and Reed’s Real Ginger Ale, and Virgil’s Handcrafted soda.sodas. Reed’s Craft Ginger Beers are unique due to the proprietary process of using fresh ginger root combined with a Jamaican inspired recipe of natural spices, honey and fruit juices. Reed’s uses this same handcrafted approach in its Reed’s Real Ginger Ale and Virgil’s line of great tasting, bold flavored craft sodas, including its award-winning Virgil’s Root Beer.

 

Reed’s is the leading ginger beer in the US; Virgil’s is the leading independent (not aligned with Coca-Cola, Pepsi or Keurig Dr. Pepper) all-naturalnatural full line craft soda and is ranked fourtha leader in the craft soda category.

 

Historical Development

 

Reed’s Original Ginger Brew, created in 1987 by Christopher J. Reed, our founder, and current Chief Innovation Officer and director, was introduced to the market in Southern California stores in 1989. By 1990, we began marketing our products through United Natural Foods Inc. (“UNFI”) and other natural food distributors and moved our production to a larger facility in Boulder, Colorado.

 

In 1991, we incorporated our business operations in the state of Florida under the name of Original Beverage Corporation and moved all production to a co-pack facility in Pennsylvania. Throughout the 1990’s, we continued to develop and launch new Ginger Brew varieties. Reed’s Ginger Brews reached broad placement in natural and gourmet foods stores nationwide through UNFI and other major specialty, natural/gourmet and mainstream food and beverage distributors.

 

In 1997, we began licensing the products of China Cola and eventually acquired the rights to that product in 2000. In 1999, we purchased the Virgil’s Root Beer brand from the Crowley Beverage Company. In 2000, we moved into an 18,000-square foot warehouse property, the Brewery, in Los Angeles, California, to headquarters. In 2001, pursuant to a reincorporation merger, we changed our state of incorporation to Delaware and also changed our name to “Reed’s, Inc.”

 

In September 2018, we completed the relocation of its headquarters to Norwalk, Connecticut. In December 2018, after a lengthy marketing and bidding process, we sold the Brewery to a company owned by Christopher J. Reed, our founder. The sale of the Brewery marked a fundamental shift in the nature of our operations and effectively eliminated our costs associated with excess manufacturing capacity.

 

Going Concern

The Company’s financial statements as of December 31, 2021 were prepared on a going concern basis. For the year ended December 31, 2021, the Company recorded a net loss of $16,402 and used cash in operations of $17,589. As of December 31, 2021, we had a cash balance of $49 with borrowing capacity of $109, stockholders’ equity of $4,203 and a working capital of $2,981. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The Company believes that its current level of cash and cash equivalents are not sufficient to fund its operations for the next 12 months.

To alleviate these conditions, management is currently evaluating various funding alternatives and may seek to raise additional funds through the issuance of equity, mezzanine or debt securities, through arrangements with strategic partners or through obtaining credit from financial institutions. As we seek additional sources of financing, there can be no assurance that such financing will be available to us on favorable terms or at all. Our ability to obtain additional financing in the debt and equity capital markets is subject to several factors, including market and economic conditions, our performance and investor sentiment with respect to us and our industry.

Industry Overview

 

Reed’s offers its portfolio of natural hand-crafted beverages in the craft specialty foods industry as natural alternatives to the $32$25 billion mainstream carbonated soft drinks (“CSD”) market in the United States as measured by IRI Multi Outlet scan data. Reed’s products are sold across the country and internationally in the following major channels: natural food, specialty food, grocery, mass merchant, convenience, club, drug, and on-premise locations (bars and restaurants).

 

Even after a year of the pandemic, overall sales growth of natural food and beverage products continues to outpace sales growth for conventional products across all retail channels. We see ample opportunity to scale our natural beverage business and grow our distribution in these channels.

 

1

Carbonated Soft Drink Industry Overview

 

The retail CSD category has ralliedgrew 9% during 2021 and the pandemic. This past year, after 13 years of declines, the retail CSD category grew 13%. The ginger ale segment grew even faster at 15.4%5% and is now a $1.1$1.3 billion dollar market. Ginger ale growth, we believe, is driven primarily by a consumer perception of ginger ale as a healthier alternative to other sodas. Our new line of ginger ales made with real ginger deliver on this perception and are poised to breakout in the segment.

 

InAs a result of the wake of COVID-19 pandemic, consumers are shifting consumption to better-for-you products. We believe there is significant growth potential from consumers switching away from mainstream beverages that contain artificial ingredients and preservatives towards great-tasting, natural alternatives.

 

Consumer Trends Driving Growth for Our Products

 

The following is a list of consumer trends that are accelerating as we exit the pandemic, and which support our brands.

 

 Natural: Interest in all-naturalnatural products has gone mainstream.
   
 Clean Label: 62% of Americans are avoiding at least one ingredient.
   
 Reduced Sugar: A favorable trend for our zero-sugar beverages, 77%67% of consumers prefer low or no sugar soft drinks. say they are reducing their sugar intake.
   
 

FunctionalityPlant Based: Right before the pandemic, 65%39% of consumers looked for function in what theyactively try to eat and drink. This accelerating trend will drive growth for our ginger-based beverages.more plant based foods.

   
 Craft:Appeal continues to grow of higher-quality, independent, and more authentic brands.
   
 Premiumization: A trend towards embracing quality has accelerated during the pandemic with consumers splurging on premium beverages at retail, including premium mixers.
   
 Better-for-you Mocktails: More consumers are seeking non-alcoholic alternatives with bold and unique flavors.
   
 Ready-to-Drink Cocktails (RTD): CategoryThe RTD category grew 126% in 2021 is exploding alongside hard seltzer as people seek novelty and variety, which puts our RTD Mules in a great position to succeed.variety.

 

Our strategies will remain responsive to these macro consumer trends as we concentrate our efforts on developing the Company’s sales and marketing functions.

 

Our Products

 

We make our hand-crafted beverages with only premium, natural ingredients. Our products are free of genetically modified organisms (“GMOs”) and artificial preservatives. Over the years, Reed’s has developed several product offerings. In 2019, we streamlined our focus to our core categories of Reed’s Ginger Beverages and Virgil’s Craft Sodas. In April 2020, we launched our new line of Reed’s Real Ginger Ales, in both Full Sugar and Zero Sugar versions,varieties, made with 2,000mg2,000 mg of fresh organic ginger. In 2021, we extended our Ginger Ale offerings with Mocktails and we entered the alcohol space with the launch of our RTD Classic Mule that is 7% ALC and Zero Sugar.

 

Reed’s Craft Ginger Beer

 

Reed’s Craft Ginger Beer is set apart from other ginger beers by its proprietary process of brewing fresh ginger root, its exclusive use of all-naturalnatural ingredients, and its authentic Jamaican-inspired recipe. We do not use artificial preservatives, artificial flavors, or colors, and Reed’s Ginger Beer is certified kosher. We offer different levels of fresh ginger content, ranging from our lightest-spiced Original, to our medium-spiced Extra, and finally to our spiciest Strongest. We also offer three sweetener options: one with cane sugar, honey and fruit juices; one with honey and pineapple juice; and another without sugar (Zero Sugar) made from an innovative blend of natural sweeteners (developed in 2018 and commercialized in 2019).sweeteners. In 2021, we expanded our Extra Ginger Beer portfolio into cans offerings.

 

62
 

 

As of the end of 2020,2021, the Reed’s Craft Ginger Beer line included five major varieties:varieties with a mix of bottles and cans:

 

Reed’s Original Ginger Beer – Our first to market product uses a Jamaican-inspired recipe that calls for fresh ginger root, lemon, lime, pineapple juice, honey, raw cane sugar, pineapple, herbs and spices.

 

Reed’s Premium Ginger Beer – Our Original Ginger Beer sweetened with honey and pineapple juice. (No cane sugar added.)

 

Reed’s Extra Ginger Beer – Contains 100% more fresh ginger than Reed’s Original recipe for extra spice.

 

Reed’s Strongest Ginger Beer – Contains 200% more fresh ginger than Reed’s Original for the strongest spice.

 

Reed’s Zero Sugar Extra Ginger Beer – launched in 2019, in bottles and cans, it uses a proprietary natural sweetening system for a zero-calorie version of our Reed’s Extra Ginger Beer.

 

Reed’s Real Ginger Ale

 

Reed’s Real Ginger Ale is unique for the category because it combines real fresh ginger with the classic, refreshing taste that consumers love. It contains nothing artificial and is Non-GMO project verified. We offer two sweetener options: one with cane sugar and the other with our zero-calorie all-natural sweetener blend.proprietary natural sweetening system.

 

NEW! Reed’s Real Ginger Ale – launched in April 2020 in standard and slimsleek 12-ounce cans. It is the only mass market ginger ale made with organic fresh ginger.

 

NEW! Reed’s Zero Sugar Real Ginger Ale – also launched in April 2020 in standard and slim cans. It uses our all-natural sweetener blendproprietary sweetening system to match the great taste of the cane sugar version in a zero-calorie drink.

 

NEW! Reed’s Mocktails- In 2021 Reed’s line extended its Zero Sugar Ginger Ale, with the launch of Mocktail Flavors. It uses our proprietary sweetening system to match the great taste of the cane sugar version in a zero-calorie drink. The two flavors are Shirley Tempting and Transfusion.

Reed’s Ready to Drink

NEW! Reed’s Zero Sugar Classic Mule: Launched in 2020 and expanded to 37 states in 2021, Reed’s first-ever alcoholic offering is packed with REAL, fresh ginger root and made through a unique handcrafted brewing and fermentation process. It contains 7% alcohol, and a light-spice flavor profile with no artificial colors, gluten, GMOs or caffeine. It is the ultimate mule, made with fresh ginger root, to be enjoyed anytime, anywhere.

Other New Ginger Beverages under the Reed’s brand

 

NEW! Reed’s Wellness Ginger Shots – launched in February 2020 offered in two varieties: Daily Ginger and Ginger Energize. These convenient, shelf-stable shots provide a ginger boost on the go.

 

NEW! Reed’s Zero Sugar Classic Mule – launched in June 2020 containing 7% ABV (Alcohol By Volume), is the ultimate mule, made with fresh ginger root, to be enjoyed anytime, anywhere.

Virgil’s Handcrafted Sodas

 

Virgil’s is a premium handcrafted soda that uses only all-naturalnatural ingredients to create bold renditions of classic flavors. We don’t use any artificial preservatives, any artificial colors, or any GMO-sourced ingredients, and our Virgil’s line is certified kosher.

 

The Virgil’s line includes the following products:

 

Handcrafted Line: Virgil’s first Handcrafted soda was launched in 1994. It began as one man’s passion to create the finest root beer ever produced and has since won numerous awards. Virgil’s difference is using all-naturalnatural ingredients to craft bold, classic soda flavors. Virgil’s Handcrafted line includes Root Beer, Vanilla Cream, Black Cherry, and Orange Cream.

 

Zero Sugar Line: Virgil’s launched a new line of Zero Sugar, Zero Calorie craft sodas in 2019. Each Zero Sugar soda is sweetened with a proprietary blend of natural sweeteners with no added sugars.sugars and is certified Keto. This all-naturalnatural line of Zero Sugar flavors includes Root Beer, Cola, Black Cherry, Vanilla Cream, Orange Cream, Lemon-Lime, Ginger Ale, Grapefruit and Lemon-Lime. The product has recently been certified Keto compliant.Dr. Better.

.

 

3

2021

2022 Product Launches

 

During the second quarter of 2021, Reed’s will launch the below:

 

Reed’s RealHard Ginger Ale Zero Sugar Line Extensions: Shirley Tempting and Transfusionin Variety 8 Packs
Reed’s Real Ginger Ale and Virgil’s 20 oz Bottles for the Convenience Channel
Virgil’s Zero Sugar Line Extensions: Dr. Better, Grapefruit, and Ginger Alein 12-ounce sleek 4 packs
Limited Edition Swing Lid Bottles 0.5 liter: Virgil’s Bavarian Nutmeg Root Beer and Flying Cauldron Butterscotch Beer
Reed’s CraftZero Sugar Stormy Mule

7

 

Our Primary Markets

 

We target a smaller segment of the estimated $32$25 billion mainstream carbonated and non-carbonated soft drink markets in the United States. Our brands are generally considered premium and natural, with upscale packaging. They are loosely defined as the craft specialty bottled carbonated soft drink category.

 

We have an experienced and geographically diverse sales force promoting our products, with senior sales representatives strategically placed in multiple regions across the country, supported by local Reed’s sales staff. Additionally, we have sales managers handling national accounts for natural, specialty, grocery, mass, club, drug and convenience channels. Our sales managers are responsible for all activities related to the sales, distribution, and marketing of our brands to our entire retail partner and distributor network in North America. The Company not only employs an internal sales force but has partnered with independent sales brokers and outside representatives to promote our products in specific channels and key targeted accounts.

 

We sell to well-known popular natural food and gourmet retailers, large grocery store chains, mass merchants, club stores, convenience and drug stores, liquor stores, industrial cafeterias (corporate feeders), and to on-premise bars and restaurants nationwide and in some international markets. We also sell our products and promotional merchandise directly to consumers via the Internet through our Amazon storefront which can be accessed through our company web site www.drinkreeds.com.

 

Some of our representative key customers include:

 

 Natural stores: Whole Foods Market, Sprouts, Natural Grocers by Vitamin Cottage, Fresh Thyme Farmers Market, Mother’s
   
 Gourmet & specialty stores: Trader Joe’s, Bristol Farms, Lazy Acres, The Fresh Market, Central Market
   
 Grocery and mass chains: Kroger (and all Kroger banners), Albertson’s/Safeway, Albertson’s, Publix, Food Lion, Stop & Shop, H.E.B., Wegmans, Target, Walmart
   
 Club stores: Costco and BJ’s
   
 Liquor stores: BevMo!, Total Wine & More, Spec’s
   
 Convenience & drug stores: Circle K, CVS Health, Rite Aid, QuikTrip

 

Our Distribution Network

 

Our products are brought to market through an extremely flexible and fluid hybrid distribution model, which is a mix of direct-store-delivery, customer warehouse, and distributor networks. The distribution system used depends on customer needs, product characteristics, and local trade practices.

4

 

Our product reaches the market in the following ways:

 

Direct to Natural & Specialty Wholesale Distributors

 

Our natural and specialty distributor partners operate a distribution network delivering thousands of SKUs of natural and gourmet products to thousands of small, independent, natural retail outlets around the U.S., along with national chain customers, both conventional and natural. This system of distribution allows our brands far reaching access to some of the most remote parts of North America. During the past year we expanded, and will continue to expand, in this distribution network.

 

Direct to Store Distribution (“DSD”) Through Non-Alcoholic and Alcoholic Beverage Distributor Network

 

Our independent distributor partners operate DSD systems which deliver primarily beverages, foods, and snacks directly to retail stores where the products are merchandised by their route sales and field sales employees. DSD enables us to merchandise with maximum visibility and appeal. DSD is especially well-suited to products frequently restocked and responds to in-store promotion and merchandising. We are primarily focused on expanding our DSD network on a national basis.

 

8

Direct to Store Warehouse Distribution

 

Some of our products are delivered from our co-packers and warehouses directly to customer warehouses. Some retailers mandate we deliver directly to them, as it is more cost effective and allows them to pass savings along to their customers. Other retailers may not mandate direct delivery, but they recommend and prefer it as they have the capability to self-distribute and can realize significant savings with direct delivery.

 

Wholesale Distribution

 

Our Wholesale Distributor network handles the wholesale shipments of our products. These distributors have a warehouse and distribution center, and ship Reed’s and Virgil’s products directly to the retailer (or to customers who opt for drop shipping).

 

International Distribution

 

We presently export Reed’s and Virgil’s brands throughout international markets via US based exporters. International markets where our brands are present are France, UK, South Africa, portions of the Caribbean, Canada, Spain, Philippines, Israel and Australia. In the UK, our Virgil’s brands can be found at Pizza Hut, Tesco Supermarket and Sainsbury.

International sales to some areas of the world are cost prohibitive, except for some specialty sales, since our premium sodas were historically packed in glass, which drives substantial freight costs when shipping overseas. Despite these cost challenges, we believe there are good opportunities to expand internationally, and we are increasing our marketing focus on these areas by adding freight friendly packages such as aluminum cans. We are open to exporting and co-packing internationally and expanding our brands into foreign markets, and we have held preliminary discussions with trading companies and import/export companies for the distribution of our products throughout Asia, Europe, Australia, and South America. We believe these areas are a natural fit for Reed’s ginger products because of the popularity and importance of ginger in international markets, especially the Asian market, where ginger is a significant part of the local diet and nutrition.

 

We believe the strength of our brands, innovation, and marketing, coupled with the quality of our products and flexibility of our distribution network, allows us to compete effectively.

 

Distribution Agreements

 

We have entered into agreements with some of our distributors that commit us to “termination fees” if we terminate our agreements early or without cause. These agreements provide for our distributor partners to have the right to distribute our products to a defined type of retailer within a defined geographic region. As is customary in the beverage industry, if we should terminate the agreement or not automatically renew the agreement, we would be obligated to make certain payments to our distributor partners. We constantly review our distribution agreements with our partners across North America.

 

5

Some of our outside distributors are not bound by written agreements with us and may discontinue their relationship with us on short notice. Most distributors handle a number of competitive products. In addition, our products are sometimes a small part of our distributors’ businesses.

 

Manufacturing Our Products

 

All of Reed’s products are produced by our co-pack partners, which assemblepartners. They brew, blend, bottle, and package our products and charge us a fee, generally by the case, for the products produced. We have a long-standing relationship with two co-packers in Pennsylvania. Additionally,Pennsylvania and two in conjunction with the sale of our plant,California. During 2020 we entered into a three-year co-packing agreementagreements with CCB, whereby CCB will produce Reed’s Inc. beverages in glass bottles at prevailing West Coast market rates. In 2019, we entered into a co-packing agreement with Sonoma Beverage Company on the West Coast. We recently engaged an additional co-packer on the East Coast, Clinton’s Ditch, and another on the West Coast, Noel Canning. We are in discussions and negotiations with additional co-packers to secure added capability for future production needs. We periodically review our co-packing relationships to ensure that they are optimal with respect to quality of production, cost and location.

9

 

Warehousing and Logistics are a significant portion of the Company’s operational costs. In order to drive efficiency and reduce costs, on February 1, 2019 we entered into a strategic partnership with Veritiv Logistics Solutions to manage all freight movement for the Company. Veritiv is one of the largest distribution service providers in North America and has expertise that will provide a competitive advantage in the movement of raw materials and finished goods. This partnership will support planning and execution of all inventory movement, assessment of storage needs and cost management.

 

We follow a “fill as needed” model to the best of our ability and have no significant order backlog.

 

New Product Development

 

While we have simplified our business and have streamlined a significant number of SKUs in order to further our primary objective of accelerating the growth of the Reed’s and Virgil’s core product offerings, we believe significant opportunity remains in the all-naturalnatural beverage space.

 

Healthier alternatives will be the future for carbonated soft drinks. We will continue to drive product development in the all-natural,natural, no and low sugar offerings in the “better for you” beverage categories. In addition, we believe there are powerful consumer trends that will help propel the growth of our brand portfolio including the increased consumption of ginger as a recognized superfood, the growing use of ginger beer in today’s popular cocktail drinks, and consumers’ increased demand for higher quality, all-naturalnatural handcrafted beverages.

 

Christopher J. Reed, the Company’s founder and Chief Innovation Officer continues to support our new product development efforts in 2020.2022. Mr. Reed possesses thirty plus years of product development and innovation experience. Recent innovations include our compelling line of full flavor, all-natural,natural, zero sugar, zero calorie sodas. Reed’s has also begun to expand and broaden its product development capabilities by engaging and working with larger, experienced beverage flavor houses and innovative ingredient research and supply companies.

 

We believe our new business model enhances our ability to be nimble and innovative, producing category leading new products in a short period of time.

 

Competition

 

Nonalcoholic Beverages

 

The nonalcoholic beverage segment of the commercial beverage industry is highly competitive, consisting of numerous companies ranging from small or emerging to very large and well established. The principal areas of competition include pricing, packaging, development of new products and flavors, and marketing campaigns. Our products compete with a wide range of drinks produced by a relatively large number of manufacturers. Many of these brands have enjoyed broad, well-established national recognition for years, through well-funded ad and other branding campaigns. Competitors in the ginger beer category include Goslings, Fever Tree, Bundaberg, Cock ‘n Bull and Q Tonic; in the craft soda category we compete with brands such as Stewart’s, IBC, Zevia, Blue Sky, Hansen’s, Henry Weinhard’s, Boylan, and Jones Soda; In the Ginger Ale category we compete with Canada Dry, Schweppes, Seagram’s and Zevia.

6

 

Important factors affecting our ability to compete successfully include the taste and flavor of products, trade and consumer promotions, rapid and effective development of new, unique cutting-edge products, attractive and different packaging, branded product advertising, and pricing. We also compete for distributors who will concentrate on marketing our products over those of our competitors, provide stable and reliable distribution, and secure adequate shelf space in retail outlets. Competitive pressures in the soft drink category could also cause our products to be unable to gain or even lose market share, or we could experience price erosion.

 

10

Despite our products having a relatively high price for a craft premium beverage product, minimal mass media advertising to date, and a small but growing presence in the mainstream market compared to many of our competitors, we believe our all-naturalnatural innovative beverage recipes, packaging, use of premium ingredients, and a proprietary ginger processing formula provide us with a competitive advantage. Our commitments to the highest quality standards and brand innovation are keys to our success.

 

Shot CategoryGinger Shots

 

Our Reed’s Wellness Ginger Shot was introduced during 2020. The shot category is very competitive, and a few mainstream companies dominate the category, but there is room for an all-naturalnatural alternative. Competition for market share and acceptance of new products is significant. Main competitors are 5-Hour Energy, Ginger Time, and Rescue Ginger Shots.

 

Candy

 

Reed’s Craft Crystallized Ginger and Reed’s Ginger Chews restaged their product line up in 2020 and we will be working with a new distribution partner in 2021.2020. The category is small and there is not a significant number of entrants. Key competitors are Chimes and Gin Gins.

Ready to Drink:

The RTD category refers to canned cocktails that offer convenience and quality for cocktail drinkers. RTD sales held strong in 2021 with triple-digit growth. According to NielsenIQ, year-over-year off-premise dollar sales increased 126 percent for RTD cocktails for the 52-week period ending October 2, 2021. According to IRI, premixed cocktails spirits-based and malt-based seltzers accounted for just over $7 billion in off-premise sales over the 52 weeks ending November 28, 2021.

The start of Covid-19, when restaurants and bars closed in March 2020, helped propel the category with consumers bringing the on-premise cocktail occasion to their homes. This was a major boost for canned, single-serve RTDs. Without the recent quality improvements of RTD cocktails, however, it’s unlikely that the category would have taken off. Today’s RTD cocktails bring much higher quality versus earlier wine coolers and malt-based hard lemonades. Premiumization has resulted in a new wave of products that boast less sugar and more transparency.  Variety has also been a key driver, allowing consumers ways to experiment without buying costly ingredients or spirits.  Reed’s is poised to leverage these trends bringing high-quality, crafted Mules made with real fresh ginger to the market.

Top selling brands in the category are High Noon, Cutwater Spirits, On The Rocks, Jose Cuervo, Skinnygirl, 1800 Tequila, Buzzballz, Bacardi, The Long Drink Company, and Fisher’s Island.  In the Mule segment, the key players include ‘Merican Mule, Cutwater Mule, and Copper Can.

 

Raw Materials

 

Substantially all of the raw materials used in the preparation, bottling and packaging of our products are purchased by Reed’s or by our contract packers in accordance with our specifications.

 

Generally, the raw materials used in our products are obtained from domestic and foreign suppliers and many of the materials have multiple reliable suppliers. This provides a level of protection against a major supply constriction or adverse cost or supply impacts. Since our raw materials are common ingredients and supply is easily accessible, we have few long-term contracts in place with our suppliers.

 

Glass Bottles and Aluminum Cans

 

A significant component of our product cost is the purchase of glass bottles and aluminum cans. In December 2017, we entered into an exclusive strategic partnership with Owens-Illinois (glass), and in February 2018 we entered into a strategic partnership with Crown Cork & Seal for aluminum cans. BothDuring 2021 we entered into an agreement with a packaging broker to supply us with 25 million sleek 12-ounce cans during 2022. These suppliers provide expertise in emerging package and material innovation that can be leveraged to further expand marketing and package offerings.

 

Working Capital Practices

 

Historically, we have financed our operations through public and private sales of common stock, issuance of preferred and common stock, convertible debt instruments, term loans and credit lines from financial institutions, and cash generated from operations. We have taken decisive action to improve our margins, including fully outsourcing our manufacturing process, streamlining our product portfolio, negotiating improved vendor contracts and restructuring our selling prices.

 

7

Licensing

 

During 2020 we entered into a licensing agreement with Full Sail Brewery headquartered in Hood River, Oregon to manufacture and sell our new line of Reed’s Alcoholic MoscowClassic Mule in 4 pack,and 12 pack 12-ounce cans, and 16 ounce12 pack 16-ounce cans. Full Sail manages all aspects of production and distribution.

11

We subsequently amended that agreement to assume the distribution rights from Full Sail and instead utilize Full Sail as a co-packer of our RTD Classic Mule line. We now fully control the sales and marketing process, and this change in distribution ownership enables us to recognize gross revenue as opposed to a royalty fee going forward.

 

Seasonality

 

Sales of our nonalcoholic beverages are somewhat seasonal with a higher than average volume in the warmer months. The volume of sales in the beverage business may be affected by weather conditions.

 

Proprietary Rights

 

We own copyrights, trademarks and trade secrets relating to our products and the processes for their production; the packages used for our products; and the design and operation of various processes and equipment used in our business. Some of our proprietary rights are licensed to our co-packers and suppliers and other parties. Reed’s ginger processing and brewing process finished beverage products and concentrate formulas are among its most valuable trade secrets.

 

We own trademarks in the United States that we consider material to our business. Trademarks in the United States are valid as long as they are in use and/or their registrations are properly maintained. Pursuant to our manufacturing and bottling agreements, we authorize our bottlers to use applicable Reed’s trademarks in connection with their manufacture, sale and distribution of our products. We have registered and intend to obtain additional trademarks in international markets as may become necessary.

 

We use confidentiality and non-disclosure agreements with employees, manufacturers and distributors to protect our proprietary rights. Mr. Reed is also subject to an intellectual property agreement with Reed’s restricting competition consistent with his fiduciary obligations to Reed’s.

 

Regulation

 

GeneralOur Company is required to comply, and it is our policy to comply, with all applicable laws in all jurisdictions in which we do business.

The production, distribution and sale in the United States of many of our products are subject to the Federal Food, Drug, and Cosmetic Act, the Federal Trade Commission Act, the Lanham Act, state consumer protection laws, competition laws, federal, state and local workplace health and safety laws, various federal, state and local environmental protection laws, and various other federal, state and local statutes and regulations applicable to the production, transportation, sale, safety, advertising, labeling and ingredients of such products. Outside the United States, the distribution and sale of our many products and related operations are also subject to numerous similar and other statutes and regulations.

 

AThe Safe Drinking Water and Toxic Enforcement Act of 1986 (“Proposition 65”) of the state of California law known as Proposition 65 requires a specific warning to appear on any product containing a component listed by the state as having been found to cause cancer or birth defects. The state maintains lists of these substances and periodically adds other substances to these lists. Proposition 65 exposes all food and beverage producers to the possibility of having to provide warnings on their products in California because it does not provide for any generally applicable quantitative threshold below which the presence of a listed substance is exempt from the warning requirement. Consequently, the detection of even a trace amount of a listed substance can subject an affected product to the requirement of a warning label. However, Proposition 65 does not require a warning if the manufacturer of a product can demonstrate that the use of that product exposes consumers to a daily quantity of a listed substance that is:

 

 below a “safe harbor” threshold that may be established;
 naturally occurring;
 the result of necessary cooking; or
 subject to another applicable exemption.

8

 

No Company beverages produced for sale in California are currently required to display warnings under this law. We are unable to predict whether a component found in a Company product might be added to the California list in the future, although the state has initiated a regulatory process in which caffeine and other natural occurring substances will be evaluated for listing. Furthermore, we are also unable to predict when or whether the increasing sensitivity of detection methodology may become applicable under this law and related regulations as they currently exist, or as they may be amended, might result in the detection of an infinitesimal quantity of a listed substance in a beverage of ours produced for sale in California.

12

 

Bottlers of our beverage products presently offer and use non-refillable, recyclable containers in the United States. Some of these bottlers also offer and use refillable containers, which are also recyclable. Legal requirements apply in various jurisdictions in the United States and overseas requiring deposits or certain taxes or fees be charged for the sale, marketing and use of certain non-refillable beverage containers. The precise requirements imposed by these measures vary. Other types of beverage container-related deposit, recycling, tax and/or product stewardship statutes and regulations also apply in various jurisdictions in the United States and overseas. We anticipate additional, similar legal requirements may be proposed or enacted in the future at local, state and federal levels, both in the United States and elsewhere.

Legislation has been proposed in Congress and by certain state and local governments which would prohibit the sale of soft drink products in non-refillable bottles and cans or require a mandatory deposit as a means of encouraging the return of such containers, each in an attempt to reduce solid waste and litter. Similarly, we are aware of proposed legislation that would impose fees or taxes on various types of containers that are used in our business. We are not currently impacted by the policies in these types of proposed legislation, but it is possible that similar or more restrictive legal requirements may be proposed or enacted within our distribution territories in the future.

 

All of our facilities and other operations in the United StatesOur co-packers are subject to various environmental protection statutes and regulations, including those relating to the use of water resources and the discharge of wastewater. Our policy is to comply with all such legal requirements. Compliance with these provisions has not had, and we do not expect such compliance to have, any material adverse effect on our capital expenditures, net income or competitive position.

Environmental MattersWe are also subject to various federal, state and international laws and regulations related to privacy and data protection, including the California Consumer Privacy Act of 2018 (“CCPA”), which became effective on January 1, 2020, and its extension, the California Privacy Rights Act (“CPRA”), which will take effect on January 1, 2023. The interpretation and application of data privacy, cross-border data transfers and data protection laws and regulations are often uncertain and are evolving in the United States and internationally. We monitor pending and proposed legislation and regulatory initiatives to ascertain their relevance to and potential impact on our business and develop strategies to address regulatory trends and developments, including any required changes to our privacy and data protection compliance programs and policies.

 

Our primary cost pertaining to environmental compliance activity is in recycling fees and redemption values. We are required to collect redemption values from our customers and remit those redemption values to the state, based upon the number of bottles or cans of certain products sold in the state.

 

Human Capital ResourcesEmployees

 

As of December 31, 2020,2021, we have 34had 31 full-time equivalent employees on our corporate staff. We employ additional people on a part-time basis as needed. We have never participated in a collective bargaining agreement. We believe relations with our employees are good.

Available Information

 

The Company maintains a website at the following address: www.reedsinc.com. The information on the Company’s website is not incorporated by reference in this report. We are subjectmake available on or through our website certain reports and amendments to the reporting requirements of the Exchange Act and, accordingly,those reports that we file annual reports, quarterly reports and other information with or furnish to the Securities and Exchange Commission or SEC. Access to copies(“SEC”) in accordance with the Securities Exchange Act of 1934, as amended (“Exchange Act”). These include our Annual Reports on Form 10-K, our Quarterly Reports on Form 10-Q and our Current Reports on Form 8-K8-K. We make this information available on our website free of charge as soon as reasonably practicable after we electronically file the information with, or furnish it to, the SEC. In addition, we routinely post on the “Investors” page of our website news releases, announcements and other filingsstatements about our business and results of operations, some of which may contain information that may be deemed material to investors. Therefore, we encourage investors to monitor the “Investors” page of our website and review the information we post on that page. The SEC maintains a website that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC including amendments to such filings, may be obtained free of charge from our website,at the following address: http://www.reedsinc.com. These filings are available promptly after we file them with, or furnish them to, the SEC. We are not incorporating our website or any information from the website into this annual report. The SEC also maintains a website, http://www.sec.gov, that contains our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Report on Form 8-K and other filings with the SEC. Access to these filings is free of charge.www.sec.gov.

 

Item 1A. Risk Factors

 

The following are some of the risks and uncertainties that could cause our actual results to differ materially from those presented in our forward-looking statements. The risks and uncertainties described below are not the only ones we face but do represent those risks and uncertainties that we believe are material to us. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also harm our business. All forward-looking statements in this document are based on information available to us as of the date hereof, and we assume no obligations to update any such forward-looking statements.

 

9

Summary of Material Risk Factors

 

● We have a history of operating losses. If we continue to suffer losses from operations,Our estimates regarding the sufficiency of our working cash resource and capital may be insufficient to supportrequirements and needs for additional financing raises substantial doubt about our ability to expand our business operationscontinue as rapidly as we would deem necessary at any time, unless we are able to obtain additional financing.a going concern.

13

 

● We may needrequire additional financing in the future,to support our working capital and execute our operating plans for fiscal 2022, which may not be available when needed or may be costly and dilutive.

 

Our secured credit facility with Rosenthal and Rosenthal, Inc. contains financial covenants that, if breached,The impact of the COVID-19 pandemic could trigger default.

● The recent global coronavirus outbreak couldcontinue to harm our business and results of operations.

 

● Disruption within our supply chain, contract manufacturing or distribution channels could have an adverse effect on our business, financial condition and results of operations.

 

● Increased market spending may not drive volume growth.

 

● Increases in costs of packaging, ingredients, fuel, and contract manufacturing tolling fees may have an adverse impact on our gross margin.

 

● If we do not adequately manage our inventory levels, our operating results could be adversely affected.

 

● It is difficult to predict the timing and amount of our sales because our distributors are not required to place minimum orders with us.

Risk Factors Related to our recently received Paycheck Protection Program Loan

We may not be entitled to forgiveness of our recently received Paycheck Protection Program Loan, and our application for the Paycheck Protection Program Loan could in the future be determined to have been impermissible.

On April 20, 2020, we were granted a Paycheck Protection Program loan (the “PPP Loan”) under the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) administered by the U.S. Small Business Administration (the “SBA”) in the aggregate amount of $770,000 pursuant to the Paycheck Protection Program (the “PPP”) under the CARES Act. The PPP Loan agreement is dated April 20, 2020, matures on April 20, 2022, bears interest at a rate of 1% per annum, with the first six months of interest deferred, is payable monthly commencing on November 2020, and is unsecured and guaranteed by the U.S. Small Business Administration. The loan term may be extended to April 20, 2025, if mutually agreed to by the Company and lender. The PPP Loan may be prepaid at any time prior to maturity with no prepayment penalties. Under the CARES Act, as amended in June 2020, loan forgiveness is generally available for the sum of documented payroll costs, covered rent payments, covered mortgage interest and covered utilities during the “Covered Period”, which is 8 weeks or 24 weeks (at the election of the Company) beginning on the date of the first disbursement of the PPP Loan. We will be required to repay any portion of the outstanding principal that is not forgiven, along with accrued interest, and we cannot provide any assurance that we will be eligible for loan forgiveness, that we will apply for forgiveness, or that any amount of the PPP Loan will ultimately be forgiven by the SBA. In order to apply for the PPP Loan, we were required to certify, among other things, that the current economic uncertainty made the PPP Loan request necessary to support our ongoing operations. We made this certification in good faith after analyzing, among other things, the maintenance of our workforce, our need for additional funding to continue operations, and our ability to access alternative forms of capital in the current market environment to offset the effects of the COVID-19 pandemic. Following this analysis, we believe that we satisfied all eligibility criteria for the PPP Loan, and that our receipt of the PPP Loan is consistent with the broad objectives of the CARES Act. The certification described above is subject to interpretation. On April 23, 2020,delisting if we do not meet the SBA issued guidance stating that it is unlikely that a public company with substantial market value and access to capital markets will be able to make the required certification in good faith. The lack of clarity regarding loan eligibility under the Paycheck Protection Program has resulted in significant media coverage and controversy with respect to public companies applying for and receiving loans. If, despite our good-faith belief that given our circumstances we satisfied all eligible requirements for the PPP Loan, we are later determined to have not been in compliance with these requirements or it is otherwise determined that we were ineligible to receive the PPP Loan, we may be required to repay the PPP Loan in its entirety and/or be subject to additional penalties. Should we be audited or reviewedNasdaq bid price rule by federal or state regulatory authorities as a result of filing an application for forgiveness of the PPP Loan or otherwise, such audit or review could result in the diversion of management’s time and attention and the incurrence of additional costs. Any of these events could have a material adverse effect on our business, results of operations and financial condition.August 15, 2022.

14

Risk Factors Relating to Our Business

The COVID-19 pandemic and related ongoing impacts may have a material adverse effect on our results of operations and financial condition.

During the year ended December 31, 2021, the COVID-19 pandemic has impacted our operating results and the Company anticipates a continued impact for the balance of the year. In addition, the pandemic may cause reduced demand for our products if, for example, the pandemic results in a recessionary economic environment which negatively effects the consumers who purchase our products. Based on the recent increase in demand for our products, we believe that over the long term, there will continue to be strong demand for our products.

Through December 31, 2021, the Company has experienced higher transportation expenses as the capacity in the freight market has not kept up with demand. The Company believes that costs will continue to increase throughout the year. In addition, the Company experienced increases in the pricing of several of its raw materials and delays in procuring several of these items. However, mitigation plans are being implemented to manage this risk. Additionally, the Company was negatively impacted by supply chain challenges impacting our ability to benefit from strong demand for and increased sales of our product. The disruption caused by labor shortages, significant raw material cost inflation, logistics issues and increased freight costs, and ongoing port congestion, resulted in suppressed margins and net income. The Company anticipates a continued impact throughout 2022.

Our ability to operate without significant incremental negative operational impact from the COVID-19 pandemic will in part depend on our ability to protect our employees and our supply chain. The Company has endeavored to follow the recommended actions of government and health authorities to protect our employees. Since the inception of the COVID-19 pandemic and through December 31, 2021, we maintained the consistency of our operations during the onset of the COVID-19 pandemic. We will continue to innovate in managing our business, coordinating with our employees and suppliers to do our part in the infection prevention and remain flexible in responding to our customers and suppliers. However, the uncertainty resulting from the pandemic could result in an unforeseen disruption to our workforce and supply chain (for example an inability of a key supplier or transportation supplier to source and transport materials) that could negatively impact our operations.

In addition, the COVID-19 pandemic may exacerbate other risks related to our business, including risks related to changes in the retail landscape, fluctuations in input costs, inflation rates, and foreign currency exchange rates; and the ability of third-party service providers and business partners to fulfill their respective commitments and responsibilities to us in a timely manner and in accordance with the agreed-upon terms. The continuing evolution of the pandemic may also present risks not currently known to us.

There is Substantial doubt about our ability to continue as a going concern.

Our financial statements as of December 31, 2021 were prepared under the assumption that we will continue as a going concern for the next twelve months from the date of issuance of these financial statements. In addition the Company’s independent registered public accounting firm, in their report on the Company’s December 31, 2021, audited financial statements, raised substantial doubt about the Company’s ability to continue as a going concern. Our ability to continue as a going concern is dependent upon our ability to obtain additional financing, drive further operating efficiencies, reduce expenditures and ultimately, create profitable operations. We may not be able to obtain additional capital on reasonable terms. Our financial statements do not include adjustments that would result from the outcome of this uncertainty.

We have significant obligations under payables and debt obligations. Our ability to operate as a going concern are contingent upon successfully obtaining additional financing. Failure to do so would adversely affect our ability to continue operations.

If capital is not available, we may then need to scale back or freeze our organic growth plans, sell our business under unfavorable terms, abd reduce expenses to manage our liquidity and capital resources. We may not be able extend or repay our current obligations, which could impact our ability to continue to operate as a going concern.

 

We have a history of operating losses.losses, which raises substantial doubt about our ability to continue as a going concern.

The accompanying financial statements have been prepared under the assumption that the Company will continue as a going concern for the next 12 months. Such assumption contemplates the realization of assets and satisfaction of liabilities in the normal course of business. For the year ended December 31, 2020,2021, the Company recorded a net loss of $10,177$16,402 and used cash in operations of $9,496.$17,589. As of December 31, 2020,2021, we had a cash balance of $595$49 with borrowing capacity of $5,166,$109, stockholders’ equity of $10,404$4,203 and a working capital of $9,528, compared$2,981. These conditions raise substantial doubt about the Company’s ability to continue as a cash balancegoing concern. The financial statements do not include any adjustments that might result from the outcome of $913, stockholder’s equity of $1,147 and working capital of $4,885 at December 31, 2019.this uncertainty.

 

During the yearsyear ended December 31, 2020 and 2019,2021 the Company experienced significant financing shortages and engaged in two separate transactionsone transaction to raise capital in 2020. Recently, the Company received2021 receiving net proceeds of $5,310$7,327 from an underwritten offering of common stockstock.

On March 11, 2022, the Company raised gross proceeds, before deducting placement agent fees and other offering expenses, are approximately $5.4 million, in April 2020, and $11,254 from an underwritten offeringa private placement of common stock in November 2020.and warrants.

 

In the event that management proceeds with sale assets rather than continuing to hold and operate all its assets long term, management’s assessment of the fair value, and ultimate recoverability, of goodwill, intangibles, and other long-lived assets would be impacted and the Company could incur significant noncash charges and cash exit costs in future periods.

In the event that additional working capital is not available, we may be forced to scale back or freeze our growth plans, sell assets on less than favorable terms, reduce expenses, and/or curtail future plans to manage our liquidity and capital resources. In the event that management elects to proceed with asset sales in the future rather than continue to hold and operate all its assets long term, management’s assessment of the fair value, and ultimate recoverability, of goodwill, intangibles, and other long-lived assets would be impacted and the Company could incur significant noncash charges and cash exit costs in future periods.

We may not be able to extend or repay our indebtedness owed to our secured lenders, which would have a material adverse effect on our financial condition and ability to continue as a going concern.

If we continueare unable to suffer losses from operations, our working capital may be insufficientservice or repay these obligations at maturity and we are otherwise unable to support our ability to expand our business operations as rapidly asextend the maturity dates or refinance these obligations, we would deem necessary atbe in default. We cannot provide any time, unless we are able to obtain additional financing. There can be no assuranceassurances that we will be able to obtain such financingraise the necessary amount of capital to service these obligations. Upon a default, our secured lenders would have the right to exercise their rights and remedies to collect, which would include foreclosing on acceptable terms, or at all. If adequate funds our assets. Accordingly, a default would have a material adverse effect on our business, and we would likely be forced to seek bankruptcy protection.

10

We are not available orin compliance with Nasdaq Listing Rule 5550(a)(2), the bid price rule. If we are not available on acceptable terms, we may notunable to cure the failure within the prescribed time period, our common stock will be ablesubject to pursue our business objectives anddelisting. A delisting would be required tomaterially reduce our level of operations, including reducing infrastructure, promotions, sales and marketing programs, personnel and other operating expenses. These events could adversely affect our business, results of operations and financial condition. If adequate funds are not available or if they are not available on acceptable terms, our ability to fund the growthliquidity of our operations, take advantagecommon stock and have an adverse effect on our market price.

On August 16, 2021, the Nasdaq Listing Qualifications Department notified us that, based on the previous 30 consecutive business days, the Company’s common stock no longer met the minimum $1 bid price per share requirement. Therefore, in accordance with the Nasdaq Listing Rules (the “Rules”), the Company was provided 180 calendar days, or until February 14, 2022, to regain compliance. The common stock did not regain compliance with the minimum $1 bid price per share requirement during this initial compliance period. However, the Nasdaq Listing Qualifications Department determined that the Company is eligible for an additional 180 calendar day period, or until August 15, 2022, to regain compliance. Their determination is based on the Company meeting the continued listing requirement for market value of opportunities, develop products or services or otherwise respondpublicly held shares and all other applicable requirements for initial listing on the Capital Market with the exception of the bid price requirement, and the Company’s written notice of its intention to competitive pressures, couldcure the deficiency during the second compliance period by effecting a reverse stock split, if necessary. If at any time during this additional time period the closing bid price of the Company’s security is at least $1 per share for a minimum of 10 consecutive business days, we will provide written confirmation of compliance and this matter will be significantly limited.closed. If we choose to implement a reverse stock split, it must complete the split no later than ten business days prior to the expiration date in order to timely regain compliance. Our board and stockholders authorized an up to one for five reverse split of our common stock to be implemented at the board’s discretion. There can be no assurance a one for five reverse split would cause our common stock to meet the bid price requirement.

 

A delisting would materially reduce the liquidity of our common stock and have an adverse effect on our market price. A delisting would also likely make it more difficult for us to obtain financing through the sale of our equity. Any such sale of equity would likely be more dilutive to our current stockholders than would be the case if our shares were listed.

We may needrequire additional financing in the future,to support our working capital and execute our operating plans for 2022, which may not be available when needed or may be costly and dilutive.

 

We may require additional financing to support our working capital needs inand fund our operating plans for fiscal 2022. To alleviate these conditions, management is currently evaluating various funding alternatives and may seek to raise additional funds through the future. The amountissuance of equity, mezzanine or debt securities, through arrangements with strategic partners or through obtaining credit from financial institutions. As we seek additional capital we may require, the timing of our capital needs and the availabilitysources of financing, to fund those needs will depend on a number of factors, including our strategic initiatives and operating plans, the performance of our business and the market conditions for debt or equity financing. Additionally, the amount of capital required will depend on our ability to meet our case sales goals and otherwise successfully execute our operating plan. We believe it is imperative to meet these sales objectives in order to lessen our reliance on externalthere can be no assurance that such financing in the future. Although we believe various debt and equity financing alternatives willwould be available to us on favorable terms or at all. Our ability to supportobtain additional financing in the debt and equity capital markets is subject to several factors, including market and economic conditions, our working capital needs, financing arrangements on acceptable terms may not be available to us when needed. performance and investor.

Additionally, these alternatives may require significant cash payments for interest and other costs or could be highly dilutive to our existing shareholders. Any such financing alternatives may not provide us with sufficient funds to meet our long-term capital requirements. If necessary, we may explore strategic transactions that we consider to be in the best interest of the Company and our shareholders, which may include, without limitation, public or private offerings of debt or equity securities, and other strategic alternatives; however, these options may not ultimately be available or feasible.

15

 

Our indebtedness and liquidity needs could restrict our operations and make us more vulnerable to adverse economic conditions.

 

Our existing indebtedness may adversely affect our operations and limit our growth, and we may have difficulty making debt service payments on such indebtedness as payments become due. We may also experience the occurrence of events of default or breach of financial covenants. If market or other economic conditions deteriorate, our ability to comply with these covenants may be impaired. If we violate any of the restrictions or covenants, a significant portion of our indebtedness may become immediately due and payable, our lenders’ commitment to make further loans to us may terminate. We might not have, or be able to obtain, sufficient funds to make these accelerated payments.

Our secured credit facility with Rosenthal and Rosenthal, Inc. contains financial covenants that, if breached, could trigger default.

Pursuant to our Financing Agreement with Rosenthal & Rosenthal, Inc. (“Rosenthal”) dated October 4, 2018 for our secured credit facility, we are required to maintain at the end of each of our fiscal quarters, tangible net worth in an amount not less than negative $1,500,000 and working capital of not less than negative $2,500,000. We met these requirements for the fiscal year ended December 31, 2020, and 2019. Any breach that is not waived by Rosenthal could trigger default.

The recent global coronavirus outbreak could harm our business and results of operations.

In March 2020 the World Health Organization declared coronavirus COVID-19 a global pandemic. This contagious disease outbreak, which has continued to spread, and any related adverse public health developments, has adversely affected workforces, customers, economies, and financial markets globally, potentially leading to an economic downturn. It has also disrupted the normal operations of many businesses, including ours. This outbreak could decrease spending, adversely affect demand for our product and harm our business and results of operations. It is not possible for us to predict the duration or magnitude of the adverse results of the outbreak and its effects on our business or results of operations at this time.

  

The COVID-19 pandemic and mitigation measures has had an adverse impact on global economic conditions, including disruption of stock markets and may impact on our ability to obtain financing on terms acceptable to us, if at all.

 

In February and March 2020, the financial markets significantly declined as the reality of the COVID-19 pandemic came into focus. The extent to which the COVID-19 pandemic continues to impact our results will depend on future developments that are highly uncertain and cannot be predicted at this time, including new information that may emerge concerning the severity of the virus and its variants and the actions to contain its impact. Disruption of stock markets had an impact on the cost of capital in 2020 and may, in the future, impact on our ability to obtain financing on terms acceptable to us, if at all.

11

Disruption within our supply chain, contract manufacturing or distribution channels could have an adverse effect on our business, financial condition and results of operations.

Our ability,The prices of ingredients, other raw materials, packaging materials, aluminum cans and other containers fluctuate depending on market conditions, governmental actions, climate change and other factors beyond our control, including the COVID-19 pandemic. Substantial increases in the prices of our or ingredients, other raw materials, packaging materials, aluminum cans and other containers, to the extent they cannot be recouped through increases in the prices of finished beverage products, could increase our suppliers, business partners, contract manufacturers, independent distributors and retailers, to produce, transport, distributeour bottling partners’ operating costs and sellreduce our profitability. Increases in the prices of our finished products is critical toresulting from a higher cost of ingredients, other raw materials, packaging materials, aluminum cans and other containers could affect affordability in some markets and reduce our success.

Damage or disruption to our suppliers or to manufacturing or distribution capabilities due to weather, natural disaster, fire or explosion, terrorism, pandemicsbottling partners’ sales. In addition, some of our ingredients as well as some packaging containers, such as COVD-19aluminum cans, are available from a limited number of suppliers. We and influenza,our bottling partners may not be able to maintain favorable arrangements and relationships with these suppliers, and our contingency plans may not be effective in preventing disruptions that may arise from shortages of any ingredients that are available from a limited number of suppliers. Adverse weather conditions may affect the supply of other agricultural commodities from which key ingredients for our products are derived. An increase in the cost, a sustained interruption in the supply, or a shortage of some of these ingredients, other raw materials, packaging materials, aluminum cans and other containers that may be caused by changes in or the enactment of new laws and regulations; a deterioration of our or our bottling partners’ relationships with suppliers; supplier quality and reliability issues; trade disruptions; changes in supply chain; and increases in tariffs; or events such as natural disasters, widespread outbreaks of infectious diseases (such as the COVID-19 pandemic), power outages, labor strikes, political uncertainties or other reasons,governmental instability, or the like could impair the manufacture, distributionnegatively impact our net operating revenues and sale of our products. Many of these events are outside of our control. Failure to take adequate steps to protect against or mitigate the likelihood or potential impact of such events, or to effectively manage such events if they occur, could adversely affect our business, financial condition and results of operations.profits.

16

 

Our reliance on distributors, retailers and brokers could affect our ability to efficiently and profitably distribute and market our products, maintain our existing markets and expand our business into other geographic markets.

 

Our ability to maintain and expand our existing markets for our products, and to establish markets in new geographic distribution areas, is dependent on our ability to establish and maintain successful relationships with reliable distributors, retailers and brokers strategically positioned to serve those areas. Most of our distributors, retailers and brokers sell and distribute competing products and our products may represent a small portion of their businesses. The success of this network will depend on the performance of the distributors, retailers and brokers of this network. There is a risk that the mentioned entities may not adequately perform their functions within the network by, without limitation, failing to distribute to sufficient retailers or positioning our products in localities that may not be receptive to our product. Our ability to incentivize and motivate distributors to manage and sell our products is affected by competition from other beverage companies who have greater resources than we do. To the extent that our distributors, retailers and brokers are distracted from selling our products or do not employ sufficient efforts in managing and selling our products, including re-stocking the retail shelves with our products, our sales and results of operations could be adversely affected. Furthermore, such third-parties’ financial position or market share may deteriorate, which could adversely affect our distribution, marketing and sales activities.

 

Our ability to maintain and expand our distribution network and attract additional distributors, retailers and brokers will depend on a number of factors, some of which are outside our control. Some of these factors include:

 

 the level of demand for our brands and products in a particular distribution area;
   
 our ability to price our products at levels competitive with those of competing products; and
   
 our ability to deliver products in the quantity and at the time ordered by distributors, retailers and brokers.

 

We may not be able to successfully manage all or any of these factors in any of our current or prospective geographic areas of distribution. Our inability to achieve success with regards to any of these factors in a geographic distribution area will have a material adverse effect on our relationships in that particular geographic area, thus limiting our ability to maintain or expand our market, which will likely adversely affect our revenues and financial results.

 

We incur significant time and expense in attracting and maintaining key distributors.

 

Our marketing and sales strategy depends in large part on the availability and performance of our independent distributors. We currently do not have, nor do we anticipate in the future that we will be able to establish, long-term contractual commitments from some of our distributors. We may not be able to maintain our current distribution relationships or establish and maintain successful relationships with distributors in new geographic distribution areas. Moreover, there is the additional possibility that we may have to incur additional expenditures to attract and maintain key distributors in one or more of our geographic distribution areas in order to profitably exploit our geographic markets.

 

If we lose any of our key distributors or national retail accounts, our financial condition and results of operations could be adversely affected.

 

We depend in large part on distributors to distribute our beverages and other products. Some of our outside distributors are not bound by written agreements with us and may discontinue their relationship with us on short notice. Some distributors handle a number of competitive products. In addition, our products are a small part of our distributors’ businesses.

 

12

We continually seek to expand distribution of our products by entering into distribution arrangements with regional bottlers or other direct store delivery distributors having established sales, marketing and distribution organizations. Many of our distributors are affiliated with and manufacture and/or distribute other soda and non-carbonated brands and other beverage products. In many cases, such products compete directly with our products.

 

The marketing efforts of our distributors are important for our success. If our brands prove to be less attractive to our existing distributors and/or if we fail to attract additional distributors, and/or our distributors do not market and promote our products above the products of our competitors, our business, financial condition and results of operations could be adversely affected.

17

 

It is difficult to predict the timing and amount of our sales because our distributors are not required to place minimum orders with us.

 

Our independent distributors and national accounts are not required to place minimum monthly or annual orders for our products. In order to reduce their inventory costs, independent distributors typically order products from us on a “just in time” basis in quantities and at such times based on the demand for the products in a particular distribution area. Accordingly, we cannot predict the timing or quantity of purchases by any of our independent distributors or whether any of our distributors will continue to purchase products from us in the same frequencies and volumes as they may have done in the past. Additionally, our larger distributors and partners may make orders that are larger than we have historically been required to fill. Shortages in inventory levels, supply of raw materials or other key supplies could negatively affect us.

 

If we do not adequately manage our inventory levels, our operating results could be adversely affected.

 

We need to maintain adequate inventory levels to be able to deliver products to distributors on a timely basis. Our inventory supply depends on our ability to correctly estimate demand for our products. Our ability to estimate demand for our products is imprecise, particularly for new products, seasonal promotions and new markets. If we materially underestimate demand for our products or are unable to maintain sufficient inventory of raw materials, we might not be able to satisfy demand on a short-term basis. If we overestimate distributor or retailer demand for our products, we may end up with too much inventory, resulting in higher storage costs, increased trade spending and the risk of inventory spoilage. If we fail to manage our inventory to meet demand, we could damage our relationships with our distributors and retailers and could delay or lose sales opportunities, which would unfavorably impact our future sales and adversely affect our operating results. In addition, if the inventory of our products held by our distributors and retailers is too high, they will not place orders for additional products, which would also unfavorably impact our sales and adversely affect our operating results.

 

Our dependence on independent contract manufacturers could make management of our manufacturing and distribution efforts inefficient or unprofitable.

 

We are expected to arrange for our contract manufacturing needs sufficiently in advance of anticipated requirements, which is customary in the contract manufacturing industry for comparably sized companies. Based on the cost structure and forecasted demand for the particular geographic area where our contract manufacturers are located, we continually evaluate which of our contract manufacturers to use. To the extent demand for our products exceeds available inventory or the production capacity of our contract manufacturing arrangements, or orders are not submitted on a timely basis, we will be unable to fulfill distributor orders on demand. Conversely, we may produce more product inventory than warranted by the actual demand for it, resulting in higher storage costs and the potential risk of inventory spoilage. Our failure to accurately predict and manage our contract manufacturing requirements and our inventory levels may impair relationships with our independent distributors and key accounts, which, in turn, would likely have a material adverse effect on our ability to maintain effective relationships with those distributors and key accounts.

 

13

Increases in costs of packaging, ingredients and contract manufacturing tolling fees may have an adverse impact on our gross margin.

 

Over the past few years, costs of organic and natural ingredients have increased due to increased demand and required the Company to obtain these ingredients from a wider population of qualified vendors. Packaging costs such as paper and aluminum cans have experienced industry wide price increases in the past and there is always the risk that the company’s co-packers increase their toll rates based on increases in their fixed and variable costs. If the Company is unable to pass on these costs, the gross margin will be significantly impacted.

 

Increased market spending may not drive volume growth

 

The Company’s marketing efforts in the past have been limited. The current increase in marketing spending may not generate an increase in sales volume resulting in a net decrease in gross revenue.

 

18

Increases in costs of energy and freight may have an adverse impact on our gross and operating margins.

An increase in the price, disruption of supply or shortage of fuel and other energy sources in markets where our bottlers operate, which may be caused by increasing demand, by events such as natural disasters, power outages and extreme weather, or by government regulations, taxes, policies or programs designed to reduce greenhouse gas emissions to address climate change, could increase our operating costs and negatively impact our profitability. An increase in the price, disruption of supply or shortage of fuel and other energy sources in any of the markets in which our independent bottling partners operate could increase the affected independent bottling partners’ operating costs and thus could indirectly negatively impact our results of operations.

 

Over the past few years, volatility in the global oil markets has resulted in high fuel prices, which many shipping companies have passed on to their customers by way of higher base pricing and increased fuel surcharges. With recent declines in fuel prices, some companies have been slow to pass on decreases in their fuel surcharges. If fuel prices increase again, we expect to experience higher shipping rates and fuel surcharges, as well as energy surcharges on our raw materials. It is hard to predict what will happen in the fuel markets in 2021. Due to the price sensitivity of our products, we may not be able to pass such increases on to our customers.

 

If we are unable to attract and retain key personnel, our efficiency and operations would be adversely affected.

 

Our success depends on our ability to attract and retain highly qualified employees in such areas as sales, marketing, product development, supply chain, finance and accounting. In general, we compete to hire new employees, and, in some cases, must train them and develop their skills and competencies. Our operating results could be adversely affected by increased costs due to increased competition for employees, higher employee turnover or increased employee benefit costs. Any unplanned turnover, particularly involving our key personnel, could negatively impact our operations, financial condition and employee morale.

 

If we fail to protect our trademarks and trade secrets, we may be unable to successfully market our products and compete effectively.

 

We rely on a combination of trademark and trade secrecy laws, confidentiality procedures and contractual provisions to protect our intellectual property rights. Failure to protect our intellectual property could harm our brand and our reputation, and adversely affect our ability to compete effectively. Further, enforcing or defending our intellectual property rights, including our trademarks, copyrights, licenses and trade secrets, could result in the expenditure of significant financial and managerial resources. We regard our intellectual property, particularly our trademarks and trade secrets, to be of considerable value and importance to our business and our success, and we actively pursue the registration of our trademarks in the United States and internationally. However, the steps taken by us to protect these proprietary rights may not be adequate and may not prevent third parties from infringing or misappropriating our trademarks, trade secrets or similar proprietary rights. In addition, other parties may seek to assert infringement claims against us, and we may have to pursue litigation against other parties to assert our rights. Any such claim or litigation could be costly. In addition, any event that would jeopardize our proprietary rights or any claims of infringement by third parties could have a material adverse effect on our ability to market or sell our brands, profitably exploit our products or recoup our associated research and development costs.

 

Litigation or legal proceedings could expose us to significant liabilities and damage our reputation.

 

We may become party to litigation claims and legal proceedings. Litigation involves significant risks, uncertainties and costs, including distraction of management attention away from our business operations. We evaluate litigation claims and legal proceedings to assess the likelihood of unfavorable outcomes and to estimate, if possible, the amount of potential losses. Based on these assessments and estimates, we establish reserves and disclose the relevant litigation claims or legal proceedings, as appropriate. These assessments and estimates are based on the information available to management at the time and involve a significant amount of management judgment. Actual outcomes or losses may differ materially from those envisioned by our current assessments and estimates. Our policies and procedures require strict compliance by our employees and agents with all U.S. and local laws and regulations applicable to our business operations, including those prohibiting improper payments to government officials. Nonetheless, our policies and procedures may not ensure full compliance by our employees and agents with all applicable legal requirements. Improper conduct by our employees or agents could damage our reputation or lead to litigation or legal proceedings that could result in civil or criminal penalties, including substantial monetary fines, as well as disgorgement of profits.

 

14

We are subject to risks inherent in sales of products in international markets.

 

Our operations outside of the United States contribute to our revenue and profitability, and we believe that developing and emerging markets present important future growth opportunities for us. However, there can be no assurance that existing or new products that we manufacture, distribute or sell will be accepted or be successful in any particular foreign market, due to local or global competition, product price, cultural differences, consumer preferences or otherwise. Here are many factors that could adversely affect demand for our products in foreign markets, including our inability to attract and maintain key distributors in these markets; volatility in the economic growth of certain of these markets; changes in economic, political or social conditions, imposition of new or increased labeling, product or production requirements, or other legal restrictions; restrictions on the import or export of our products or ingredients or substances used in our products; inflationary currency, devaluation or fluctuation; increased costs of doing business due to compliance with complex foreign and U.S. laws and regulations. If we are unable to effectively operate or manage the risks associated with operating in international markets, our business, financial condition or results of operations could be adversely affected.

19

 

Changes in accounting standards and subjective assumptions, estimates and judgments by management related to complex accounting matters could significantly affect our financial results.

 

The United States generally accepted accounting principles and related pronouncements, implementation guidelines and interpretations with regard to a wide variety of matters that are relevant to our business, such as, but not limited to, stock-based compensation, trade spend and promotions, and income taxes are highly complex and involve many subjective assumptions, estimates and judgments by our management. Changes to these rules or their interpretation or changes in underlying assumptions, estimates or judgments by our management could significantly change our reported results.

 

If we are unable to build and sustain proper information technology infrastructure, our business could suffer.

 

We depend on information technology as an enabler to improve the effectiveness of our operations and to interface with our customers, as well as to maintain financial accuracy and efficiency. If we do not allocate and effectively manage the resources necessary to build and sustain the proper technology infrastructure, we could be subject to transaction errors, processing inefficiencies, the loss of customers, business disruptions, or the loss of or damage to intellectual property through security breaches.

 

We could be subject to cybersecurity attacks.

 

Cybersecurity attacks are evolving and include malicious software, attempts to gain unauthorized access to data, and other electronic security breaches that could lead to disruptions in business processes, unauthorized release of confidential or otherwise protected information and corruption of data. Such unauthorized access could subject us to operational interruption, damage to our brand image and private data exposure, and harm our business.

 

20

Risks Factors Relating to Our Industry

 

The current aluminum shortage can harm our ability to meet consumer demand.

 

As a craft beverage company, we do not meet volume requirements to have a contract in place with our aluminum can supplier. Craft beverage companies such as us are facing an aluminum can shortage. We anticipate we will continue to see supply issues with all sizes of aluminum cans. This aluminum can shortage cancould harm our ability to timely produce enough product to meet consumer demand.

 

15

We may experience a reduced demand for some of our products due to health concerns (including obesity) and legislative initiatives against sweetened beverages.

 

Consumers are concerned about health and wellness; public health officials and government officials are increasingly vocal about obesity and its consequences. There has been a trend among some public health advocates and dietary guidelines to recommend a reduction in sweetened beverages, as well as increased public scrutiny, potential new taxes on sugar-sweetened beverages, and additional governmental regulations concerning the marketing and labeling/packing of the beverage industry. Additional or revised regulatory requirements, whether labeling, tax or otherwise, could have a material adverse effect on our financial condition and results of operations. Further, increasing public concern with respect to sweetened beverages could reduce demand for our beverages and increase desire for more low-calorie soft drinks, water, enhanced water, coffee-flavored beverages, tea, and beverages with natural sweeteners. We are continuously working to launch new products that round out our diversified portfolio.

 

Legislative or regulatory changes that affect our products could reduce demand for products or increase our costs.

 

Taxes imposed on the sale of certain of our products by federal, state and local governments in the United States, Canada or other countries in which we operate could cause consumers to shift away from purchasing our beverages. Several municipalities in the United States have implemented or are considering implementing taxes on the sale of certain “sugared” beverages, including non-diet soft drinks, fruit drinks, teas and flavored waters to help fund various initiatives. These taxes could materially affect our business and financial results.

 

Additional taxes levied on us could harm our financial results.

 

Recent legislative proposals to reform U.S. taxation of non-U.S. earnings could have a material adverse effect on our financial results by subjecting a significant portion of our non-U.S. earnings to incremental U.S. taxation and/or by delaying or permanently deferring certain deductions otherwise allowed in calculating our U.S. tax liabilities.

 

We compete in an industry that is brand-conscious, so brand name recognition and acceptance of our products are critical to our success.

 

Our business is substantially dependent upon awareness and market acceptance of our products and brands by our targeted consumers. In addition, our business depends on acceptance by our independent distributors of our brands as beverage brands that have the potential to provide incremental sales growth rather than reduce distributors’ existing beverage sales. Although we believe that we have been relatively successful towards establishing our brands as recognizable brands in the all-naturalnatural “better for you” beverage industry, it may be too early in the product life cycle of these brands to determine whether our products and brands will achieve and maintain satisfactory levels of acceptance by independent distributors, retail customers and consumers. We believe that the success of our brands will also be substantially dependent upon acceptance of our product name brands. Accordingly, any failure of our brands to maintain or increase acceptance or market penetration would likely have a material adverse effect on our revenues and financial results.

 

Competition from traditional non-alcoholic beverage manufacturers may adversely affect our distribution relationships and may hinder development of our existing markets, as well as prevent us from expanding our markets.

 

We target a niche in the estimated $32$25 billion carbonated and non-carbonated soft drink marketsmarket in the US, Canada and international markets. Our brands are generally regarded as premium and natural, with upscale packaging and are loosely defined as the artisanal (craft), premium bottled carbonated soft drink category. The soft drink industry is highly fragmented, and the craft soft drink category consists of such competitors as IBC, Stewart’s, Zevia, Henry Weinhard’s, Hansen’s, Izze, Boylan and Jones Soda, to name a few. These brands have the advantage of being seen widely in the national market and being commonly known for years through well-funded ad campaigns. Our products have a relatively high price for an artisanal premium beverage product, minimal mass media advertising to date and a small but growing presence in the mainstream market compared to some of our larger competitors.

21

 

The beverage industry is highly competitive. We compete with other beverage companies not only for consumer acceptance but also for shelf space in retail outlets and for marketing focus by our distributors, all of which also distribute other beverage brands. Our products compete with a wide range of drinks produced by a relatively large number of manufacturers, most of which have substantially greater financial, marketing and distribution resources than ours. Some of these competitors are placing pressure on independent distributors not to carry competitive sparkling brands such as ours. We also compete with regional beverage producers and “private label” soft drink suppliers.

16

 

Increased competitor consolidations, market-place competition, particularly among branded beverage products, and competitive product and pricing pressures could impact our earnings, market share and volume growth. If, due to such pressure or other competitive threats, we are unable to sufficiently maintain or develop our distribution channels, we may be unable to achieve our current revenue and financial targets. As a means of maintaining and expanding our distribution network, we intend to introduce new, innovative products and packages. We may not be successful in doing this and other companies may be more successful in this regard over the long term. Competition, particularly from companies with greater financial and marketing resources than ours, could have a material adverse effect on our existing markets, as well as on our ability to expand the market for our products.

 

We compete in an industry characterized by rapid changes in consumer preferences and public perception, so our ability to continue developing new products to satisfy our consumers’ changing preferences will determine our long-term success.

 

Failure to introduce new products or product extensions into the marketplace as current ones mature and to meet our consumers’ changing preferences could prevent us from gaining market share and achieving long-term profitability. Product lifecycles can vary, and consumers’ preferences and loyalties change over time. Although we try to anticipate these shifts and innovate new products to introduce to our consumers, we may not succeed. Customer preferences also are affected by factors other than taste, such as health and nutrition considerations and obesity concerns, shifting consumer needs, changes in consumer lifestyles, increased consumer information and competitive product and pricing pressures. Sales of our products may be adversely affected by the negative publicity associated with these issues. If we do not adequately anticipate or adjust to respond to these and other changes in customer preferences, we may not be able to maintain and grow our brand image and our sales may be adversely affected.

 

Global economic conditions may continue to adversely impact our business and results of operations.

 

The beverage industry, and particularly those companies selling premium beverages, can be affected by macro-economic factors, including changes in national, regional, and local economic conditions, unemployment levels and consumer spending patterns, which together may impact the willingness of consumers to purchase our products as they adjust their discretionary spending. Adverse economic conditions may negatively impact the ability of our distributors to obtain the credit necessary to fund their working capital needs, which could negatively impact their ability or desire to continue to purchase products from us in the same frequencies and volumes as they have done in the past. If we experience adverse economic conditions in the future, sales of our products could be adversely affected, collectability of accounts receivable may be compromised, and we may face obsolescence issues with our inventory, any of which could have a material adverse impact on our operating results and financial condition.

 

If we encounter product recalls or other product quality issues, our business may suffer.

 

Product quality issues, real or imagined, or allegations of product contamination, even when false or unfounded, could tarnish our image and could cause consumers to choose other products. In addition, because of changing government regulations or implementation thereof, or allegations of product contamination, we may be required from time to time to recall products entirely or from specific markets. Product recalls could affect our profitability and could negatively affect brand image.

 

22

We could be exposed to product liability claims.

 

Although we have product liability and basic recall insurance, insurance coverage may not be sufficient to cover all product liability claims that may arise. To the extent our product liability coverage is insufficient, a product liability claim would likely have a material adverse effect upon our financial condition. In addition, any product liability claim brought against us may materially damage the reputation and brand image of our products and business.

 

17

Our business is subject to many regulations and noncompliance is costly.

 

The production, marketing and sale of our beverages, including contents, labels, caps and containers, are subject to the rules and regulations of various federal, provincial, state and local health agencies. If a regulatory authority finds that a current or future product or production run is not in compliance with any of these regulations, we may be fined, or production may be stopped, which would adversely affect our financial condition and results of operations. Similarly, any adverse publicity associated with any noncompliance may damage our reputation and our ability to successfully market our products. Furthermore, the rules and regulations are subject to change from time to time and while we closely monitor developments in this area, we cannot anticipate whether changes in these rules and regulations will impact our business adversely. Additional or revised regulatory requirements, whether labeling, environmental, tax or otherwise, could have a material adverse effect on our financial condition and results of operations.

 

Significant additional labeling or warning requirements may inhibit sales of affected products.

 

Various jurisdictions may seek to adopt significant additional product labeling or warning requirements relating to the chemical content or perceived adverse health consequences of certain of our products. These types of requirements, if they become applicable to one or more of our products under current or future environmental or health laws or regulations, may inhibit sales of such products. In California, a law requires that a specific warning appear on any product that contains a component listed by the state as having been found to cause cancer or birth defects. This law recognizes no generally applicable quantitative thresholds below which a warning is not required. If a component found in one of our products is added to the list, or if the increasing sensitivity of detection methodology that may become available under this law and related regulations as they currently exist, or as they may be amended, results in the detection of an infinitesimal quantity of a listed substance in one of our beverages produced for sale in California, the resulting warning requirements or adverse publicity could affect our sales.

 

We may not be able to develop successful new beverage products, which are important to our growth.

 

An important part of our strategy is to increase our sales through the development of new beverage products. We cannot provide assurance that we will be able to continue to develop, market and distribute future beverage products that will enjoy market acceptance. The failure to continue to develop new beverage products that gain market acceptance could have an adverse impact on our growth and materially adversely affect our financial condition. We may have higher obsolescent product expense if new products fail to perform as expected due to the need to write off excess inventory of the new products.

 

Our results of operations may be impacted in various ways by the introduction of new products, even if they are successful, including the following:

 

 sales of new products could adversely impact sales of existing products;
   
 we may incur higher cost of goods sold and selling, general and administrative expenses in the periods when we introduce new products due to increased costs associated with the introduction and marketing of new products, most of which are expensed as incurred; and
   
 when we introduce new platforms and package sizes, we may experience increased freight and logistics costs as our co-packers adjust their facilities for the new products.

 

23

The growth of our revenues is dependent on acceptance of our products by mainstream consumers.

 

We have dedicated significant resources to introduce our products to the mainstream consumer. As such, we have increased our sales force and executed agreements with distributors who, in turn, distribute to mainstream consumers at grocery stores and other retailers. If our products are not accepted by the mainstream consumer, our business could suffer.

 

18

Our failure to accurately estimate demand for our products could adversely affect our business and financial results.

 

We may not correctly estimate demand for our products. Our ability to estimate demand for our products is imprecise, particularly with new products, and may be less precise during periods of rapid growth, particularly in new markets. If we materially underestimate demand for our products or are unable to secure sufficient ingredients or raw materials including, but not limited to, glass, cans, cartons, labels, flavors or packing arrangements, we might not be able to satisfy demand on a short-term basis. Furthermore, industry-wide shortages of certain juice concentrates and sweeteners have been and could, from time to time in the future, be experienced, which could interfere with and/or delay production of certain of our products and could have a material adverse effect on our business and financial results. We do not use hedging agreements or alternative instruments to manage this risk.

 

The loss of our largest customers would substantially reduce revenues.

 

Our customers are material to our success. If we are unable to maintain good relationships with our existing customers, our business could suffer.

 

During the year ended December 31, 2020,2021, the Company had two broker/distributors that accounted for approximately 25%19% and 12%11% of its sales, respectively; and during the year ended December 31, 2019,2020, the Company had two broker/distributors that accounted for 12%25% and 11%12% of its sales, respectively. These two broker/distributors serve hundreds if not thousands of various retail chains and end customers.

 

No other customer exceeded 10% of sales for either period.

 

The loss of our largest vendors would substantially reduce revenues.

 

Our vendors are important to our success. If we are unable to maintain good relationships with our existing vendors, our business could suffer.

 

During the year ended December 31, 2021, the Company’s largest two vendors accounted for approximately 13%, and 10% of its purchases, respectively. During the year ended December 31, 2020, the Company’s largest two vendors accounted for approximately 12%, and 11% of its purchases, respectively. During the year ended December 31, 2019, the Company’s largest three vendors accounted for approximately 12%, 11%, and 10% of its purchases, respectively.

 

As of December 31, 2021, no Company vendor accounted for more than 10% of the total accounts payable. As of December 31, 2020, the Company’s largest two vendors accounted for 12% and 10% of the total accounts payable, respectively. As of December 31, 2019, the Company’s largest three vendors accounted for 19%, 15% and 14% of the total accounts payable, respectively.

 

No other account was more than 10% of the balance of accounts payable in either period.

 

The loss of our third-party distributors could impair our operations and substantially reduce our financial results.

 

We depend in large part on distributors to distribute our beverages and other products. Some of our outside distributors are not bound by written agreements with the Company and may discontinue their relationship with us on short notice. Some distributors handle a number of competitive products. In addition, our products are a small part of our distributors’ businesses.

 

We continually seek to expand distribution of our products by entering into distribution arrangements with regional bottlers or other direct store delivery distributors having established sales, marketing and distribution organizations. Many of our distributors are affiliated with and manufacture and/or distribute other soda and non-carbonated brands and other beverage products. In many cases, such products compete directly with our products.

 

24

The marketing efforts of our distributors are important for our success. If our brands prove to be less attractive to our existing distributors and/or if we fail to attract additional distributors, and/or our distributors do not market and promote our products above the products of our competitors, our business, financial condition and results of operations could be adversely affected.

 

19

Price fluctuations in, and unavailability of, raw materials and packaging that we use could adversely affect us.

 

We do not enter into hedging arrangements for raw materials. Although theThe prices of raw materials that we use have not increased significantly in recent years, ouryears. Our results of operations would be adversely affected if the price of these raw materials were to rise, and we were unable to pass these costs on to our customers.

 

We depend upon an uninterrupted supply of the ingredients for our products, a significant portion of which we obtain overseas, principally from Peru, Fiji and Indonesia. Any decrease in the supply of these ingredients or increase in the prices of these ingredients as a result of any adverse weather conditions, pests, crop disease, interruptions of shipment or political considerations, among other reasons, could substantially increase our costs and adversely affect our financial performance.

 

We also depend upon an uninterrupted supply of packaging materials, such as glass, cans and paper items. We obtain bottles both domestically and internationally. Any decrease in supply of these materials or increase in the prices of the materials, as a result of decreased supply or increased demand, could substantially increase our costs and adversely affect our financial performance.

 

The loss of any of our co-packers could impair our operations and substantially reduce our financial results.

 

We rely on third parties, called co-packers in our industry, to produce our beverages.

 

During the years ended December 31, 20202021 and 2019,2020, the Company had utilized six and four, respectively, separate US based co-packers for most its production needs. Although there are other packers that could produce the Company’s beverages, a change in packers may cause a delay in the production process, which could ultimately affect operating results.

 

Our co-packing arrangements with other companies are on a short-term basis and such co-packers may discontinue their relationship with us on short notice. Our co-packing arrangements expose us to various risks, including:

 

 if any of those co-packers were to terminate our co-packing arrangement or have difficulties in producing beverages for us, our ability to produce our beverages would be adversely affected until we were able to make alternative arrangements; and
   
 our business reputation would be adversely affected if any of the co-packers were to produce inferior quality.

 

We believe that we have substantially reduced this risk by reducing our reliance upon any single co-packer. We are in discussion and negotiation with additional co-packers to ensure added capability for future production needs.

 

We compete in an industry characterized by rapid changes in consumer preferences and public perception, so our ability to continue to market our existing products and develop new products to satisfy our consumers’ changing preferences will determine our long-term success.

 

Consumers are seeking greater variety in their beverages. Our future success will depend, in part, upon our continued ability to develop and introduce different and innovative beverages. In order to retain and expand our market share, we must continue to develop and introduce different and innovative beverages and be competitive in the areas of quality and health, although there can be no assurance of our ability to do so. There is no assurance that consumers will continue to purchase our products in the future. Additionally, many of our products are considered premium products and to maintain market share during recessionary periods, we may have to reduce profit margins, which would adversely affect our results of operations. In addition, there is increasing awareness and concern for the health consequences of obesity. This may reduce demand for our non-diet beverages, which could affect our profitability. Product lifecycles for some beverage brands and/or products and/or packages may be limited to a few years before consumers’ preferences change. The beverages we currently market are in varying stages of their lifecycles and there can be no assurance that such beverages will become or remain profitable for us. The beverage industry is subject to changing consumer preferences and shifts in consumer preferences may adversely affect us if we misjudge such preferences. We may be unable to achieve volume growth through product and packaging initiatives. We also may be unable to penetrate new markets. If our revenues decline, our business, financial condition and results of operations will be materially and adversely affected.

 

2520
 

Our quarterly operating results may fluctuate because of the seasonality of our business.

 

Our highest revenues occur during the summer and fall, the third and fourth quarters of each fiscal year. These seasonality issues may cause our financial performance to fluctuate. In addition, beverage sales can be adversely affected by sustained periods of bad weather.

 

Our manufacturing process is not patented.

 

None of the manufacturing processes used in producing our products are subject to a patent or similar intellectual property protection. Our only protection against a third party using our recipes and processes is confidentiality agreements with the companies that produce our beverages and with our employees who have knowledge of such processes. If our competitors develop substantially equivalent proprietary information or otherwise obtain access to our knowledge, we will have greater difficulty in competing with them for business, and our market share could decline.

 

If we are not able to retain the full-time services of our management team, it will be more difficult for us to manage our operations and our operating performance could suffer.

 

Our business is dependent, to a large extent, upon the services of our management team. We do have a written employment agreement with two of five members of our management team. In addition, we do not maintain key person life insurance on any of our management team. Therefore, in the event of the loss or unavailability of any member of the management team to us, there can be no assurance that we would be able to locate in a timely manner or employ qualified personnel to replace him or her. The loss of the services of any member of our management team or our failure to attract and retain other key personnel over time would jeopardize our ability to execute our business plan and could have a material adverse effect on our business, results of operations and financial condition.

 

The price of our common stock may be volatile, and a shareholder’s investment in our common stock could suffer a decline in value.

 

There has been significant volatility in the volume and market price of our common stock, and this volatility may continue in the future. In addition, factors such as quarterly variations in our operating results, litigation involving us, general trends relating to the beverage industry, actions by governmental agencies, national economic and stock market considerations as well as other events and circumstances beyond our control could have a significant impact on the future market price of our common stock and the relative volatility of such market price.

 

A prolonged decline in the price of our common stock could result in a reduction in the liquidity of our common stock and a reduction in our ability to raise capital. If we are unable to raise the funds required for all of our planned operations and key initiatives, we may be forced to allocate funds from other planned uses, which may negatively impact our business and operations, including our ability to develop new products and continue our current operations.

 

Many factors that are beyond our control may significantly affect the market price of our shares. These factors include:

 

 price and volume fluctuations in the stock markets;
   
 changes in our revenues and earnings or other variations in operating results;

26
 

 any shortfall in revenue or increase in losses from levels expected by us or securities analysts;
   
 changes in regulatory policies or law;
   
 operating performance of companies comparable to us; and
   
 general economic trends and other external factors.

 

Even if an active market for our common stock is established, stockholders may have to sell their shares at prices substantially lower than the price they paid for them or might otherwise receive than if a broad public market existed.

 

21

There has been a very limited public trading market for our securities and the market for our securities may continue to be limited and be sporadic and highly volatile.

 

There is currently a limited public market for our common stock. Holders of our common stock may, therefore, have difficulty selling their shares, should they decide to do so. In addition, there can be no assurances that such markets will continue or that any shares which may be purchased, may be sold without incurring a loss. Any such market price of our shares may not necessarily bear any relationship to our book value, assets, past operating results, financial condition or any other established criteria of value, and may not be indicative of the market price for the shares in the future.

 

Future financings could adversely affect common stock ownership interest and rights in comparison with those of other security holders.

 

Our board of directors has the power to issue additional shares of common or preferred stock up to the amounts authorized in our certificate of incorporation without stockholder approval, subject to restrictive covenants contained in the Company’s contracts. If additional funds are raised through the issuance of equity or convertible debt securities, the percentage ownership of our existing stockholders will be reduced, and these newly issued securities may have rights, preferences or privileges senior to those of existing stockholders. If we issue any additional common stock or securities convertible into common stock, such issuance will reduce the proportionate ownership and voting power of each other stockholder. In addition, such stock issuances might result in a reduction of the book value of our common stock. Any increase of the number of authorized shares of common stock or preferred stock would require board and shareholder approval and subsequent amendment to our certificate of incorporation.

 

Risk Factors Related to Distribution of Alcoholic Beverages

 

Demand for our products may be adversely affected by many factors, including changes in consumer preferences and trends.

 

Consumer preferences may shift due to a variety of factors including changes in demographic and social trends, public health initiatives, product innovations, changes in vacation or leisure activity patterns and a downturn in economic conditions, which may reduce consumers’ willingness to purchase distilled spirits or cause a shift in consumer preferences away from ginger beer based cocktails toward beer, wine or non-alcoholic beverages. Our success depends in part on fulfilling available opportunities to meet consumer needs and anticipating changes in consumer preferences with successful new products and product innovations. The competitive position of our brands could also be affected adversely by any failure to achieve consistent, reliable quality in the product or in service levels to customers.

 

We face substantial competition in our industry and many factors may prevent us from competing successfully.

 

We compete based on product taste and quality, brand image, price, service and ability to innovate in response to consumer preferences. The global spirits industry is highly competitive and is dominated by several large, well-funded international companies. It is possible that our competitors may either respond to industry conditions or consumer trends more rapidly or effectively or resort to price competition to sustain market share, which could adversely affect our sales and profitability.

 

27

Adverse public opinion about alcohol could reduce demand for our products.

 

Anti-alcohol groups have, in the past, advocated successfully for more stringent labeling requirements, higher taxes and other regulations designed to discourage alcohol consumption. More restrictive regulations, negative publicity regarding alcohol consumption and/or changes in consumer perceptions of the relative healthfulness or safety of beverage alcohol could decrease sales and consumption of alcohol and thus the demand for our products. This could, in turn, significantly decrease both our revenues and our revenue growth, causing a decline in our results of operations.

 

22

Class action or other litigation relating to alcohol abuse, or the misuse of alcohol could adversely affect our business.

 

Companies in the beverage alcohol industry are, from time to time, exposed to class action or other litigation relating to alcohol advertising, product liability, alcohol abuse problems or health consequences from the misuse of alcohol. It is also possible that governments could assert that the use of alcohol has significantly increased government funded health care costs. Litigation or assertions of this type have adversely affected companies in the tobacco industry, and it is possible that we, as well as our suppliers, could be named in litigation of this type.

 

Also, lawsuits have been brought in a number of states alleging that beverage alcohol manufacturers and marketers have improperly targeted underage consumers in their advertising. Plaintiffs in these cases allege that the defendants’ advertisements, marketing and promotions violate the consumer protection or deceptive trade practices statutes in each of these states and seek repayment of the family funds expended by the underage consumers. While we have not been named in these lawsuits, we could be named in similar lawsuits in the future. Any class action or other litigation asserted against us could be expensive and time-consuming to defend against, depleting our cash and diverting our personnel resources and, if the plaintiffs in such actions were to prevail, our business could be harmed significantly.

 

Regulatory decisions and legal, regulatory and tax changes could limit our business activities, increase our operating costs and reduce our margins.

 

Our business is subject to extensive regulation in all of the countries in which we operate. This may include regulations regarding production, distribution, marketing, advertising and labeling of beverage alcohol products. We are required to comply with these regulations and to maintain various permits and licenses. We are also required to conduct business only with holders of licenses to import, warehouse, transport, distribute and sell beverage alcohol products. We cannot assure you that these and other governmental regulations applicable to our industry will not change or become more stringent. Moreover, because these laws and regulations are subject to interpretation, we may not be able to predict when and to what extent liability may arise. Additionally, due to increasing public concern over alcohol-related societal problems, including driving while intoxicated, underage drinking, alcoholism and health consequences from the abuse of alcohol, various levels of government may seek to impose additional restrictions or limits on advertising or other marketing activities promoting beverage alcohol products. Failure to comply with any of the current or future regulations and requirements relating to our industry and products could result in monetary penalties, suspension or even revocation of our licenses and permits. Costs of compliance with changes in regulations could be significant and could harm our business, as we could find it necessary to raise our prices to maintain profit margins, which could lower the demand for our products and reduce our sales and profit potential.

 

Also, the distribution of beverage alcohol products is subject to extensive taxation both in the U.S. and internationally (and, in the U.S., at both the federal and state government levels), and beverage alcohol products themselves are the subject of national import and excise duties in most countries around the world. An increase in taxation or in import or excise duties could also significantly harm our sales revenue and margins, both through the reduction of overall consumption and by encouraging consumers to switch to lower-taxed categories of beverage alcohol.

28

 

Risk Factors Related to Our Common Stock

 

If we are not able to achieve our objectives for our business, the value of an investment in our Company could be negatively affected.

 

In order to be successful, we believe that we must, among other things:

 

 increase the volume for our products
   
 continue to find savings in our cost of goods (co-packer fees, packaging and ingredients);
   
 expand the number of co-packers for our core and innovation products;
   
 continue to recruit and retain top talent;
   
 drive increased awareness through our brand pull campaigns, and trial and repeat purchase of our core brands;

23

 drive increased SKU placement on shelf, and open new outlets of retail distribution through our investment in sales resources, partnerships and trade marketing support;
   
 manage our operating expenses to sufficiently support operating activities and
   
 avoid significant increases in variable costs relating to production, marketing and distribution.

 

We may not be able to meet these objectives, which could have a material adverse effect on our results of operations. We have incurred significant operating expenses in the past and may do so again in the future and, as a result, will need to increase revenues in order to improve our results of operations. Our ability to increase sales volume will depend primarily on success in marketing initiatives with industry brokers, improving our distribution base with DSD companies, introducing new no sugar brands, and focusing on the existing core brands in the market. Our ability to successfully enter new distribution areas and obtain national accounts will, in turn, depend on various factors, many of which are beyond our control, including, but not limited to, the continued demand for our brands and products in target markets, the ability to price our products at competitive levels, the ability to establish and maintain relationships with distributors in each geographic area of distribution and the ability in the future to create, develop and successfully introduce one or more new brands, products, and product extensions.

 

Anti-takeover provisions in our charter documents and under Delaware law could make an acquisition of us more difficult, limit attempts by our stockholders to replace or remove our current management and limit the market price of our common stock.

 

Provisions in our certificate of incorporation and bylaws may have the effect of delaying or preventing a change of control or changes in our management. Our amended and restated certificate of incorporation and amended and restated bylaws include provisions that:

 

 authorize our board of directors to issue, without further action by the stockholders, shares of undesignated preferred stock;
   
 specify that special meetings of our stockholders can be called only upon the request of a majority of our board of directors or our Chief Executive Officer;
   
 establish an advance notice procedure for stockholder proposals to be brought before an annual meeting, including proposed nominations of persons for election to our board of directors; and
   
 prohibit cumulative voting in the election of directors.

 

29

These provisions may frustrate or prevent any attempts by our stockholders to replace or remove our current management by making it more difficult for stockholders to replace members of our board of directors, which is responsible for appointing the members of our management, and may discourage, delay or prevent a transaction involving a change of control of our Company that is in the best interest of our minority stockholders. Even in the absence of a takeover attempt, the existence of these provisions may adversely affect the prevailing market price of our common stock if they are viewed as discouraging future takeover attempts.

 

Furthermore, we are subject to the provisions of Section 203 of the Delaware General Corporation Law. In general, Section 203 prohibits a publicly held Delaware corporation from engaging in a “business combination” with an “interested stockholder” for a three-year period following the time that this stockholder becomes an interested stockholder, unless the business combination is approved in a prescribed manner. A “business combination” includes, among other things, a merger, asset or stock sale or other transaction resulting in a financial benefit to the interested stockholder. An “interested stockholder” is a person who, together with affiliates and associates, owns, or did own within three years prior to the determination of interested stockholder status, 15% or more of the corporation’s voting stock. Under Section 203, a business combination between a corporation and an interested stockholder is prohibited unless it satisfies one of the following conditions:

 

 before the stockholder became interested, the board of directors approved either the business combination or the transaction which resulted in the stockholder becoming an interested stockholder;

24

 upon consummation of the transaction which resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes of determining the voting stock outstanding, shares owned by persons who are directors and also officers, and employee stock plans, in some instances; or
   
 at or after the time the stockholder became interested, the business combination was approved by the board of directors of the corporation and authorized at an annual or special meeting of the stockholders by the affirmative vote of at least two-thirds of the outstanding voting stock which is not owned by the interested stockholder.

 

The existence of this provision may have an anti-takeover effect with respect to transactions the Company’s board of directors does not approve in advance. Section 203 may also discourage attempts that might result in a premium over the market price for the shares of Common Stock held by stockholders.

 

These provisions of Delaware law and the Certificate of Incorporation could have the effect of discouraging others from attempting hostile takeovers and, as a consequence, they may also inhibit temporary fluctuations in the market price of the Company’s common stock that often result from actual or rumored hostile takeover attempts. These provisions may also have the effect of preventing changes in the Company’s management. It is possible that these provisions could make it more difficult to accomplish transactions that stockholders may otherwise deem to be in their best interests.

 

Collectively, members of our board of directors and our executive officers hold approximately 8%11.2% of the Company’s outstanding common stock, beneficially own approximately 10%26.7% of our common stock and may greatly influence the outcome of all matters on which stockholders vote.

 

Collectively, members of our board of directors and our executive officers hold approximately 8%11.2% of our outstanding common stock and beneficially own approximately 10%26.7% of our common stock. Members of our board of directors and our executive officers may influence the outcome of certain matters on which stockholders vote. (Beneficial ownership is calculated pursuant to Section 13d-3 of the Securities Exchange Act of 1934, as amended, and includes shares underlying derivative securities which may be exercised or converted within 60 days.)

30

 

If securities analysts or industry analysts downgrade our shares, publish negative research or reports, or do not publish reports about our business, our share price and trading volume could decline.

 

The trading market for our common stock will be influenced by the research and reports that industry or securities analysts publish about us, our business and our industry. If one or more analysts adversely change their recommendation regarding our shares or our competitors’ stock, our share price would likely decline. If one or more analysts cease coverage of us or fail to regularly publish reports on us, we could lose visibility in the financial markets, which in turn could cause our share price or trading volume to decline. As a result, the market price for our common stock may decline.

 

We have the ability to issue additional shares of our common stock and shares of preferred stock without asking for stockholder approval, which could cause your investment to be diluted.

 

Our Articles of Incorporation authorize the Board of Directors to issue up to 120,000,000180,000,000 shares of common stock and up to 500,000 shares of preferred stock. The power of the Board of Directors to issue shares of common stock, preferred stock or warrants or options to purchase shares of common stock or preferred stock is generally not subject to stockholder approval. Accordingly, any additional issuance of our common stock, or preferred stock that may be convertible into common stock, may have the effect of diluting your investment, and the new securities may have rights, preferences and privileges senior to those of our common stock.

 

25

Substantial sales of our stock may impact the market price of our common stock.

 

Future sales of substantial amounts of our common stock, including shares that we may issue upon exercise of options and warrants, could adversely affect the market price of our common stock. Further, if we raise additional funds through the issuance of common stock or securities convertible into or exercisable for common stock, the percentage ownership of our stockholders will be reduced, and the price of our common stock may fall.

 

Our common stock is thinly traded, and investors may be unable to sell some or all of their shares at the price they would like, or at all, and sales of large blocks of shares may depress the price of our common stock.

 

Our common stock has historically been sporadically or “thinly-traded,” meaning that the number of persons interested in purchasing shares of our common stock at prevailing prices at any given time may be relatively small or nonexistent. As a consequence, there may be periods of several days or more when trading activity in shares of our common stock is minimal or non-existent, as compared to a seasoned issuer that has a large and steady volume of trading activity that will generally support continuous sales without an adverse effect on share price. This could lead to wide fluctuations in our share price. Investors may be unable to sell their common stock at or above their purchase price, which may result in substantial losses. Also, as a consequence of this lack of liquidity, the trading of relatively small quantities of shares by our stockholders may disproportionately influence the price of shares of our common stock in either direction. The price of shares of our common stock could, for example, decline precipitously in the event a large number of shares of our common shares are sold on the market without commensurate demand, as compared to a seasoned issuer that could better absorb those sales without adverse impact on its share price.

 

We do not intend to pay any cash dividends on our shares of common stock in the near future, so our shareholders will not be able to receive a return on their shares unless they sell their shares.

 

We intend to retain any future earnings to finance the development and expansion of our business. We do not anticipate paying any cash dividends on our common stock in the foreseeable future. There is no assurance that future dividends will be paid, and if dividends are paid, there is no assurance with respect to the amount of any such dividend. Unless we pay dividends, our shareholders will not be able to receive a return on their shares unless they sell such shares.

Risk Factors Related to Environmental and Social Factors

Water scarcity and poor quality could negatively impact our costs and capacity.

Water is a main ingredient in substantially all of our products, is vital to the production of the agricultural ingredients on which our business relies and is needed in our manufacturing process. It also is critical to the prosperity of the communities we serve and the ecosystems in which we operate. Water is a limited resource in many parts of the world, facing unprecedented challenges from overexploitation, increasing demand for food and other consumer and industrial products whose manufacturing processes require water, increasing pollution and emerging awareness of potential contaminants, poor management, lack of physical or financial access to water, sociopolitical tensions due to lack of public infrastructure in certain areas of the world and the effects of climate change. As the demand for water continues to increase around the world, and as water becomes scarcer and the quality of available water deteriorates, we may incur higher costs or face capacity constraints, which could adversely affect our profitability.

Increased demand for food products and decreased agricultural productivity may negatively affect our business.

As part of the manufacture of our beverage products, we and our bottling partners use a number of key ingredients that are derived from agricultural commodities; decreased agricultural productivity in certain regions of the world as a result of changing weather patterns; increased agricultural regulations; and other factors have in the past, and may in the future, limit the availability and/or increase the cost of such agricultural commodities and could impact the food security of communities around the world.

26

Climate change and legal or regulatory responses thereto may have a long-term adverse impact on our business and results of operations.

There is increasing concern that a gradual increase in global average temperatures due to increased concentration of carbon dioxide and other greenhouse gases in the atmosphere will cause significant changes in weather patterns around the globe and an increase in the frequency and severity of natural disasters. Decreased agricultural productivity in certain regions of the world as a result of changing weather patterns may limit the availability or increase the cost of key agricultural commodities, which are important sources of ingredients for our products, and could impact the food security of communities around the world. Climate change may also exacerbate water scarcity and cause a further deterioration of water quality in affected regions, which could limit water availability for our independent bottlers. Increased frequency or duration of extreme weather conditions could also impair production capabilities, disrupt our supply chain or impact demand for our products. Increasing concern over climate change also may result in additional legal or regulatory requirements designed to reduce or mitigate the effects of carbon dioxide and other greenhouse gas emissions on the environment. Increased energy or compliance costs and expenses due to increased legal or regulatory requirements may cause disruptions in, or an increase in the costs associated with, the manufacturing and distribution of our beverage products. The effects of climate change and legal or regulatory initiatives to address climate change could have a long-term adverse impact on our business and results of operations.

.

Adverse weather conditions could reduce the demand for our products.

The sales of our products are influenced to some extent by weather conditions in the markets in which we operate. Unusually cold or rainy weather during the summer months may have a temporary effect on the demand for our products and contribute to lower sales, which could have an adverse effect on our results of operations for such periods.

 

Item 1B. Unresolved Staff Comments

 

Not applicable.

 

Item 2. Property

 

The Company leases 8,620 square feet of office space in Norwalk, Connecticut, which serves as our principal executive offices. The lease commenced September 1, 2018 and continues in effect for a period of 6.55.5 years.

 

Item 3. Legal Proceedings

 

From time to time, we are a party to ordinary, routine litigation incidental to our business. Our management evaluates our exposure to these claims and proceedings individually and in the aggregate and provides for potential losses on such litigation if the amount of the loss is estimable and the loss is probable.

We are not party to any material pending legal proceedings (including environmental proceedings), other than ordinary, routine litigation incidental to the business at the current time. Although the results of such litigation matters and claims cannot be predicted with certainty, we believe that the final outcome of ordinary, routine litigation will not have a material adverse impact on our financial position, liquidity, or results of operations.

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

3127
 

 

PART II

 

Item 5. Market for Common Equity and Related Stockholder Matters and Issuer Purchases of Equity Securities

 

We voluntarily withdrew the principal listing of our common stock, par value $0.0001 per share from the NYSE American, LLC and transferred the listing to The Nasdaq Stock Market, LLC. The listing and trading of our common stock on the NYSE American, LLC ended at market close on May 9, 2019 and that trading began on the Nasdaq Capital Market at market open on May 10, 2019 under the stock symbol “REED”.

 

On December 21, 2020,2021, our shareholders approved an increase in the number of authorized shares of common stock from 100120 million to 120180 million. As of December 31, 2020,March 25, 2022, there were approximately 5,000170 holders of record of the common stock (including only non-objecting beneficial owners of record) and 86,317,096112,440,142 outstanding shares of common stock.

We currently have no expectation to pay cash dividends to holders of our common stock in the foreseeable future.

 

Unregistered Sales of Equity Securities

 

During the year ended December 31, 2020, we paid dividendsNone that have not been previously disclosed in a Current Report on Series A Preferred Stock through the issuance of 4,530 shares of common stock. These equity securities were not registered under the Securities Act.Form 8-K.

 

Equity Compensation Plans

 

Pursuant to the SEC’s Regulation S-K Compliance and Disclosure Interpretation 106.01, the information required by this Item pursuant to Item 201(d) of Regulation S-K relating to securities authorized for issuance under the Corporation’s equity compensation plans is located in Item 12 of Part III of this Annual Report and is incorporated herein by reference.

32

 

Item 6. Selected Financial Data[Reserved]

As a smaller reporting company, Reed’s is not required to provide the information required by this Item 6.

 

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our financial statements and the related notes appearing elsewhere in this Annual Report. This discussion and analysis may contain forward-looking statements based on assumptions about our future business. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of certain factors, including but not limited to those set forth under “Risk Factors” and elsewhere in this Annual Report.

 

Amounts presented in the discussion below are in thousands, except share and per share amounts.

 

Results of Operations

 

Overview

 

During the year ended December 31, 2020,2021, the Company expanded its retail footprint outside of grocery and natural channels that historically represent the majority of our products sold. The Company continued to expand growth in its 12-ounce can product line led by Ginger Ale and Ginger Beer growth, fully utilizedutilizing its expanded network of co-packers and implemented an upgraded set of quality protocols.to support this growth. In addition to our traditional sales channels, the Company is utilizing its ecommerce platform that includes their branded web sites and Amazon to offer its line of shots, ginger candy and drinks packaged in cans.

 

TwoA public equity offeringsoffering which closed during the year ended December 31, 2020,2021, provided the Company with funds for working capital and general corporate purposes. These funds enabled us to initiate the implementation of our 20202021 strategy that included driving growth while strategically reducing operating costs.

 

The Company remains focused on driving sales growth and improving margin. The sales growth focus is on channel expansion, new product introduction and improved sales execution. The margin enhancement initiative is driven by co-packer upgrades, better leveraged purchasing and improved efficiency. Underpinning these initiatives is a focus on strategically reducing operating costs.

 

3328
 

COVID-19 Considerations

 

During the year ended December 31, 2020,2021, the COVID-19 pandemic did not have a material net impact onhas impacted our operating results.results and the Company anticipates a continued impact for the balance of the year. In the future,addition, the pandemic may cause reduced demand for our products if, for example, the pandemic results in a recessionary economic environment which negatively effects the consumers who purchase our products. Based on the recent increase in demand for our products, we believe that over the long term, there will continue to be strong demand for our products.

 

Through December 31, 2021, the Company has experienced higher transportation expenses as the capacity in the freight market has not kept up with demand. The Company believes that costs will continue to increase throughout the year. In addition, the Company experienced increases in the pricing of several of its raw materials and delays in procuring several of these items. However, mitigation plans are being implemented to manage this risk. Additionally, the Company was negatively impacted by supply chain challenges impacting our ability to benefit from strong demand for and increased sales of our product. The disruption caused by labor shortages, significant raw material cost inflation, logistics issues and increased freight costs, and ongoing port congestion, resulted in suppressed margins and net income. The Company anticipates a continued impact throughout 2022.

Our ability to operate without significant incremental negative operational impact from the COVID-19 pandemic will in part depend on our ability to protect our employees and our supply chain. The Company has endeavored to follow the recommended actions of government and health authorities to protect our employees. Since the inception of the COVID-19 pandemic and through the year ended December 31, 2020,2021, we maintained the consistency of our operations during the onset of the COVID-19 pandemic. We will continue to innovate in managing our business, coordinating with our employees and suppliers to do our part in the infection prevention and remain flexible in responding to our customers and suppliers. However, the uncertainty resulting from the pandemic could result in an unforeseen disruption to our workforce and supply chain (for example an inability of a key supplier or transportation supplier to source and transport materials) that could negatively impact our operations.

 

Through December 31, 2020, the COVID-19 pandemic has not negatively impacted the Company’s liquidity position as of such date. Net sales for the year ended December 31, 20202021, were up 23%19% from the prior year period. Through December 31, 2020,2021, we continue to generate cash flows to meet our short-term liquidity needs, and we expect to maintain access to the capital markets. We have also not observed any material impairments of our assets or a significant change in the fair value of our assets due to the COVID-19 pandemic.

 

For additional information on risk factors related to the pandemic or other risks that could impact our results, please refer to “Risk Factors” in Part I, Item 1A of this Form 10-K.

 

29

Results of Operations – Year Ended December 31, 20202021

 

The following table sets forth key statistics for the years ended December 31, 20202021 and 2019,2020, in thousands:

 

  Year Ended December 31,  Pct. 
  2020  2019  Change 
Gross sales (A) $46,801  $39,300   19%
Less: Promotional and other allowances (B)  5,186   5,480   -5%
Net sales $41,615  $33,820   23%
             
Cost of goods produced (C)  28,849   25,635   13%
% of Gross sales  62%  65%    
% of Net sales  69%  76%    
Cost of goods sold – idle capacity (D)  -   309   -100%
% of Net sales  -%  1%    
Gross profit $12,766  $7,876   62%
% of Net sales  31%  23%    
             
Expenses            
Delivery and handling $6,856  $5,993   14%
% of Net sales  16%  18%    
Dollar per case ($)  2.76   2.83     
Selling and marketing  7,503   9,188   -18%
% of Net sales  18%  27%    
General and administrative  7,023   7,551   -7%
% of Net sales  17%  22%    
Total Operating expenses  21,382   22,732   -6%
             
Loss from operations $(8,616) $(14,856)  -42%
             
Interest expense and other expense $(1,561) $(1,256)  24%
             
Net loss $(10,177) $(16,112)  -37%
             
Loss per share – basic and diluted $(0.17) $(0.46)  -63%
             
Weighted average shares outstanding - basic & diluted  60,644,842   35,058,004   73%

34

  Year Ended December 31,  Pct. 
  2021  2020  Change 
Gross billing (A) $54,658  $46,801   17%
Less: Promotional and other allowances (B)  5,059   5,186   -2%
Net sales $49,599  $41,615   19%
             
Cost of goods sold  36,001   28,849   25%
% of Gross billing  66%  62%    
% of Net sales  73%  69%    
Gross profit $13,598  $12,766   7%
% of Net sales  27%  31%    
             
Expenses            
Delivery and handling $11,939  $6,856   74%
% of Net sales  24%  16%    
Dollar per case ($)  3.95   2.76     
Selling and marketing  9,665   7,503   29%
% of Net sales  19%  18%    
General and administrative  7,965   7,023   13%
% of Net sales  16%  17%    
Total Operating expenses  29,569   21,382   38%
             
Loss from operations $(15,971) $(8,616)  85%
             
Interest expense and other expense $(431) $(1,561)  -72%
             
Net loss $(16,402) $(10,177)  61%
             
Loss per share – basic and diluted $(0.18) $(0.17)  7%
             
Weighted average shares outstanding - basic & diluted  91,234,406   60,644,842   50%

 

(A) GrossWe define gross billing as the total sales are used internally by managementfor the Company unadjusted for costs related to generating those sales. Management utilizes gross billing as an indicator of and to monitor operating performance including sales performance of particular products salesperson performance, product growth or declines and overall Company performance. The use of gross sales allows evaluation of sales performancesalespersons before the effect of any promotional items,or other allowances, which are determined in accordance with GAAP, and can mask certain performance issues. We therefore believe that the presentation of gross salesbilling provides a useful measure of our operating performance. Gross sales are not a measure that is recognized under GAAP and should not be considered as an alternative to net sales, which is determined in accordance with GAAP, and should not be used alone as an indicator of operating performance in place of net sales. Additionally, gross salesbilling may not be comparable to similarly titled measures used by other companies, as gross sales havebilling has been defined by our internal reporting practices. In addition, gross sales may not be realized in the form of cash receipts as promotional payments and allowances may be deducted from payments received from certain customers.practices.

(B) AlthoughWe define promotional and other allowances as costs deducted from gross billing which are associated with generating those sales. Management utilizes promotional and other allowances as an indicator of and to monitor operating performance of products, salespersons, and customer agreements. We believe that the presentation of promotional and other allowances provides a useful measure of our operating performance. The presentation of promotional and other allowances facilitates an evaluation of their impact on the determination of net sales and the spending levels incurred or correlated with such sales. The expenditures described in this line item are determined in accordance with GAAP and meet GAAP requirements, the disclosure thereof does not conform to GAAP presentation requirements. Additionally, our definition of promotional and other allowances may not be comparable to similar items presented by other companies. Promotional and other allowances primarily include consideration given to the Company’s distributors or retail customers including, but not limited to the following: (i) reimbursements given to the Company’s distributors for agreed portions of their promotional spend with retailers, including slotting, shelf space allowances and other fees for both new and existing products; (ii) the Company’s agreed share of fees given to distributors and/or directly to retailers for in-store marketing and promotional activities; (iii) the Company’s agreed share of slotting, shelf space allowances and other fees given directly to retailers; (iv) incentives given to the Company’s distributors and/or retailers for achieving or exceeding certain predetermined sales goals; and (v) discounted or free products. The presentation of promotional and other allowances facilitates an evaluation of their impact on the determination of net sales and the spending levels incurred or correlated with such sales. Promotional and other allowances constitute a material portion of our marketing activities. The Company’s promotional allowance programs with its numerous distributors and/or retailers are executed through separate agreements in the ordinary course of business. These agreements generally provide for one or more of the arrangements described above and are of varying durations, ranging from one week to one year.

(C) Cost of goods produced: Cost of goods produced consists of the costs of raw materials and packaging utilized in the manufacture of products, co-packing fees, repacking fees, in-bound freight charges, inventory adjustments, as well as certain internal transfer costs. Cost of goods produced is used internally by management to measure the direct costs of goods sold, aside from unallocated plant costs. Cost of goods produced is not a measure that is recognized under GAAP and should not be considered as an alternative to cost of goods sold, which is determined in accordance with GAAP, and should not be used alone as an indicator of operating performance in place of cost of goods sold.

(D) Cost of goods sold – idle capacity: Cost of goods sold – idle capacity consists of direct production costs in excess of charges allocated to our finished goods in production. Plant costs in excess of production allocations are expensed in the period incurred rather than added to the cost of finished goods produced. Plant costs include labor costs, production supplies, repairs and maintenance, and inventory write-off. Our charges for labor and overhead allocated to our finished goods are determined on a market cost basis, which is lower than our actual costs incurred. Cost of goods sold – idle capacity is not a measure that is recognized under GAAP and should not be considered as an alternative to cost of goods sold, which is determined in accordance with GAAP, and should not be used alone as an indicator of operating performance in place of cost of goods sold.

 

3530
 

Sales, Cost of Sales, and Gross Margins

 

The following chart sets forth key statistics for the transition of the Company’s top line activity through the years ended December 31, 2020.2021.

 

 Total Total     Per Case Per Case     Total Total     Per Case Per Case    
 2020  2019  vs PY  2020  2019  vs PY  2021  2020  vs PY  2021  2020  vs PY 
Cases:                                                
Reed’s  1,254   970   29%              1,605   1,254   28%            
Virgil’s  1,204   1,083   11%              1,388   1,204   15%            
Total Core  2,458   2,053   20%              2,993   2,458   22%            
Non Core  2   33   -94%              2   2   0%            
Candy  26   34   -24%              28   26   8%            
Total  2,486   2,120   17%              3,023   2,486   22%            
                                                
Gross Sales:                        
Gross Billing:                        
Core $45,324  $37,769   20% $18.4  $18.4   0% $53,263  $45,324   18% $17.8  $18.4   -3%
Non Core  556   560   -1%  278.0   16.9   1,548%  362   556   -35%  181.0   278.0   -35%
Candy  921   971   -5%  35.4   28.6   24%  1,033   921   12%  36.9   35.4   4%
Total $46,801  $39,300   19%  18.8   18.5   2% $54,658  $46,801   17%  18.1   18.8   -4%
                                                
Discounts: Total $(5,186) $(5,480)  -5% $(2.1) $(2.6)  -19% $(5,059) $(5,186)  -2% $(1.7) $(2.1)  -20%
                                                
COGS:                                                
Core $(28,139) $(24,286)  16% $(11.4) $(11.8)  -3% $(34,804) $(28,139)  24% $(11.6) $(11.4)  2%
Non Core  (110)  (678)  -84%  (55.0) $(20.5)  168%  (304)  (110)  176%  (152.0) $(55.0)  176%
Candy  (600)  (671)  -11%  (23.1) $(19.8)  16%  (893)  (600)  49%  (31.9) $(23.1)  38%
Idle Plant  -   (309)  -100%  -   (0.1)  -100%
Total $(28,849) $(25,944)  11% $(11.6) $(12.2)  -5% $(36,001) $(28,849)  25% $(11.9) $(11.6)  3%
                                                
Gross Margin: $12,766  $7,876   62% $5.1  $3.7   38% $13,598  $12,766   7% $4.5  $5.1   -12%
as % Net Sales  31%  23%                  27%  31%                

Sales, Cost of Sales, and Gross Margins

 

As part of the Company’s ongoing initiative to simplify and streamline operations by reducing the number of SKUs, the Company has identified core products on which to place its strategic focus. These core products consist of Reed’s and Virgil’s branded beverages. Beginning in 2020, ourNon-core products consist primarily of Wellness Shots, are captured in Non-core products. Non-core products for 2019 consist primarily ofcandy and slower selling discontinued Reed’s and Virgil’s SKUs.

 

As a result of our decision to focus on the core Reed’s and Virgil’s beverage brands and simplify operations by reducing the overall number of SKUs that we offer, the Company’s coreCore beverage volume for the year ended December 31, 2020,2021, represents 98%99% of all beverage volume.

 

Sales

Core brand gross revenuebilling increased by 20%18% to $45,324$53,263 compared to the same period last year, driven by Reed’s volume growth of 29%28% and Virgil’s volume growth of 15%. The result is an increase in total gross revenuebilling of 19%17%, to $46,801$54,658 in the year ended December 31, 2020,2021, from $39,300$46,801 during the same period last year.year ended December 31, 2020. Price on our core brands remained flat from the prior year, while volume grew 20% as compareddecreased 3% to the same period last year.$17.80 per case due to a shift in mix to lower priced, higher margin products.

 

Discounts as a percentage of gross salesbilling decreased to 11%9% from 14%11% in the same period last year. As a result, net sales revenue grew 23%19% in the year ended December 31, 20202021, to $41,615,$49,599, compared to $33,820$41,615 in the same period last year.

 

36

Cost of Goods Sold and Produced

 

Cost of goods sold increased $2,905$7,152 during the year ended December 31, 20202021, as compared to the same period last year. As a percentage of net sales, cost of goods sold infor the year ended December 31, 2020 improved to 69%2021, was 73% as compared to 77%69% for the same period last year.

 

The total cost of goods per case decreasedincreased to $11.60$11.91 per case in the year ended December 31, 20202021, from $12.24$11.60 per case for the same period last year. The cost of goods sold per case on core brands was $11.45$11.63 during the year ended December 31, 2020,2021, compared to $11.83$11.45 for the same period last year. Improvements in COGS have been driven by cost savings initiatives on core brands.

 

Gross Margin

 

Gross margin increased to 31%was 27% for the year ended December 31, 2020,2021, compared to 23%31% for the same period last year. The improvements in gross margin have been driven by reduced discount spend and cost savings initiatives.

 

31

Operating Expenses

 

Delivery and Handling Expenses

 

Delivery and handling expenses consist of delivery costs to customers and warehousing costs incurred for handling our finished goods after production. Delivery and handling expenses increased by $863$5,083 in the yearyears ended December 31, 20202021, to $6,856$11,939 from $5,993$6,856 in the same period last year, driven by increased volumes.volumes, ecommerce fulfilment costs, and increasing freight rates due to market conditions. Delivery costs in the year ended December 31, 20202021, were 24% of net sales and $3.95 per case, compared to 16% of net sales and $2.76 per case compared to 18% of net sales and $2.83 per case during the same period last year. The improvement was driven by a reduction in cross country shipments but this savings was negatively impacted by increasing freight rates due to Covid-19.

 

Selling and Marketing Expenses

 

Marketing expenses consist of direct marketing, marketing labor, and marketing support costs. Selling expenses consist of all other selling-related expenses including personnel and contractor support.

Total selling and marketing expenses were $7,503increased $2,162 to $9,665 during the year ended December 31, 2020,2021, compared to $9,188$7,503 during the same period last year. As a percentage of net sales, selling and marketing costs decreasedincreased to 18%19% during the year ended December 31, 2020,2021, as compared to 27%18% during the same period last year. The decreaseincrease was driven by the lapping of the “Fooled Your Mom” campaign from 2019, and reduced expenditures on trade shows and sponsorships, partially offset by an increase instaffing costs, stock compensation, and market research.distributor buyout.

 

General and Administrative Expenses

 

General and administrative expenses consist primarily of the cost of executive, administrative, operations and finance personnel, as well as professional fees. General and administrative expenses decreasedincreased in the year ended December 31, 20202021, to $7,965 from $7,023 from $7,551, a decreasean increase of $528$942 over the same period last year. The decreaseincrease was driven by a $638 decrease in severance expense,higher legal settlements, liquor licensing fees, loss on sale of assets, recycling fees, postage, public company costs, travel expenses, depreciation, and a $147 decrease in professional and consulting fees,bad debt, partially offset by a $76 increase inlower stock option expense and $181 increase in other general and administrative expenses.compensation.

 

Loss from Operations

 

The loss from operations was $8,616$15,971 for the year ended December 31, 2020,2021, as compared to a loss of $14,856$8,616 in the same period last year driven by increased gross profit and reductionsoffset by increases in operating expenses discussed above.

 

Interest and Other ExpenseIncome (Expense)

 

Interest and other expenseincome for the year ended December 31, 2020,2021, consisted of $262$1,201 of interest expense offset by $770 gain on forgiveness of debt. During the same period last year, interest and other expense consisted of $1,307 of interest expense, loss on extinguishment of debt $1,307 of interest expense$262, offset by the change in fair value of our warrant liability of $8. During the same period last year, interest and other expense consisted of $1,286 of interest expense offset by the change in fair value of our warrant liability of $30.

 

37

Modified EBITDA

 

In addition to our GAAP results, we present Modified EBITDA as a supplemental measure of our performance. However, Modified EBITDA is not a recognized measurement under GAAP and should not be considered as an alternative to net income, income from operations or any other performance measure derived in accordance with GAAP, or as an alternative to cash flow from operating activities as a measure of liquidity. We define Modified EBITDA as net income (loss), plus interest expense, depreciation and amortization, stock-based compensation, changes in fair value of warrant expense, and one-time restructuring-related costs including employee severance and asset impairment.

 

Management considers our core operating performance to be that which our managers can affect in any particular period through their management of the resources that affect our underlying revenue and profit generating operations during that period. Non-GAAP adjustments to our results prepared in accordance with GAAP are itemized below. You are encouraged to evaluate these adjustments and the reasons we consider them appropriate for supplemental analysis. In evaluating Modified EBITDA, you should be aware that in the future we may incur expenses that are the same as or similar to some of the adjustments in this presentation. Our presentation of Modified EBITDA should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items.

 

32

Set forth below is a reconciliation of net loss to Modified EBITDA for the year ended December 31, 20202021 and 20192020 (in thousands):

 

 Year Ended December 31,  Year Ended December 31, 
 2020 2019  2021  2020 
Net loss $(10,177) $(16,112) $(16,402) $(10,177)
             
Modified EBITDA adjustments:             
Depreciation and amortization 204 152   243   204 
Interest expense 1,307 1,286   1,201   1,307 
Stock option and other noncash compensation 1,592 1,296   1,927   1,592 
Gain on extinguishment of debt  (770)  - 
Legal settlement  292   - 
Loss on extinguishment of debt 262 -   -   262 
Change in fair value of warrant liability (8) (30)  -   (8)
Impairment and severance costs  5  643   -   5 
Total EBITDA adjustments $3,362 $3,347  $2,893  $3,362 
             
Modified EBITDA $(6,815) $(12,765) $(13,509) $(6,815)

 

We present Modified EBITDA because we believe it assists investors and analysts in comparing our performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. In addition, we use Modified EBITDA in developing our internal budgets, forecasts and strategic plan; in analyzing the effectiveness of our business strategies in evaluating potential acquisitions; making compensation decisions; and in communications with our board of directors concerning our financial performance. Modified EBITDA has limitations as an analytical tool, which includes, among others, the following:

 

 Modified EBITDA does not reflect our cash expenditures, or future requirements, for capital expenditures or contractual commitments;
   
 Modified EBITDA does not reflect changes in, or cash requirements for, our working capital needs;
   
 Modified EBITDA does not reflect future interest expense, or the cash requirements necessary to service interest or principal payments, on our debts; and
   
 Although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and Modified EBITDA does not reflect any cash requirements for such replacements.

 

38

Liquidity, and Capital Resources and Going Concern

 

The accompanying financial statements have been prepared under the assumption that the Company will continue as a going concern.concern for one year from the date these financial statements are issued. Such assumption contemplates the realization of assets and satisfaction of liabilities in the normal course of business.

For the year ended December 31, 2020,2021, the Company recorded a net loss of $10,177$16,402 and used cash in operations of $9,496. As of December 31, 2020, we had a cash balance of $595 with borrowing capacity of $5,166, stockholders’ equity of $10,404 and a working capital of $9,528, compared$17,589. These conditions raise substantial doubt regarding our ability to a cash balance of $913, stockholders’ equity of $1,147 and working capital of $4,885 at December 31, 2019. Notwithstanding the loss for 2020, management projects adequate cash from operations and available line of credit in 2021 to ensure continuation of the Companycontinue as a going concern for a period of at least one year from the date of issuance of these financial statements. In addition the Company’s independent registered public accounting firm, in their report on the Company’s December 31, 2021, audited financial statements, raised substantial doubt about the Company’s ability to continue as a going concern.

 

In April 2020,During 2021, the Company conducted a public offering of 15,333,334 sharesofferings and sold 6.7 million of its common shares and received net proceeds of $7,327.

On March 10, 2022, the Company entered into a Securities Purchase Agreement (“Purchase Agreement”) with certain institutional and accredited investors (the “Purchasers”) pursuant to which the Purchasers agreed to purchase, and the Company agreed to issue and sell to the Purchasers in a private placement, an aggregate of 18,594,571 shares (“Shares”) of the Company’s common stock, $0.0001 par value (“Common Stock”), and warrants (“Warrants”) to purchase an aggregate of 9,297,289 shares of Common Stock (the “Private Placement”). The purchase price per share of common stock and associated warrant was $0.28 for the investors (other than officers and directors of the Company) and $0.3502 for the officers and directors of the Company in compliance with the rules of the Nasdaq Stock Market. Each whole warrant entitles the holder to purchase one share of common stock at a public offeringan exercise price of $0.375$0.2877 per share. The netwarrants are exercisable at a per share exercise price of $0.2877 for a period of five years commencing six months from the closing date. Officers and directors of the Company purchased approximately $1.1 million of the securities in the offering.  The gross proceeds to the Company, from this offering are $5,310, after deducting underwriting discounts and commissionsplacement agent fees and other offering expenses.expenses, are approximately $5.1 million.

 

In November 2020, the Company conducted a public offering of 21,562,500 shares of its common shares at a public offering price of $0.523 per share. The net proceeds to the Company from this offering are $11,254, after deducting underwriting discounts and commissions and other offering expenses.

33

 

Historically, we have financed our operations through public and private sales of common stock, issuance of preferred and common stock, convertible debt instruments, term loans and credit lines from financial institutions, and cash generated from operations. WeManagement is currently evaluating various funding alternatives and may seek to raise additional funds through the issuance of equity, mezzanine or debt securities, through arrangements with strategic partners or through obtaining credit from financial institutions. In addition, we have taken decisive action to improve our margins, including fully outsourcing our manufacturing process, streamlining our product portfolio, negotiating improved vendor contracts and restructuring our selling prices.

 

Critical Accounting Policies and Estimates

 

Use of Estimates and Assumptions. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Those estimates and assumptions include estimates for reserves of uncollectible accounts receivables, assumptions used in valuing inventories at net realizable value, impairment testing of recorded long-term tangible and intangible assets, the valuation allowance for deferred tax assets, accruals for potential liabilities, assumptions made in valuing stock instruments issued for services, and assumptions used in valuing warrant liabilities, and assumptions used in the determination of the Company’s liquidity.

 

Accounts Receivable. Accounts receivable are recorded at the invoiced amounts. The Company evaluates the collectability of its trade accounts receivable based on a number of factors. In circumstances where the Company becomes aware of a specific customer’s inability to meet its financial obligations to the Company, a specific reserve for bad debts is estimated and recorded, which reduces the recognized receivable to the estimated amount the Company believes will ultimately be collected. In addition to specific customer identification of potential bad debts, bad debt charges are recorded based on the Company’s historical losses and an overall assessment of past due trade accounts receivable outstanding.

39

 

Inventory. Inventory is stated at the lower of cost or net realizable value. We regularly review our inventory quantities on hand and record a provision for excess and obsolete inventory based primarily on our estimated forecast of product demand and our ability to sell the product(s) concerned. Demand for our products can fluctuate significantly. Factors that could affect demand for our products include unanticipated changes in consumer preferences, general market conditions or other factors, which may result in cancellations of advance orders or a reduction in the rate of reorders placed by customers. Additionally, our management’s estimates of future product demand may be inaccurate, which could result in an understated or overstated provision required for excess and obsolete inventory.

 

Revenue Recognition. Revenue and costs of sales are recognized when control of the products transfers to our customer, which generally occurs upon shipment from our facilities. The Company’s performance obligations are satisfied at that time. The Company does not have any significant contracts with customers requiring performance beyond delivery, and contracts with customers contain no incentives or discounts that could cause revenue to be allocated or adjusted over time. Shipping and handling activities are performed before the customer obtains control of the goods and therefore represent a fulfillment activity rather than a promised service to the customer.

 

Stock Compensation Expense. The Company periodically issues stock options and restricted stock awards to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for such grants issued and vesting based on ASC 718, Compensation-Stock Compensation whereby the value of the award is measured on the date of grant and recognized as compensation expense on the straight-line basis over the vesting period. The Company recognizes the fair value of stock-based compensation within its Statements of Operations with classification depending on the nature of the services rendered.

 

Recent Accounting Pronouncements

 

See Note 2 of the financial statements for a discussion of recent accounting pronouncements.

 

Item 7A. Quantitative and Qualitative Disclosures about Market Risk

 

As a smaller reporting company, Reed’s is not required to provide the information required by this Item 7A.

 

4034
 

Item 8. Financial Statements

 

Report of Independent Registered Public Accounting Firm(PCAOB Firm ID: 572)F-1F-2
  
Financial Statements: 
  
Balance Sheets as of December 31, 20202021 and December 31, 2019F-2
Statements of Operations for the years ended December 31, 2020 and 2019F-3
  
Statements of Changes in Stockholders’ EquityOperations for the years ended December 31, 20202021 and 20192020F-4
  
Statements of Cash FlowsChanges in Stockholders’ Equity for the years ended December 31, 20202021 and 20192020F-5
  
Statements of Cash Flows for the years ended December 31, 2021 and 2020F-6
Notes to Financial Statements for the years ended December 31, 20202021 and 20192020F-6F-7

 

41F-1

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Stockholders and Board of Directors of Reed’s, Inc.

 

Opinion on the Financial Statements

 

We have audited the accompanying balance sheets of Reed’s, Inc. (the “Company”) as of December 31, 20202021 and 2019,2020, the related statements of operations, changes in stockholders’ equity, (deficit), and cash flows for the years then ended, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 20202021 and 2019,2020, and the results of its operations and its cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States of America.

 

Going Concern

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the financial statements, during the year ended December 31, 2021, the Company incurred a net loss and utilized cash in operations. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. Management’s plans to alleviate these conditions are also described in Note 1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit MattersMatter

 

The critical audit mattersmatter communicated below are mattersis a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relaterelates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit mattersmatter below, providing a separate opinionsopinion on the critical audit mattersmatter or on the accounts or disclosures to which they relate.it relates.

 

Inventory ReservesValuation

 

As described in Notes 2 and 3 to the financial statements, the Company’s inventories are valued at the lower of cost or net realizable value, determined on first-in, first-out (“FIFO”) basis. The Company also determines a reserve for slow movingManagement considers historical usage, forecasted demand in relation to inventory on hand, market conditions, and potentially obsolete inventory equal to the difference between the cost of the inventory and the estimatedother factors when estimating net realizable value of the inventory based on estimated reserve percentages, which consider historical usage, known trends, inventory age, and market conditions. At December 31, 2020, the balance of inventory and inventory reserves were $11.3 million and $0.2, respectivelyvalue.

 

We identified management’s estimation of the reserve for slow moving and potentially obsoletenet realizable value of inventory as a critical audit matter, because of the significant judgmentjudgments made by management in estimating future demand and market conditions which are used to arrive at the slow moving and potentially obsolete inventory reserve, and thenet realizable value. This required a high degree of auditor judgment subjectivity and increased auditor effort in performing procedures and evaluating the reasonableness of the significant assumptions used in developing the reserve.

The primary procedures we performed to address this critical audit matter included:

We evaluated the reasonableness of the significant assumptions used by management including those related to forecasted inventory usage by considering historic sales activity and sales forecast
We tested the completeness, accuracy, and relevance of the underlying data used in management’s estimates of slow-moving and potentially obsolete inventory.
We tested the calculations and application of management’s methodologies related to the valuation estimates of slow-moving and potentially obsolete inventory.
We developed an independent expectation of the excess and potentially obsolete inventory reserve using historic inventory activity and compared our independent expectation to the amount recorded in the financial statements.
We evaluated management’s ability to accurately estimate the reserve by comparing actual write-off activity in the current year to the excess and potentially obsolete reserve estimated by the Company in the prior year.
We tested inventory write-off activity subsequent to December 31, 2020 to discern whether there were any indications that the reserve for excess and potentially obsolete inventory may be understated.

Evaluation of Liquidity

As described in Note 1 to the financial statements, Management believes, based on the Company’s operating plan, that projected cash from operations and available line of credit financing is sufficient to fund operations for at least one year from the date the Company’s December 31, 2020, financial statements are issued.

We identified management’s evaluation of the Company’s liquidity as a critical audit matter due to the significant judgments required by management in developing assumptions in preparing the Company’s forecasted cash flows. Addressing the matter involved especially challenging auditor judgment and effort in performing procedures and evaluating evidence supporting management’s funding requirements.auditing such assumptions.

 

The primary procedures we performed to address this critical audit matter included:

 

ConsiderationWe obtained an understanding of positive and negative evidence impacting management’s forecasts, including market and industry trends.process for estimating net realizable value.
 ConsiderationWe assessed the reasonableness of the Company’s historical ability to raise capital.
Testingmanagement’s forecasted product demand and tested the completeness and accuracy of the underlying data used by management in preparing the forecasted cash flows by comparison to prior period forecasts to actual results.analyses and whether they were consistent with the historical data and evidence obtained in other areas of the audit.   
 Evaluating the sufficiencyWe evaluated management’s product demand forecast for reasonableness considering historical sales by product, comparing prior period estimates to actual results of the Company’s liquidity disclosure.same period, and considering trends within the industry that could impact the movement of the products provided by the Company.   
We developed an independent expectation of the net realizable value of inventory using historic inventory activity and compared our independent expectation to the amount recorded in the financial statements.

 

We have served as the Company’s auditor since 2004.

 

/s/Weinberg & Company, P.A. 
Los Angeles, California 
March 30, 2021April 15, 2022 

F-1F-2

REED’S INC.

REED’S, INC,

BALANCE SHEETS

(Amounts in thousands, except share amounts)

 

  December 31, 2020  December 31, 2019 
       
ASSETS        
Current assets:        
Cash $595  $913 
Accounts receivable, net of allowance of $234 and $375, respectively  4,718   2,099 
Receivable from related party  682   356 
Inventory, net of reserve for obsolescence of $194 and $646, respectively  11,119   10,508 
Prepaid expenses and other current assets  1,341   420 
Total current assets  18,455   14,296 
         
Property and equipment, net of accumulated depreciation of $361 and $482, respectively  920   1,053 
Equipment held for sale, net of impairment reserves of $96 and $96, respectively  67   67 
Intangible assets  615   576 
Total assets $20,057  $15,992 
         
LIABILITIES AND STOCKHOLDERS’ EQUITY        
Current liabilities:        
Accounts payable $6,746  $5,357 
Payable to related party  557   182 
Accrued expenses  895   646 
Revolving line of credit  -   3,177 
Current portion of note payable  599   - 
Current portion of lease liabilities  130   49 
Total current liabilities  8,927   9,411 
         
Lease liabilities, less current portion  555   737 
Note payable, less current portion  171     
Convertible note to a related party  -   4,689 
Warrant liability  0   8 
Total liabilities  9,653   14,845 
         
Stockholders’ equity:        
Series A Convertible Preferred stock, $10 par value, 500,000 shares authorized, 9,411 shares issued and outstanding  94   94 
Common stock, $.0001 par value, 120,000,000 and 100,000,000 shares authorized, respectively; 86,317,096 and 47,595,206 shares issued and outstanding, respectively  9   5 
Additional paid in capital  97,031   77,596 
Accumulated deficit  (86,730)  (76,548)
Total stockholders’ equity  10,404   1,147 
Total liabilities and stockholders’ equity $20,057  $15,992 

The accompanying notes are an integral part of these financial statements.

F-2

REED’S, INC.

STATEMENTS OF OPERATIONS

For the Years Ended December 31, 2020 and 2019

(Amounts in thousands, except share and per share amounts)

  2020  2019 
  Year Ended December 31, 
  2020  2019 
Net Sales $41,615  $33,820 
Cost of goods sold  28,849   25,944 
Gross profit  12,766   7,876 
         
Operating expenses:        
Delivery and handling expense  6,856   5,993 
Selling and marketing expense  7,503   9,188 
General and administrative expense  7,023   7,551 
Total operating expenses  21,382   22,732 
         
Loss from operations  (8,616)  (14,856)
         
Loss on extinguishment of debt  (262)  - 
Interest expense  (1,307)  (1,286)
Change in fair value of warrant liability  8   30 
         
Net loss  (10,177)  (16,112)
         
Dividends on Series A Convertible Preferred Stock  (5)  (5)
         
Net loss attributable to common stockholders $(10,182) $(16,117)
         
Loss per share – basic and diluted $(0.17) $(0.46)
         
Weighted average number of shares outstanding – basic and diluted  60,644,842   35,058,004 
  December 31, 2021  December 31, 2020 
       
ASSETS        
Current assets:        
Cash $49  $595 
Accounts receivable, net of allowance of $215 and $234, respectively  5,183   4,718 
Receivable from related party  933   682 
Inventory  17,049   11,119 
Prepaid expenses and other current assets  1,491   1,341 
Total current assets  24,705   18,455 
         
Property and equipment, net of accumulated depreciation of $561 and $361, respectively  992   920 
Equipment held for sale  -   67 
Intangible assets  624   615 
Total assets $26,321  $20,057 
         
LIABILITIES AND STOCKHOLDERS’ EQUITY        
Current liabilities:        
Accounts payable $10,434  $6,746 
Accrued expenses  286   895 
Revolving line of credit  10,229   - 
Payable to related party  

614

   

557

 
Current portion of note payable  -   599 
Current portion of lease liabilities  161   130 
Total current liabilities  21,724   8,927 
         
Lease liabilities, less current portion  394   555 
Note payable, less current portion  -   171 
Total liabilities  22,118   9,653 
         
Stockholders’ equity:        
Series A Convertible Preferred stock, $10 par value, 500,000 shares authorized, 9,411 shares issued and outstanding  94   94 
Common stock, $.0001 par value, 180,000,000 and 120,000,000 shares authorized, respectively; 93,733,975 and 86,317,096 shares issued and outstanding, respectively  9   9 
Additional paid in capital  107,237   97,031 
Accumulated deficit  (103,137)  (86,730)
Total stockholders’ equity  

4,203

   10,404 
Total liabilities and stockholders’ equity $26,321  $20,057 

 

The accompanying notes are an integral part of these financial statements.

 

F-3

 

REED’S, INC.

STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)OPERATIONS

For the Years Ended December 31, 20202021 and 20192020

(Amounts in thousands, except share and per share amounts)

 

  Shares  Amount  Shares  Amount  Capital  Deficit  Total 
  Common Stock  Preferred Stock  Additional Paid In  Accumulated  Total Stockholders’ Equity 
  Shares  Amount  Shares  Amount  Capital  Deficit  (Deficit) 
Balance, December 31, 2018  25,729,461  $3   9,411  $94  $53,591  $(60,431) $(6,743)
Fair value of vested options  -   -   -   -   790   -   790 
Fair value of vested restricted shares granted to Directors for services  46,035   -   -   -   132   -   132 
Fair value of vested restricted shares granted to a former officer for services  442,002   -   -   -   374   -   374 
Fair value of vested restricted shares granted to Directors and officers for services                            
Fair value of vested restricted shares granted to Directors and officers for services, shares                            
Dividends on Series A Convertible Preferred Stock  4,254   -   -   -   5   (5)  - 
Common shares issued pursuant to the rights offerings, net of offering costs  21,150,417   2   -   -   22,339   -   22,341 
Exercise of warrants  223,037   -   -   -   365   -   365 
Fair value of warrants issued on extinguishment of debt                            
Common shares issued on conversion of note payable                            
Common shares issued on conversion of note payable, shares                            
Exercise of options                            
Exercise of options, shares                            
Net Loss  -   -   -   -   -   (16,112)  (16,112)
Balance, December 31, 2019  47,595,206   5   9,411   94   77,596   (76,548)  1,147 
Balance, December 31, 2019  47,595,206   5   9,411   94   77,596   (76,548)   1,147 
Fair value of vested options  -   -   -   -   1,176   -   1,176 
Fair value of vested restricted shares granted to Directors and officers for services  444,740   -   -   -   416   -   416 
Fair value of warrants issued on extinguishment of debt  -   -   -   -   402   -   402 
Dividends on Series A Convertible Preferred Stock  4,530   -   -   -   5   (5)  - 
Common shares issued pursuant to the rights offerings, net of offering costs  36,895,834   4   -   -   16,560   -   16,564 
Common shares issued on conversion of note payable  1,339,286               857       857 
Exercise of options  37,500   -   -   -   19   -   19 
Net Loss  -   -   -   -   -   (10,177)  (10,177)
Balance, December 31, 2020  86,317,096  $9   9,411  $94  $97,031  $(86,730) $10,404 
  2021  2020 
  Year Ended December 31, 
  2021  2020 
Net Sales $49,599  $41,615 
Cost of goods sold  36,001   28,849 
Gross profit  13,598   12,766 
         
Operating expenses:        
Delivery and handling expense  11,939   6,856 
Selling and marketing expense  9,665   7,503 
General and administrative expense  7,965   7,023 
Total operating expenses  29,569   21,382 
         
Loss from operations  (15,971)  (8,616)
         
Loss on extinguishment of debt  -   (262)
Gain on extinguishment of PPP note payable  770   - 
Interest expense  (1,201)  (1,307)
Change in fair value of warrant liability  -   8 
         
Net loss  (16,402)  (10,177)
         
Dividends on Series A Convertible Preferred Stock  (5)  (5)
         
Net loss attributable to common stockholders $(16,407) $(10,182)
         
Loss per share – basic and diluted $(0.18) $(0.17)
         
Weighted average number of shares outstanding – basic and diluted  91,234,406   60,644,842 

 

The accompanying notes are an integral part of these financial statements.

 

F-4

 

REED’S, INC.

STATEMENTS OF CASH FLOWSCHANGES IN STOCKHOLDERS’ EQUITY

For the Years Ended December 31, 20202021 and 20192020

(Amounts in thousands)thousands except share amounts)

 

  December 31, 2020  December 31, 2019 
Cash flows from operating activities:        
Net loss $(10,177) $(16,112)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation  88   61 
Gain on sale of property & equipment  -   (45)
Loss on termination of leases  -   8 
Loss on extinguishment of debt  262     
Amortization of debt discount  452   323 
Amortization of right of use assets  116   91 
Fair value of vested options  1,176   790 
Fair value of vested restricted shares granted to directors and officers for services  416   506 
Decrease in accounts receivable allowance  (141)  (248)
Increase (decrease) in inventory reserve  (452)  449 
Decrease in fair value of warrant liability  (8)  (30)
Accrual of interest on convertible note to a related party  558   528 
Lease liability  (28)  - 
Changes in operating assets and liabilities:        
Accounts receivable  (2,478)  757 
Inventory  (159)  (3,575)
Prepaid expenses and other assets  (759)  (645)
Accounts payable  1,390   (182)
Accrued expenses  248   (837)
Net cash used in operating activities  (9,496)  (18,161)
Cash flows from investing activities:        
Intangible asset trademark costs  (39)    
Proceeds from sale of property and equipment  -   45 
Purchase of property and equipment  (122)  (322)
Net cash used in investing activities  (161)  (277)
Cash flows from financing activities:        
Borrowings under revolving line of credit  50,975   54,831 
Repayments of revolving line of credit  (54,636)  (58,827)
Capitalization of financing costs  (130)  (130)
Proceeds from loan payable  770   - 
Amounts from related party  49   195 
Repayment of convertible note payable  (4,250)  - 
Principal repayments on finance lease obligation  (22)  (48)
Exercise of options  19   - 
Exercise of warrants  -   365 
Proceeds from sale of common stock  16,564   22,341 
Net cash provided by financing activities  9,339   18,727 
         
Net increase (decrease) in cash  (318)  289 
Cash at beginning of period  913   624 
Cash at end of period $595  $913 
         
Supplemental disclosures of cash flow information:        
Cash paid for interest $1,740  $498 
Non-cash investing and financing activities:        
Offset accounts receivable related party and accounts payable related party $153  $-  
Dividends on Series A Convertible Preferred Stock $5  $5 
  Shares  Amount  Shares  Amount  Capital  Deficit  (Deficit) 
  Common Stock  Preferred Stock  Additional Paid In  Accumulated  

Total

Stockholders’ Equity

 
  Shares  Amount  Shares  Amount  Capital  Deficit  (Deficit) 
Balance, December 31, 2019  47,595,206  $5   9,411  $94  $77,596  $(76,548) $1,147 
Fair value of vested options  -   -   -   -   1,176   -   1,176 
Fair value of warrants issued as financing costs                            
Fair value of vested restricted shares granted to officers                            
Fair value of vested restricted shares granted to officers, shares                            
Fair value of vested restricted shares granted to Directors for services  444,740   -   -   -   416   -   416 
Fair value of warrants issued on extinguishment of debt  -   -   -   -   402   -   402 
Dividends on Series A Convertible Preferred Stock  4,530   -   -   -   5   (5)  - 
Repurchase of common stock                            
Repurchase of common stock, shares                            
Common shares issued for financing costs                            
Common shares issued for financing costs, shares                            
Common shares issued pursuant to a rights offerings, net of offering costs  36,895,834   4   -   -   16,560   -   16,564 
Common shares issued on conversion of note payable  1,339,286               857       857 
Exercise of options  37,500   -   -   -   19   -   19 
Net Loss  -   -   -   -   -   (10,177)  (10,177)
Balance, December 31, 2020  86,317,096   9   9,411   94   97,031   (86,730)  10,404 
Beginning balance, value  86,317,096   9   9,411   94   97,031   (86,730)  10,404 
Fair value of vested options  -   -   -   -   1,684   -   1,684 
Fair value of warrants issued as financing costs  -   -   -   -   458   -   458 
Fair value of vested restricted shares granted to officers  282,727   -   -   -   243   -   243 
Dividends on Series A Convertible Preferred Stock  4,645   -   -   -   5   (5)  - 
Repurchase of common stock  (13,493)              (15)      (15)
Common shares issued on exercise of options  63,000               32       32 
Common shares issued for financing costs  400,000               472       472 
Common shares issued pursuant to a rights offerings, net of offering costs  6,680,000   -   -   -   7,327   -   7,327 
Net Loss  -   -   -   -   -   (16,402)  (16,402)
Balance, December 31, 2021  93,733,975  $9   9,411  $94  $

107,237

  $(103,137) $

4,203

 
Ending balance, value  93,733,975  $9   9,411  $94  $107,237  $(103,137) $4,203 

 

The accompanying notes are an integral part of these financial statements.

 

F-5

 

REED’S, INC.

STATEMENTS OF CASH FLOWS

For the Years Ended December 31, 2021 and 2020

(Amounts in thousands)

  December 31, 2021  December 31, 2020 
Cash flows from operating activities:        
Net loss $(16,402) $(10,177)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation  143   88 
Loss on disposal of property & equipment  67   - 
Gain on termination of leases  (2)  - 
Gain on extinguishment of PPP note payable  (770)  - 
Loss on extinguishment of debt  -   262 
Amortization of debt discount  162   452 
Amortization of prepaid financing costs  295   - 
Fair value of vested options  1,684   1,176 
Fair value of vested restricted shares granted to directors and officers for services  243   416 
Decrease in accounts receivable allowance  (19)  (141)
Inventory write-off  (59)  (452)
Decrease in fair value of warrant liability  -   (8)
Accrual of interest on convertible note to a related party  -   558 
Lease liability  (115)  (28)
Changes in operating assets and liabilities:        
Accounts receivable  (446)  (2,478)
Inventory  (5,871)  (159)
Prepaid expenses and other assets  322 (759)
Decrease in right of use assets  100   116 
Accounts payable  3,688   1,390 
Accrued expenses  (609)  248 
Net cash used in operating activities  (17,589)  (9,496)
Cash flows from investing activities:        
Intangible asset trademark costs  (9)  (39)
Purchase of property and equipment  (326)  (122)
Net cash used in investing activities  (335)  (161)
Cash flows from financing activities:        
Borrowings under revolving line of credit  66,234   50,975 
Repayments of revolving line of credit  (56,005)  (54,636)
Capitalization of financing costs  -   (130)
Proceeds from loan payable  -   770 
Amounts from related party  (193)  49 
Repayment of convertible note payable  -   (4,250)
Principal repayments on finance lease obligation  (2)  (22)
Exercise of options  32   19 
Repurchase of common stock  (15)  - 
Proceeds from sale of common stock  7,327   16,564 
Net cash provided by financing activities  17,378   9,339 
         
Net decrease in cash  (546)  (318)
Cash at beginning of period  595   913 
Cash at end of period $49  $595 
         
Supplemental disclosures of cash flow information:        
Cash paid for interest $430  $1,740 
Non-cash investing and financing activities:        
Offset accounts receivable related party and accounts payable related party $-  $153 
Dividends on Series A Convertible Preferred Stock $5  $5 
Fair value of warrant recorded to prepaid expenses $458  $- 
Common Shares issued for financing costs $472  $- 
Note Payable principal extinguished $770  $- 

The accompanying notes are an integral part of these financial statements.

F-6

REED’S, INC.

NOTES TO FINANCIAL STATEMENTS

For the Years Ended December 31, 20202021 and 20192020

(In thousands, except share and per share amounts)

 

1. Operations and Liquidity

 

Reed’s, Inc.Inc, (the “Company”) is the owner and maker of both Reed Craft Ginger Beer and Reed’s Real Ginger Ale and Virgil’s Handcrafted Sodas. EstablishedReed’s, Inc, The Company was established in 1989 Reed’sand is America’s best-selling Ginger Beer brand and has been the leader and innovatorincorporated in the ginger beer categorystate of Delaware. 

Going Concern

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying financial statements, for decades. Virgil’sthe year ended December 31, 2021, the Company recorded a net loss of $16,402 and used cash in operations of $17,589. These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year of the date that the financial statements are issued. The financial statements do not include any adjustments that might be necessary if the Company is America’s best-selling independent, full lineunable to continue as a going concern.

As of natural craft sodas.December 31, 2021, we had a cash balance of $49 with borrowing capacity of $109, stockholders’ equity of $4,203 and a working capital of $2,981. On March 10, 2022, the Company issued 18,594,571 shares of common stock and warrants to purchase 9,297,289 shares of common stock in a private placement. The Reed’s Inc. portfolio is sold in over 40,000 retail stores nationwide. Reed’s Ginger Beers are unique duenet proceeds to the proprietaryCompany, after deducting placement agent fees and other offering expenses, are approximately $5,100 (see Note 15).

Historically, we have financed our operations through public and private sales of common stock, issuance of preferred and common stock, convertible debt instruments, term loans and credit lines from financial institutions, and cash generated from operations. To alleviate these conditions, management is currently evaluating various funding alternatives and may seek to raise additional funds through the issuance of equity, mezzanine or debt securities, through arrangements with strategic partners or through obtaining credit from financial institutions. As we seek additional sources of financing, there can be no assurance that such financing would be available to us on favorable terms or at all. Our ability to obtain additional financing in the debt and equity capital markets is subject to several factors, including market and economic conditions, our performance and investor sentiment with respect to us and our industry.

We have also taken decisive action to improve our margins, including fully outsourcing our manufacturing process, of using fresh ginger root combined with a Jamaican inspired recipe of natural spicesstreamlining our product portfolio, negotiating improved vendor contracts and fruit juices. Reed’s uses this same handcrafted approach in its Reed’s Real Ginger Ale and Virgil’s line of great tasting, bold flavored craft sodas, including its award-winning Virgil’s Root Beer.restructuring our selling prices.

 

COVID-19 Considerations

 

During the year ended December 31, 2020,2021, the COVID-19 pandemic did not have a material net impact onhas impacted our operating results.results and the Company anticipates a continued impact for the balance of the year. In the future,addition, the pandemic may cause reduced demand for our products if, for example, the pandemic results in a recessionary economic environment which negatively effects the consumers who purchase our products. Based on the recent increase in demand for our products, we believe that over the long term, there will continue to be strong demand for our products.

 

Through December 31, 2021, the Company has experienced higher transportation expenses as the capacity in the freight market has not kept up with demand. The Company believes that costs will continue to increase throughout the year. In addition, the Company experienced increases in the pricing of several of its raw materials and delays in procuring several of these items. However, mitigation plans are being implemented to manage this risk. Additionally, the Company was negatively impacted by supply chain challenges impacting our ability to benefit from strong demand for and increased sales of our product. The disruption caused by labor shortages, significant raw material cost inflation, logistics issues and increased freight costs, and ongoing port congestion, resulted in suppressed margins and net income. The Company anticipates a continued impact throughout 2022.

Our ability to operate without significant incremental negative operational impact from the COVID-19 pandemic will in part depend on our ability to protect our employees and our supply chain. The Company has endeavored to follow the recommended actions of government and health authorities to protect our employees. Since the inception of the COVID-19 pandemic and through the year ended December 31, 2020,2021, we maintained the consistency of our operations during the onset of the COVID-19 pandemic. We will continue to innovate in managing our business, coordinating with our employees and suppliers to do our part in the infection prevention and remain flexible in responding to our customers and suppliers. However, the uncertainty resulting from the pandemic could result in an unforeseen disruption to our workforce and supply chain (for example an inability of a key supplier or transportation supplier to source and transport materials) that could negatively impact our operations.

 

Through December 31, 2020, the COVID-19 pandemic has not negatively impacted the Company’s liquidity position as of such date. Net sales for the year ended December 31, 20202021, were up 23%19% from the prior year period. Through December 31, 2020,2021, we continue to generate cash flows to meet our short-term liquidity needs, and we expect to maintain access to the capital markets. We have also not observed any material impairments of our assets or a significant change in the fair value of our assets due to the COVID-19 pandemic.

Liquidity

The accompanying financial statements have been prepared under the assumption that the Company will continue as a going concern. Such assumption contemplates the realization of assets and satisfaction of liabilities in the normal course of business. For the year ended December 31, 2020, the Company recorded a net loss of $10,177 and used cash in operations of $9,496. As of December 31, 2020, we had a cash balance of $595with borrowing capacity of $5,166, stockholders’ equity of $10,404and a working capital of $9,528. Notwithstanding the net loss for 2020, management projects adequate cash from operations and available line of credit in 2021 to ensure continuation of the Company as a going concern for at least one year from the date the Company’s 2020 financial statements are issued.

During 2020, the Company conducted public offerings and sold 36.9 million of its common shares and received net proceeds of $16,564 (see Note 11).

Historically, we have financed our operations through public and private sales of common stock, issuance of preferred and common stock, convertible debt instruments, term loans and credit lines from financial institutions, and cash generated from operations. We have taken decisive action to improve our margins, including fully outsourcing our manufacturing process, streamlining our product portfolio, negotiating improved vendor contracts and restructuring our selling prices.

 

F-6F-7

 

2. Significant Accounting Policies

 

Use of Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Those estimates and assumptions include estimates for reserves of uncollectible accounts receivables, assumptions used in valuing inventories at net realizable value, impairment testing of recorded long-term tangible and intangible assets, the valuation allowance for deferred tax assets, accruals for potential liabilities, assumptions made in valuing stock instruments issued for services, and assumptions used in valuing warrant liabilities, and assumptions used in the determination of the Company’s liquidity.

 

Accounts Receivable

 

Accounts receivable are generally recorded at the invoiced amounts net of an allowance for expected losses. The Company evaluates the collectability of its trade accounts receivable based on a number of factors. In circumstances where the Company becomes aware of a specific customer’s inability to meet its financial obligations to the Company, a specific reserve for bad debts is estimated and recorded, which reduces the recognized receivable to the estimated amount the Company believes will ultimately be collected. In addition to specific customer identification of potential bad debts, bad debt charges are recorded based on the Company’s historical losses and an overall assessment of past due trade accounts receivable outstanding.

 

The allowance for accounts receivable is established through a provision reducing the carrying value of receivables. At December 31, 20202021 and 2019,2020, the allowance was $234 215and $375234, respectively.

 

Inventory

 

Inventory is stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out (“FIFO”) basis. We regularly review our inventory quantities on hand and record a provision for excess and obsolete inventory based primarily on our estimated forecast of product demand and our ability to sell the product(s) concerned. Demand for our products can fluctuate significantly. Factors that could affect demand for our products include unanticipated changes in consumer preferences, general market conditions or other factors, which may result in cancellations of advance orders or a reduction in the rate of reorders placed by customers. Additionally, our management’s estimates of future product demand may be inaccurate, which could result in an understated or overstated provision required for excess and obsolete inventory. At December 31, 2021 and 2020, and 2019, the reserveinventory has been reduced by cumulative write-downs for inventory obsolescence aggregatedaggregating $135and $194 and $646, respectively.

 

F-8

Property and Equipment

 

Property and equipment is stated at cost. Expenditures for major renewals and improvements that extend the useful lives of property and equipment or increase production capacity are capitalized, and expenditures for repairs and maintenance are charged to expense as incurred. Depreciation is calculated using accelerated and straight-line methods over the estimated useful lives of the assets as follows:

Schedule of Estimated Useful Lives of Property and Equipment and Related Depreciation

Property and Equipment Type Years of Depreciation
Computer hardware and software 3-7 years
Machinery and equipment 5 years

F-7

 

Management assesses the carrying value of property and equipment whenever events or changes in circumstances indicate that the carrying value may not be recoverable. If there is indication of impairment, management prepares an estimate of future cash flows expected to result from the use of the asset and its eventual disposition. If these cash flows are less than the carrying amount of the asset, an impairment loss is recognized to write down the asset to its estimated fair value. For the years ended December 31, 20202021 and 2019,2020, the Company determined there were no0 indicators of impairment of its property and equipment.

 

Intangible Assets

 

Intangible assets are comprised of indefinite-lived brand names acquired, so classified because we anticipate that these brand names will contribute cash flows to the Company perpetually. Indefinite-lived intangible assets are not amortized but are assessed for impairment annually, or more frequently if events or circumstances indicate that assets might be impaired and evaluated annually to determine whether the indefinite useful life is appropriate. As part of our impairment test, we first assess qualitative factors to determine whether it is more likely than not the asset is impaired. If further testing is necessary, we compare the estimated fair value of our asset with its book value. If the carrying amount of the asset exceeds its fair value, as determined by its discounted cash flows, an impairment loss is recognized in an amount equal to that excess. For the years ended December 31, 20202021 and 2019,2020, the Company determined there was 0impairment of its indefinite-lived brand names.

Warrant Liabilities

Various stock sales made by the Company to finance operations have been accompanied by the issuance of warrants. Some of these warrant agreements contain fundamental transaction provisions which may give rise to an obligation of the Company to pay cash to the warrant holders in the event that a fundamental transaction occurs (such as a merger or change in control of the Company) and such cash payment is elected by the holder. For accounting purposes, in accordance with ASC 480, Distinguishing Liabilities from Equity, those warrants with fundamental transaction terms are accounted for as liabilities given the terms may give rise to an obligation of the Company to the warrant holders. These liabilities are measured at fair value at each reporting period and the change in the fair value is recognized in earnings in the accompanying Statements of Operations.

Fair value is estimated using the Black-Scholes-Merton Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or restricted stock, and future dividends. Expense is recorded based upon the value derived from the Black-Scholes-Merton Option Pricing model and based on actual experience. The assumptions used in the Black-Scholes-Merton Option Pricing model could materially affect the amount of expense recorded in future periods.

 

Revenue Recognition

 

The Company recognizes revenue in accordance with Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers (“ASC 606”). The underlying principle of ASC 606 is to recognize revenue to depict the transfer of goods or services to customers at the amount expected to be collected. ASC 606 creates a five-step model that requires entities to exercise judgment when considering the terms of contract(s), which include (1) identifying the contract or agreement with a customer, (2) identifying our performance obligations in the contract or agreement, (3) determining the transaction price, (4) allocating the transaction price to the separate performance obligations, and (5) recognizing revenue as each performance obligation is satisfied.

F-8

 

Revenue and costs of sales are recognized when control of the products transfers to our customer, which generally occurs upon shipment from our facilities. The Company’s performance obligations are satisfied at that time. The Company does not have any significant contracts with customers requiring performance beyond delivery, and contracts with customers contain no incentives or discounts that could cause revenue to be allocated or adjusted over time. Shipping and handling activities are performed before the customer obtains control of the goods and therefore represent a fulfillment activity rather than a promised service to the customer.

 

All of the Company’s products are offered for sale as finished goods only, and there are no performance obligations required post-shipment for customers to derive the expected value from them.

 

The Company does not allow for returns, except for damaged products when the damage occurred pre-fulfillment. Damaged product returns have historically been insignificant. Because of this, the stand-alone nature of our products, and our assessment of performance obligations and transaction pricing for our sales contracts, we do not currently maintain a contract asset or liability balance for obligations. We assess our contracts and the reasonableness of our conclusions on a quarterly basis.

 

Cost of Goods Sold

 

Cost of goods sold is comprised of the costs of raw materials and packaging utilized in the manufacture of products, co-packing fees, repacking fees, in-bound freight charges, as well as certain internal transfer costs. Additionally, cost of goods sold includes direct production costs in excess of charges allocated to finished goods in production. Plant costs include labor costs, production supplies, repairs and maintenance, depreciation, direct inventory write-off charges and adjustments to the inventory reserve. Charges for labor and overhead allocated to finished goods are determined on a market cost basis, which may be lower than the actual costs incurred. Plant costs in excess of production allocations are expensed in the period incurred rather than added to the cost of finished goods produced. Expenses not related to the production of our products are classified as operating expenses.

 

F-9

Delivery and Handling Expense

 

Shipping and handling costs are comprised of purchasing and receiving, inspection, warehousing, transfer freight, and other costs associated with product distribution after manufacture and are included as part of operating expenses.

 

Advertising Costs

 

Advertising costs are expensed as incurred and are included in selling and marketing expense. Advertising costs aggregated $1,5181,418 and $2,5701,518 for the years ended December 31, 20202021 and 2019,2020, respectively.

 

Stock Compensation Expense

 

The Company periodically issues stock options and restricted stock awards to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for such grants issued and vesting based on ASC 718, Compensation-Stock Compensation whereby the value of the award is measured on the date of grant and recognized for employees as compensation expense on the straight-line basis over the vesting period. Recognition of compensation expense for non-employees is in the same period and manner as if the Company had paid cash for the services. The Company recognizes the fair value of stock-based compensation within its Statements of Operations with classification depending on the nature of the services rendered.

 

The fair value of the Company’s stock options is estimated using the Black-Scholes-Merton Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or restricted stock, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes-Merton Option Pricing model and based on actual experience. The assumptions used in the Black-Scholes-Merton Option Pricing model could materially affect compensation expense recorded in future periods.

F-9

 

Income Taxes

 

The Company uses an asset and liability approach for accounting and reporting for income taxes that allows recognition and measurement of deferred tax assets based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. A valuation allowance is provided for deferred tax assets if it is more likely than not these items will either expire before the Company is able to realize their benefits, or that future deductibility is uncertain. The Company’s policy is to recognize interest and/or penalties related to income tax matters in income tax expense.

 

Loss per Common Share

 

Basic earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of shares of common stock outstanding during the year. Diluted earnings (loss) per share is computed by dividing the net income applicable to common stockholders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Potential common shares are excluded from the computation when their effect is antidilutive.

 

F-10

For the years ended December 31, 20202021 and 2019,2020, the calculations of basic and diluted loss per share are the same because potential dilutive securities would have had an anti-dilutive effect. The potentially dilutive securities consisted of the following:

Schedule of Potentially Dilutive Securities

 

December 31,

2020

  

December 31,

2019

  

December 31, 2021

 

December 31, 2020

 
Convertible note to a related party  -   2,266,667 
Warrants  3,362,241   6,413,782   4,538,479   3,362,241 
Common stock equivalent of Series A Convertible Preferred Stock  37,644   37,644   37,644   37,644 
Unvested restricted common stock  150,000   -   111,164   150,000 
Options  9,417,898   3,265,580   10,522,995   9,417,898 
Total  12,967,783   11,983,673   15,210,282   12,967,783 

 

The Series A Convertible Preferred Stock is convertible into Common shares at the rate of 1:4.

 

Fair Value of Financial Instruments

 

The Company uses various inputs in determining the fair value of its financial assets and liabilities and measures these assets on a recurring basis. Financial assets recorded at fair value are categorized by the level of subjectivity associated with the inputs used to measure their fair value. Accounting Standards Codification Section 820 defines the following levels of subjectivity associated with the inputs:

 

Level 1—Quoted prices in active markets for identical assets or liabilities.

Level 2—Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly.

Level 3—Unobservable inputs based on the Company’s assumptions.

 

The carrying amounts of financial assets and liabilities, such as cash and cash equivalents, accounts receivable, short-term bank loans, accounts payable, notes payable and other payables, approximate their fair values because of the short maturity of these instruments. The carrying values of capital lease obligations and long-term financing obligations approximate their fair values because interest rates on these obligations are based on prevailing market interest rates.

 

As of December 31, 2020, and 2019, the Company’s balance sheets included Level 2 liabilities comprised of the fair value of warrant liabilities aggregating $0 and $8, respectively (see Note 10).

Segments

 

The Company operates in one 1segment for the manufacture and distribution of our products. In accordance with the “Segment Reporting” Topic of the ASC, the Company’s chief operating decision maker has been identified as the Chief Executive Officer and President, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Existing guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about products and services, major customers, and the countries in which the entity holds material assets and reports revenue. All material operating units qualify for aggregation under “Segment Reporting” due to their similar customer base and similarities in:in economic characteristics;characteristics, nature of products and services;services, and procurement, manufacturing and distribution processes. Since the Company operates in one segment, all financial information required by “Segment Reporting” can be found in the accompanying financial statements.

 

F-10

Concentrations

 

The Company’s cash balances on deposit with banks are guaranteed by the Federal Deposit Insurance Corporation (FDIC) up to $250. Generally, the Company’s policy is to minimize borrowing costs by immediately applying cash receipts to borrowings against its credit facility. From time to time, however, the Company may be exposed to risk for the amounts of funds held in bank accounts in excess of the FDIC limit. To minimize the risk, the Company’s policy is to maintain cash balances with high quality financial institutions.

 

Gross sales. During the year ended December 31, 2021, the Company’s largest two customers accounted for 19% and 11% of gross sales, respectively. During the year ended December 31, 2020, the Company’s largest two customers accounted for 25% and 12% of gross sales, respectively. During the year ended December 31, 2019, the Company’s largest two customers accounted for 12% and 11% of gross sales, respectively.

 

Accounts receivable. As of December 31, 2021, the Company had accounts receivable from one customer which comprised 18% of its gross accounts receivable. As of December 31, 2020, the Company had accounts receivable from one customer which comprised 23% of its gross accounts receivable. As of December 31, 2019, the Company had accounts receivable from one customer which comprised 14% of its gross accounts receivable.

F-11

 

During the years ended December 31, 20202021 and 2019, respectively,2020, the Company utilized six and four, respectively, separate co-packers for most its production and bottling of beverage products in the United States. With the December 31, 2018 sale of its manufacturing plant, theThe Company no longer conducts a manufacturing operation, accordingly it utilizes co-packers to produce 100% of its products as of those dates.products. The Company has long-standing relationships with two different co-packers, and in conjunction with the sale of its manufacturing plant we entered into a third co-packing agreement with California Custom Beverage LLC (“CCB”), the purchaser of the plant (see Note 15)13). CCB is 100% owned by Chris Reed, founder of the Company and currentformerly Chief InformationExecutive Officer, Chairman, director, and director.most recently, Chief Innovation Officer. Although there are other packers, a change in co-packers may cause a delay in the production process, which could ultimately affect operating results.

 

Purchases from vendors. During the year ended December 31, 2021, the Company’s largest two vendors accounted for approximately 13% and 10% of all purchases, respectively. During the year ended December 31, 2020, the Company’s largest two vendors accounted for approximately 12% and 11% of all purchases, respectively. During the year ended December 31, 2019, the Company’s largest three vendors accounted for approximately 12%, 11%, and 10% of all purchases, respectively.

 

Accounts payable. As of December 31, 201202021, no vendor accounted for more than 10% the total accounts payable. As of December 31, 2020, the Company’s largest two vendors accounted for 12% and 10% of the total accounts payable, respectively. As of December 31, 2019, the Company’s largest three vendors accounted for 19%, 15% and 14% of the total accounts payable, respectively.

 

Recent Accounting Pronouncements

 

In June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments. ASU 2016-13 requires entities to use a forward-looking approach based on current expected credit losses (“CECL”) to estimate credit losses on certain types of financial instruments, including trade receivables. This may result in the earlier recognition of allowances for losses. ASU 2016-13 is effective for the Company beginning January 1, 2023, and early adoption is permitted. The Company does not believe the potential impact of the new guidance and related codification improvements will be material to its financial position, results of operations and cash flows.

 

In August 2020, the FASB issued ASU No. 2020-06 (“ASU 2020-06”) Debt—“Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity.” ASU 2020-06 will simplify the accounting for convertible instruments by reducingreduces the number of accounting models for convertible debt instruments by eliminating the cash conversion and beneficial conversion models. The diluted net income per share calculation for convertible preferred stock. Limitinginstruments will require the accounting models will result in fewer embedded conversion features being separately recognized fromCompany to use the host contract as compared with current GAAP. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting and (2) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. ASU 2020-06 also amends the guidance for the derivatives scope exception forif-converted method. For contracts in an entity’s own equity, the type of contracts primarily affected by this update are freestanding and embedded features that are accounted for as derivatives under the current guidance due to reduce form-over-substance-based accounting conclusions.a failure to meet the settlement conditions of the derivative scope exception. This update simplifies the related settlement assessment by removing the requirements to (i) consider whether the contract would be settled in registered shares, (ii) consider whether collateral is required to be posted, and (iii) assess shareholder rights. ASU 2020-06 will beis effective January 1, 2024, for the Company January 1, 2024.and the provisions of this update can be adopted using either the modified retrospective method or a fully retrospective method. Early adoption is permitted, but no earlier than January 1, 2021, including interim periods within that year. Management is currently evaluatingEffective January 1, 2021, the effect of the adoption ofCompany early adopted ASU 2020-06 and that adoption did not have an impact on theour financial statements but currently does not believe ASU 2020-06 will have a significant impact on the Company’s accounting for its convertible debt instruments. The effect will largely depend on the composition and terms of the financial instruments at the time of adoption.related disclosures.

F-11

 

Other recent accounting pronouncements issued by the FASB, its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future financial statements.

 

3. Inventory

 

Inventory is valued at the lower of cost (first-in, first-out) or net realizable value and net of reserves is comprised of the following (in thousands):

Schedule of Inventory

 

December 31,

2020

  

December 31,

2019

  

December 31, 2021

 

December 31, 2020

 
Raw materials and packaging $6,793  $4,261  $11,221  $6,793 
Finished products  4,326   6,247   5,828   4,326 
Total $11,119  $10,508  $17,049  $11,119 

 

F-12

The Company has recorded a reserve for slow moving and potentially obsolete inventory. The reserve at December 31, 2020 and 2019 was $194 and $646, respectively.

4. Property and Equipment

 

Property and equipment is comprised of the following (in thousands):

Schedule of Property and Equipment

 

December 31,

2020

  

December 31,

2019

  December 31, 2021  December 31, 2020 
Right-of-use assets under operating leases $724  $730  $724  $724 
Right-of-use assets under finance leases  54   179   -   54 
Computer hardware and software  400   543   400   400 
Machinery and equipment  103   83   429   103 
Total cost  1,281   1,535   1,553   1,281 
Accumulated depreciation and amortization  (361)  (482)  (561)  (361)
Net book value $920  $1,053  $992  $920 

 

Depreciation expense for the years ended December 31, 20202021 and 20192020 was $88143 and $2488, respectively, and amortization of right-of-use assets for the years ended December 31, 20202021 and 20192020 was $116 100and $91116, respectively. During the year ended December 31, 2021, the Company disposed of right-of-use assets under finance leases with a cost of $48 and accumulated amortization of $38 and terminated $13 of related finance leases payable (see Note 8). During the year ended December 31, 2020, the Company disposed of right-of-use assets under finance leases with a net book value of $51and terminated $51of related finance leases (see Note 9)8). Additionally, during the year ended December 31, 2020, the Company reclassified $6of right-of-use assets under operating leases to right-of-use assets under finance leases and disposed of fully depreciated computer hardware and software of $244with zero 0net book value.

 

Equipment held for sale consists of the following (in thousands):

Schedule of Equipment Held for Sale

 

December 31,

2020

  

December 31,

2019

  

December 31, 2021

 

December 31, 2020

 
Equipment held for sale $163  $163  $                -  $163 
Reserve  (96)  (96)  -   (96)
Net book value $67  $67  $-  $67 

 

The balance as ofDuring the year ended December 31, 20202021, the Company disposed the equipment held for sale and 2019 consistsrecorded a loss on disposal of residual manufacturing equipment, at estimated net realizable value, which management anticipates selling during 2021.$67.

F-12

 

5. Intangible Assets

 

Intangible assets are comprised of brand names acquired, specifically Virgil’s, and costs related to trademarks. They have been assigned an indefinite life, as we currently anticipate that they will contribute cash flows to the Company perpetually. These indefinite-lived intangible assets are not amortized but are assessed for impairment annually and evaluated annually to determine whether the indefinite useful life remains appropriate. We first assess qualitative factors to determine whether it is more likely than not that the asset is impaired. If further testing is necessary, we compare the estimated fair value of our asset with its book value. If the carrying amount of the asset exceeds its fair value, as determined by the discounted cash flows expected to be generated by the asset, an impairment loss is recognized in an amount equal to that excess. Based on management’s assessment, there were 0 indications of impairment at December 31, 2020.2021.

 

During the year ended December 31, 2020,2021, the Company capitalized costs of $399 pertaining to legal and other fees incurred in applying for international trademarks for Reeds and Virgil’s brands.

Intangible assets consist of the following (in thousands):

Summary of Intangible Assets

 

December 31,

2020

  

December 31,

2019

  December 31, 2021  December 31, 2020 
Brand names $576  $576  $576  $576 
Trademarks  39   -   48   39 
Total $615  $576  $624  $615 

 

F-13

6. Line of Credit

 

Amounts outstanding under the Company’s credit facilities are as follows (in thousands):

Schedule of Amount Outstanding Under Credit Facilities

  

December 31,

2020

  

December 31,

2019

 
Line of Credit $        -  $3,661 
Capitalized finance costs  -   (484)
Net balance $-  $3,177 
  December 31, 2021  December 31, 2020 
Line of Credit $10,229  $                - 

On October 4, 2018, the Company entered into a financing agreement with Rosenthal & Rosenthal, Inc. (“Rosenthal”). The financing agreement provides a maximum borrowing capacity of $13,000. Borrowings are based on a formula of eligible accounts receivable and inventories (the “permitted borrowings”) plus advances (an “over-advance” of up to $4,000) in excess of permitted borrowings. At December 31, 2020,2021, the unused borrowing capacity under the financing agreement was $5,166109. The line of credit maturesautomatically renews each year until terminated. The line of credit matured on March 30, 2022 and was automatically renewed to mature on March 30, 20212023, with automatic yearly renewals thereafter until terminated..

 

Borrowings under the Rosenthal financing agreement bear interest at the greater of prime or 4.75%, plus an additional 2.0% to 3.5% depending on whether the borrowing is based upon receivables, inventory or is an over-advance. Additionally, the line of credit is subject to monthly facility and administration fees, and aggregate minimum monthly fees (including interest) of $4.

 

The line of credit is secured by substantially all of the assets, excluding intellectual property, of the Company. The over-advance is secured by all of Reed’s intellectual property collateral. Additionally, any over-advance iswas guaranteed by an irrevocable stand-by letter of credit in the amount of $1,500, issued by Daniel J. Doherty III and the Daniel J. Doherty, III 2002 Family Trust, affiliates of Raptor/Harbor Reeds SPV LLC (“Raptor”). As of December 31, 2020, Raptor beneficially owns 7.4% ofOn March 11, 2021, the Company’s outstanding common stock. In the event of a default underCompany entered into an amendment to the financing agreement, releasing that irrevocable standby letter of credit of $1,500 by Raptor haswith a put option to purchase from Rosenthal the entire amount$2,000 pledge of any outstanding over-advance plus accrued interest, priorsecurities to Rosenthal declaring an eventby John J. Bello and Nancy E. Bello, as Co-Trustees of default underThe John and Nancy Bello Revocable Living Trust.

John J. Bello, current Chairman and former Interim Chief Executive Officer of Reed’s, is a related party. He is also a greater than 5% beneficial owner of Reed’s common stock. As consideration for the collateral support, Mr. Bello received 400,000 shares of Reed’s restricted stock. The Company determined the fair value of the 400,000 restricted stock to be $472 which was recorded as a prepaid financing agreement.costs of which $75 remains in prepaid expenses and other current assets on the balance sheet at December 31, 2021. The prepaid financing fee is to be amortized over a twelve-month period. During the year ended December 31, 2021, the company amortized $397 of the prepaid financing costs to interest expense.

 

The financing agreement with Rosenthal includes customary restrictions that limit our ability to engage in certain types of transactions, including our ability to utilize tangible and intangible assets as collateral for other indebtedness. Additionally, the agreement contains a financial covenant that requires us to meet certain minimum working capital and tangible net worth thresholds as of the end of each quarter. We were in compliance with the terms of our agreement with Rosenthal as of December 31, 2020.2021.

F-13

 

The Company annually incurs an additional $130 of fees from the bank, which is equal to 1% of the $13,000$13,000 borrowing limit. These costs have been capitalized and recorded as a debt discount and are amortized over the remaining life of the Rosenthal agreement. Amortization of debt discount was $452 and $323 for the year ended December 31, 2020 and 2019, respectively. On December 31, 2020, the remaining unamortized debt discount of $162 is included in prepaid expense and other current assets on the balance sheet.

7. Convertible Note to a Related Party

The Convertible Note to a Related Party consists Amortization of the following (in thousands):

Schedule of Convertible Notes

  

December 31,

2020

  

December 31,

2019

 
12% Convertible Note Payable $       -  $3,400 
Accrued Interest  -   1,289 
Total obligation $-  $4,689 

On April 21, 2017, pursuant to a Securities Purchase Agreement, the Company issued a secured, convertible, subordinated, non-redeemable note in the principal amount ofdebt discount was $3,400 (the “Raptor Note”) and warrants to purchase 1,416,667 shares of common stock.

The Raptor Note bears interest at a rate of 12% per annum, compounded monthly. It is secured by the Company’s assets, subordinate to the first priority security interest of Rosenthal & Rosenthal (see Note 6). The note may not be prepaid and matures on April 21, 2021. It may be converted, at any time and from time to time, into shares of common stock of the Company, at a revised conversion price of $1.50.

The warrant will expire on April 21, 2022162 and has an adjusted exercise price of $1.50452 per share. The note and warrant contain customary anti-dilution provisions, and the shares of common stock issuable upon conversion of the note and exercise of the warrant have been registered on Form S-3. The investor was also granted the right to participate in future financing transactions of the Company for a term of two years.

On December 11, 2020, the Company entered into a Satisfaction, Settlement and Release Agreement with Raptor satisfying all of its obligations to Raptor as its junior secured lender. In full satisfaction of the Raptor Note, including release of collateral, and termination of related junior lender documentation, the Company (a) paid Raptor $4,250 in cash, (b) issued to Raptor a 5-year warrant with a fair value of $402 to purchase 1,000,000 shares of the Company common stock with an exercise price of $0.644 per share, and (c) issued to Raptor 1,339,286 shares of Common Stock with a fair value of $857 upon conversion of $750 of the Raptor Note at a reduced per share conversion price of $0.56 per share. The aggregate amount of the cash paid, the fair value of the warrants issued, and the fair value of shares issued upon conversion of the Raptor Note was approximately $5,509. The carrying amount of the balance of the Raptor note, including accrued interest, was approximately $5,247, resulting in a loss on extinguishment of debt of $262 recorded on the statements of operations during the year ended December 31, 2020.2021, and 2020, respectively. On December 31, 2021, the remaining unamortized debt discount of $65 is included in prepaid expense and other current assets on the balance sheet.

 

F-14

8.

7. Note Payable

 

On April 20, 2020, the Company was granted a loan (the “PPP loan”) from City National Bank in the aggregate amount of $770, pursuant to the Paycheck Protection Program (the “PPP”) under the CARES Act.At December 31, 2020, the note payable balance was $770,. During the year ended December 31, 2021, the Company was notified that its PPP loan forgiveness application was approved in full, and the Company recorded the loan forgiveness as a gain on extinguishment of which $599770 was reflected as the current portion of note payable..

 

The PPP loan agreement is dated April 20, 2020, matures on April 20, 2022, bears interest at a rate of 1% per annum, with the first six months of interest deferred, is payable monthly commencing on November 2020, and is unsecured and guaranteed by the U.S. Small Business Administration. We applied ASC 470, Debt, to account for the PPP loan. Funds from the PPP loan may only be used for qualifying expenses as described in the CARES Act, including qualifying payroll costs, qualifying group health care benefits, qualifying rent and debt obligations, and qualifying utilities. The Company believes it used the entire loan amount for qualifying expenses. Under the terms of the PPP, certain amounts of the loan may be forgiven if they are used for qualifying expenses. The Company was in compliance with the terms of the PPP loan as of December 31, 2020.

F-14

If the conditions outlined in the PPP loan program are adhered to by the Company, all or part of such loan could be forgiven. The Company believes that all or a substantial portion of the PPP loan is eligible for forgiveness. The Company applied for full forgiveness of the PPP loan on March 17, 2021. As for the potential loan forgiveness, once the PPP loan is, in part or wholly, forgiven and a legal release is received, the liability would be reduced by the amount forgiven and a gain on extinguishment would be recorded. However, the Company cannot provide any assurance whether the PPP loan will ultimately be forgiven by the SBA.

9.8. Leases Liabilities

 

The Company determines whether a contract is, or contains, a lease at inception. Right-of-use assets represent the Company’s right to use an underlying asset during the lease term, and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at lease commencement based upon the estimated present value of unpaid lease payments over the lease term. The Company leases its headquarters office, and certain office equipment and automobiles. Leases with an initial term of 12 months or less are not included on the balance sheets.

 

During the years ended December 31, 20202021 and 2019,2020, lease costs totaled $181179 and $181, respectively.

 

As of December 31, 2018, lease liabilities totaled $852, made up of finance leases liabilities of $133 and operating lease liabilities of $719. During the year ended December 31, 2019, the Company made payments of $44 towards its finance lease liability and $22 towards its operating lease liability. As of December 31, 2019, the Company’s lease liabilities totaled $786, made up of finance lease liabilities of $89 and operating lease liabilities of $697. During the year ended December 31, 2020, the Company terminated $51 of finance leases, and made payments of $22 towards its finance lease liability and $28 towards its operating lease liability. As of December 31, 2020, lease liabilities totaled $685, made up of finance lease liabilities of $16 and operating lease liabilities of $669. During the year ended December 31, 2021, the Company terminated $13 of finance leases, and made payments of $2 towards its finance lease liability and $78 towards its operating lease liability. As of December 31, 2021, operating lease liabilities totaled $555.

 

As of December 31, 2020,2021, the weighted average remaining lease terms for an operating lease and finance lease are 4.003.00 years and 0.28 years, respectively.years. As of December 31, 2020,2021, the weighted average discount rate for operating lease is 12.60% and 6.03% for finance lease..

 

Future minimum lease payments under the leases are as follows (in thousands):

Schedule of Future Minimum Lease Payments Under Leases

  Dec 31, 2020 
Years Ending December 31,    Amounts 
2021 $209 
2022  222  $222 
2023  226   226 
2024  221   221 
2025  -   - 
2026  - 
Total payments  878   669 
Less: Amount representing interest  (193)  (114)
Present value of net minimum lease payments  685   555 
Less: Current portion  (130)  (161)
Non-current portion $555  $394 

 

F-15

 

10. Warrant Liability

Various sales of common stock made by the Company to finance operations have been accompanied by the issuance of warrants. Some of these warrant agreements contain fundamental transaction provisions which may give rise to an obligation of the Company to pay cash to the warrant holders. For accounting purposes, in accordance with ASC 480, Distinguishing Liabilities from Equity, those warrants with fundamental transaction terms are accounted for as liabilities given the terms may give rise to an obligation of the Company to the warrant holders. These liabilities are measured at fair value at each reporting period and the change in the fair value is recognized in earnings in the accompanying Statements of Operations.

The fair value of the warrant liability was determined using the Black-Scholes-Merton option pricing model at December 31, 2020 and December 31, 2019, using the following assumptions:

Schedule of Warrant Liability Using Assumptions

  

December 31,

2020

  

December 31,

2019

 
       
Stock Price $0.59  $0.91 
Risk free interest rate  0.48%  1.95%
Expected volatility  76.35%  83.36%
Expected life in years  0.42   1.42 
Expected dividend yield  0%  0%
Number of Warrants containing fundamental transaction provisions  138,762   138,762 
Fair Value of Warrants $-  $8 

The risk-free interest rate is based on rates established by the Federal Reserve Bank. The Company uses the historical volatility of its common stock to estimate its future volatility. The expected life of the warrant is based upon its remaining contractual life. The expected dividend yield reflects that the Company has not paid dividends to its common stockholders in the past and does not expect to do so in the foreseeable future.

The following table sets forth a summary of the changes in the estimated fair value of the warrant liability during the year ended December 31, 2020 and 2019:

Schedule of Warrant Liability

  December 31,
2020
  December 31,
2019
 
Beginning Balance $       8  $38 
Change in fair value  (8)  (30)
Ending balance $-  $8 

11. 9. Stockholders’ Equity

 

Series A Convertible Preferred Stock

 

Series A Convertible Preferred Stock (the “Preferred Stock”) consists of $10 par value, 5% non-cumulative, non-voting, participating preferred stock, with a liquidation preference of $10.00 per share. 500,000 shares are authorized. As of December 31, 2020,2021, and 2019,2020, there were 9,411 shares outstanding. Each share of Preferred Stock can be converted into four shares of the Company’s common stock.

 

Dividends are payable at the rate of 5% annually, pro-rata and non-cumulative. The dividend can be paid in cash or, at the discretion of our board of directors, in shares of common stock based on its then fair market value. The Company cannot declare or pay any dividend on shares of our common stock until the holders of the Preferred Stock have received their annual dividend. In addition, the holders of the Preferred Stock are entitled to receive pro rata distributions of dividends on an “as converted” basis with the holders of our common stock.

 

F-16

In the event of any liquidation, dissolution or winding up of the Company, or if there is a change of control event as defined, the holders of the Preferred Stock are entitled to receive, prior to distributions to the holders of common stock, $10.00$10.00 per share plus all accrued and unpaid dividends. Thereafter, all remaining assets are distributed pro rata among all security holders. Since June 30, 2008, the Company has the right, but not the obligation, to redeem all or any portion of the Preferred Stock at $10.00$10.00 per share, the original issue price, plus all accrued and unpaid dividends.

 

The Preferred Stock may be converted at any time, at the option of the holder, into four shares of common stock, subject to adjustment in the event of stock splits, reverse stock splits, stock dividends, recapitalization, reclassification, and similar transactions. The Company is obligated to reserve authorized but unissued shares of common stock sufficient to affect the conversion of all outstanding shares of Preferred Stock.

 

Except as provided by law, the holders of the Preferred Stock do not have the right to vote on any matters, including the election of directors. However, so long as any shares of Preferred Stock are outstanding, the Company shall not, without the approval of a majority of the preferred stockholders, authorize or issue any equity security having a preference over the Preferred Stock with respect to dividends, liquidation, redemption or voting, including any other security convertible into or exercisable for any senior preferred stock.

 

During the yearsyear ended December 31, 2020, and 2019, the Company paid dividends on the Preferred Stock through the issuance of 4,530 and 4,254 shares of its common stock, respectively, which based upon the then-current market price of the stock equated to dividends of $5 in each of the years. NoDuring the year ended December 31, 2021, the Company accrued dividends on the Preferred Stock of $5 and is included in accrued expenses in the accompanying balance sheets. NaN shares of Series A preferred stock were converted into common stock in 20202021 and 2019.2020.

 

Common Stock

 

The Company’s common stock has a par value of $.0001. On December 30, 2021, our shareholders approved an increase in the authorized number of common shares from 120,000,000 to 180,000,000. On December 21, 2020, our shareholders approved an increase in the authorized number of common shares from 100,000,000 to 120,000,000. As of December 31, 2020,2021, there were 120,000,000180,000,000 shares authorized, with 86,317,096 outstanding. As of December 31, 2019, there were 100,000,000shares authorized, and 47,595,20693,733,975 shares of common stock outstanding. As of December 31, 2020, there were 120,000,000shares authorized with 86,317,096 shares of common stock outstanding.

 

F-16

Common Stock Issuance

In May 2021, the Company conducted a public offering of 6,680,000 shares of its common shares at a public offering price of $1.18 per share. The net proceeds to the Company from this offering are $7,327, after deducting underwriting discounts and commissions and other offering expenses.

 

In November 2020, the Company conducted a public offering of 21,562,500 shares of its common shares at a public offering price of $0.56 per share. The net proceeds to the Company from this offering are $11,254, after deducting underwriting discounts and commissions and other offering expenses.

 

In April 2020, the Company conducted a public offering of 15,333,334 shares of its common shares at a public offering price of $0.375 per share. The net proceeds to the Company from this offering are $5,310, after deducting underwriting discounts and commissions and other offering expenses.

 

In October 2019, the Company conducted a public offering of 13,416,667Common stock repurchases shares of its common shares at a public offering price of $0.60 per share. The net proceeds to the Company from this offering are $7,474, after deducting underwriting discounts and commissions and other offering expenses.

 

In February 2019,During the year ended December 31, 2021, the Company conducted a public offering ofrepurchased 7,733,75013,493 shares of its common shares at a public offering pricestock from an officer for $15 based on the market value of $2.10 per share.share on the date repurchased. The net proceeds toCompany retired the Company from this offering are $14,867shares., after deducting underwriting discounts and commissions and other offering expenses.

 

12. 10. Share-Based Payments

 

Management believes that the ability to issue equity compensation, in order to incentivize performance by employees, directors, and consultants, is essential to the Company’s growth strategy.

 

On September 29, 2017, the 2017 Compensation Plan (the “2017 Plan”) was approved by our shareholders. Initially it provided for the issuance of up to 3,000,000 shares. On December 13, 2018 our shareholders approved a 3,500,000 share increase in the number of shares issuable under the 2017 Plan. Options issued and forfeited under the 2017 Plan contain an Evergreen provision and cannot be re-priced without shareholder approval. As of December 31, 2020 and 2019, shares issuable under the 2017 Plan were 1,168,258 and 3,436,864, respectively. With the shareholder approval of the 2020 Equity Incentive Plan on December 21, 2020, no further shares will be issued from the 2017 Compensation Plan.

 

F-17

On December 21, 2020, the 2020 Equity Incentive Plan (the “2020 Plan”) was approved by our shareholders. The 2020 Plan provides for the issuance of up to 8,500,000shares. Options issued and forfeited under the 2020 plan contain an Evergreen provision and cannot be re-priced without shareholder approval. As of December 31, 2020,2021, shares issuable under the 2020 Plan were 3,874,048.

 

The 2020 Plan permits the grant of options and stock awards to our employees, directors and consultants. The options may constitute either “incentive stock options” within the meaning of Section 422 of the Internal Revenue Code or “non-qualified stock options”. The Plan is currently administered by the board of directors. The exercise price of an option granted under the plan cannot be less than 100% of the fair market value per share of common stock on the date of the grant of the option. Options may not be granted under the plan on or after the tenth anniversary of the adoption of the plan. Incentive stock options granted to a person owning more than 10% of the combined voting power of the common stock cannot be exercisable for more than five years.years. When an option is exercised, the purchase price of the underlying stock is received in cash, except that the plan administrator may permit the exercise price to be paid in any combination of cash, shares of stock having a fair market value equal to the exercise price, or as otherwise determined by the plan administrator.

 

F-17

Restricted common stock

 

The following table summarizes restricted stock activity during the years ended December 31, 20202021 and 2019:2020:

Summary of Non-vested Restricted Stock Activity

 Unvested
Shares
  Issuable
Shares
  Fair Value
at Date of
Issuance
  Weighted
Average
Grant Date
Fair Value
  Unvested
Shares
  Issuable
Shares
  Fair Value
at Date of
Issuance
  Weighted
Average
Grant Date
Fair Value
 
Balance, December 31, 2018  598,370   -  $592  $1.63 
Balance, December 31, 2019  -   -  $-  $- 
Granted  46,035   -   132   2.88   594,740   -   508   0.85 
Vested  (488,037)  488,037   -   -   (444,740)  444,740   -   - 
Forfeited  (156,368)  -   (218)  1.60   -   -   -   - 
Issued  -   (488,037)  (506)  -   -   (444,740)  (416)  - 
Balance, December 31, 2019  -   -   -   - 
Balance, December 31, 2019  -   -   -   - 
Balance, December 31, 2020  150,000   -   92   0.89 
                
Granted  594,740   -   508   0.85   245,900   -   226   0.92 
Vested  (444,740)  444,740   -   -   (282,727)  282,727   -   - 
Forfeited  (2,009)  -   -   0.89 
Issued  -   (444,740)  (416)  -   -   (282,727)  (264)  - 
Balance, December 31, 2020  150,000   -  $92  $0.89 
Balance, December 31, 2021  111,164   -  $54  $0.89 

During the year ended December 31, 2021, the Company issued 245,900 restricted stock awards to five non-employee directors. 61,475 of these restricted stock awards vested on February 1, 2021, May 1, 2021, August 1, 2021, and November 1, 2021. The aggregate fair value of the stock awards was $226 based on the market price of our common stock price which was $0.92 per share on the date of grants and is amortized as shares vest.

 

During the year ended December 31, 2020, the Company issued 594,740 shares of restricted stock to a director and two executive employees. 350,000 of these shares vested immediately, 94,740 shares vested in increments of 47,370 each over a two-month period of October and November 2020, 75,000 shares will vest in increments of 18,750 each over four years from the date of grant, and 75,000 shares will vest over four years based on performance criteria determined by the Board of Directors or Compensation Committee. Unvested shares remain subject to forfeiture if vesting conditions are not met. The aggregate fair value of the stock awards was $508 based on the market price of our common stock price which ranged from $0.81 to $0.95 per share on the dates of grants and is amortized as shares vest.

The total fair value of restricted common stock vesting during the year ended December 31, 20202021 and 20192020 was $416243 and $506416, respectively, and is included in general and administrative expenses in the accompanying statements of operations. As of December 31, 2020,2021, the amount of unvested compensation related to issuances of restricted common stock was $9254, which will be recognized as an expense in future periods as the shares vest. When calculating basic loss per share, these shares are included in weighted average common shares outstanding from the time they vest. When calculating diluted net income per share, these shares are included in weighted average common shares outstanding as of their grant date.

 

F-18

In 2018, the Company awarded an aggregate of 784,004 shares of restricted common stock to Valentin Stalowir, former Chief Executive Officer of the Company, pursuant to his employment agreement with the Company. The 784,004 restricted shares had an aggregate fair value of $1,291 based on the market price of our common stock on the dates of grant. Of the 784,004 restricted shares, 185,634 shares vested and were issued during 2018. On October 31, 2019, the Company entered into a Separation, Settlement and Release of Claims Agreement with Mr. Stalowir in connection with his resignation as Chief Executive Officer and the subsequent termination of his employment. As part of the Agreement, 442,002 shares of restricted common stock issued in 2018 vested and were issued, and the balance of 156,368 unvested shares of restricted common stock issued to Mr. Stalowir in 2018 were forfeited. During the year ended December 31, 2019, the Company recognized $374 as compensation expense related to the fair value of vested restricted shares.

During the year ended December 31, 2019, the Company issued 46,035 shares of restricted stock to members of the board of directors. 17,652 shares vested immediately and the balance of 28,383 shares vested throughout 2019. The aggregate fair value of the stock awards was $132 based on the market price of our common stock on the dates of grant. During the year ended December 31, 2019, the total of 46,035 shares vested and were issued, and $132 was recognized as compensation expense.

During the year ended December 31, 2019, the Company recognized a total $506 as compensation expense related to vesting of shares of restricted common stock.

Stock Options

 

As of December 31, 2020,2021, the Company has issued stock options to purchase an aggregate of 9,417,89810,522,995 shares of common stock. The Company’s stock option activity during the years ended December 31, 20202021 and 20192020 is as follows:

Schedule of Stock Option Activity

 Shares  Weighted-
Average
Exercise Price
  Weighted-
Average
Remaining
Contractual
Terms (Years)
  Aggregate
Intrinsic
Value
  Shares  Weighted-
Average
Exercise Price
  Weighted-
Average
Remaining
Contractual
Terms (Years)
  Aggregate
Intrinsic
Value
 
Outstanding at December 31, 2018  3,674,286  $2.16   8.53  $1,026 
Granted  1,431,840   2.48         
Exercised  -   -         
Unvested forfeited or expired  (1,571,794)  2.25         
Vested forfeited or expired  (268,702)  3.07         
Outstanding at December 31, 2019  3,265,630  $2.19   7.09  $6 
Outstanding at December 31, 2019  3,265,630  $2.19   7.09   6   3,265,630  $2.19   7.09  $6 
Granted  6,893,752   0.87           6,893,752   0.87         
Exercised  (37,500)  0.50           (37,500)  0.50         
Unvested forfeited or expired  (515,941)  2.10           (515,941)  2.10         
Vested forfeited or expired  (188,043)  4.20           (188,043)  4.20         
Outstanding at December 31, 2020  9,417,898  $1.19   8.55  $78   9,417,898  $1.19   8.55  $78 
Exercisable at December 31, 2020  2,266,440  $1.45   6.09  $78 
Granted  3,386,882   1.05         
Exercised  (63,000)  0.50         
Unvested forfeited or expired  (2,052,954)  1.22         
Vested forfeited or expired  (165,831)  2.83         
Outstanding at December 31, 2021  10,522,995  $1.12   7.88  $- 
Exercisable at December 31, 2021  3,671,949  $1.24   6.40  $- 

During the year ended December 31, 2021, the Company received proceeds of $32 and issued 63,000 shares of common shares on the exercise of stock options.

During the year ended December 31, 2021, the Company approved options exercisable into 3,386,882 shares to be issued pursuant to Reed’s 2020 Equity Incentive Plan. 3,386,882 options were issued to employees, 1,693,441 options vesting annually over a four-year vesting period, and 1,693,441 options that will vest based on performance criteria to be established by the board of directors

The stock options are exercisable at prices ranging from $0.98 to $1.18 per share and expire in ten years. The total fair value of these options at grant date was approximately $2,412, which was determined using a Black-Scholes-Merton option pricing model with the following average assumption: stock price of $1.05 per share, expected term of six years, volatility of 79%, dividend rate of 0%, and weighted average risk-free interest rate of 0.98%. The expected term represents the weighted-average period of time that share option awards granted are expected to be outstanding giving consideration to vesting schedules and historical participant exercise behavior; the expected volatility is based upon historical volatility of the Company’s common stock; the expected dividend yield is based on the fact that the Company has not paid dividends in the past and does not expect to pay dividends in the future; and the risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of measurement corresponding with the expected term of the share option award.

 

During the year ended December 31, 2020, the Company approved options exercisable into 4,625,952 shares to be issued pursuant to Reed’s 2020 Equity Incentive Plan, and 2,267,800 shares to be issued pursuant to Reed’s 2017 Incentive Compensation Plan. 6,558,752 options were issued to employees including 3,279,376 options that vest annually over a four-yearfour-year vesting period, and 3,279,376 options that will vest based on performance criteria to be established by the board. In addition, 335,000 options granted to consultants, board members, and former employees vest over various periods.

F-19

 

The stock options are exercisable at a weighted average price $0.87 per share and expire in ten years. The total fair value of these options at grant date was approximately $3,561, which was determined using a Black-Scholes-Merton option pricing model with the following average assumption: average stock price of $0.87$0.87 per share, weight average expected term of 5.91 years, weighted average volatility ranging from 76%, dividend rate of 0%, and weighted average risk-free interest rate of 0.48%. The fair value of the options of $3,561$3,561 will be amortized as the options vest over a weighted average period of 2.67 years.

 

During the year ended December 31, 2019, the Company approved options to be issued pursuant to Reed’s 2017 Incentive Compensation Plan to certain current employees totaling 1,258,000 shares. One half of these options vest annually over a four-year vesting period; the other half of these options will vest based on performance criteria to be established by the board. In addition, during the year ended December 31, 2019, the Company granted options to purchase 113,330 shares of common stock to new board members. Options granted to consultants, former employees, and board members vest at various periods. On September 11, 2019, the Company granted options to purchase 60,510 shares of common stock to certain consultants. None of the options granted to the consultants to purchase 60,510 shares of common stock vested and were forfeited, resulting in 0 compensation expense.

The stock options are exercisable at a price ranging from $2.33 to $3.37 per share and expire in ten years. Total fair value of these options at grant date was approximately $911, which was determined using the Black-Scholes-Merton option pricing model with the following average assumption: stock price ranging from $2.33 to $3.37 per share, expected term of seven years, volatility of 61%, dividend rate of 0% and risk-free interest rate ranging from 1.39% to 2.60%.

In the measurement of stock options granted in 20202021 and 2019,2020, the expected term represents the weighted-average period of time that share option awards granted are expected to be outstanding giving consideration to vesting schedules and historical participant exercise behavior; the expected volatility is based upon historical volatility of the Company’s common stock; the expected dividend yield is based on the fact that the Company has not paid dividends in the past and does not expect to pay dividends in the future; and the risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of measurement corresponding with the expected term of the share option award.

 

During the year ended December 31, 20202021 and 2019,2020, the Company recognized $1,1761,684 and $7901,176 of compensation expense relating to vested stock options. As of December 31, 2020,2021, the aggregate amount of unvested compensation related to stock options was approximately $3,5612,833 which will be recorded as an expense in future periods as the options vest.

 

F-19

As of December 31, 2020,2021, the outstanding options have anno intrinsic value of $78.value. The aggregate intrinsic value was calculated as the difference between the closing market price as of December 31, 2020,2021, which was $0.590.36, and the exercise price of the outstanding stock options.

 

Additional information regarding options outstanding and exercisable as of December 31, 2020,2021, is as follows:

Schedule of Information Regarding Stock Options

   Options Outstanding  Options Exercisable 
Range of Exercise Price  Number of
Shares
Outstanding
  Weighted
Average
Exercise
Price
  Weighted
Average
Remaining
Contractual
Life (years)
  Number of
Shares
Exercisable
  Weighted
Average
Exercise
Price
 
$0.50 - $0.88   1,860,300  $0.66   9.05   860,300  $0.50 
$0.89 - $1.34   4,975,952   0.95   9.70   -   - 
$2.49 - $3.74   1,899,605   1.74   5.96   1,060,240   1.72 
$2.49 - $3.74   582,091   2.78   6.92   245,950   2.69 
$5.01 - $5.01   99,950   3.74   1.05   99,950   3.74 
     9,417,898  $1.19   8.55   2,266,440  $1.45 

F-20

   Options Outstanding  Options Exercisable 
Range of Exercise Price  Number of
Shares
Outstanding
  Weighted
Average
Exercise
Price
  Weighted
Average
Remaining
Contractual
Life (years)
  Number of
Shares
Exercisable
  Weighted
Average
Exercise
Price
 
$0.50 - $0.88   1,749,336  $0.66   8.18   1,022,824  $0.57 
$0.89 - $1.34   6,718,000   0.99   8.76   1,145,591   0.95 
$1.60 - $2.40   1,609,753   1.73   4.43   1,222,878   1.72 
$2.44 - $3.66   415,906   2.71   6.23   250,656   2.82 
$3.74 - $5.61   30,000   3.74   0.75   30,000   3.74 
     10,522,995  $1.12   7.88   3,671,949  $1.12 

 

13. 11. Stock Warrants

 

As of December 31, 2020,2021, the Company has issued warrants to purchase an aggregate of 3,362,2414,538,479 shares of common stock. The Company’s warrant activity during the years ended December 31, 20202021 and 20192020 is as follows:

Schedule of Warrant Activity

 Shares  

Weighted

-Average Exercise Price

  Weighted-Average Remaining Contractual Terms (Years)  Aggregate Intrinsic Value  Shares  

Weighted

-Average Exercise Price

  Weighted-Average Remaining Contractual Terms (Years)  Aggregate Intrinsic Value 
                  
Outstanding at December 31, 2018  6,897,277  $2.06    2.42  $1,447 
Granted  -   -         
Exercised  (283,495)  2.09         
Forfeited or expired  (200,000)   5.60         
Outstanding at December 31, 2019  6,413,782   2.06   1.52  $- 
Outstanding at December 31, 2019  6,413,782   2.06   1.52  $-   6,413,782  $2.06   1.52  $                   - 
Granted  1,000,000   0.64           1,000,000   0.64         
Exercised  -   -           -   -         
Forfeited or expired  (4,051,541)  2.03           (4,051,541)  2.03         
Outstanding at December 31, 2020  3,362,241  $1.56   2.49  $-   3,362,241   1.56   2.49  $- 
Exercisable at December 31, 2020  3,362,241  $1.56   2.49  $- 
Granted  1,500,000   0.46         
Exercised  -   -         
Forfeited or expired  (323,762)  4.04         
Outstanding at December 31, 2021  4,538,479  $1.02   2.77  $- 
Exercisable at December 31, 2021  4,538,479  $1.02   2.77  $- 

 

On November 24, 2021, the Company granted John Bello, current Chairman, significant shareholder and former Interim Chief Executive Officer of Reed’s, who is a related party, a 5-year warrant to purchase 1,500,000 shares of the Company common stock with an exercise price of $0.46. The fair value of the warrants granted was determined to be $458 and was recorded as a prepaid financing costs. During the year ended December 31, 2021, the Company amortized $148 of prepaid financing costs to interest expense, leaving a balance remaining of $310 to be amortized through July 2022. The fair value of the warrant was calculated using the Black-Scholes option pricing model using the following assumptions – stock price of $0.46; exercise price of $0.44; expected life of 5 years; volatility of 84.7%; dividend rate of 0% and discount rate of 0.77%. As of December 31, 2021, the outstanding warrants have no intrinsic value. The risk-free interest rate is based on rates established by the Federal Reserve Bank. The Company uses the historical volatility of its common stock to estimate its future volatility. The expected life of the warrant is based upon its remaining contractual life. The expected dividend yield reflects that the Company has not paid dividends to its common stockholders in the past and does not expect to do so in the foreseeable future.

On December 11, 2020, the Company issued to Raptor a 5-year warrant to purchase 1,000,000 shares of the Company common stock with an exercise price of $0.64 (see Note 7). The fair value of the warrants granted was determined to be $402. The fair value of the warrant was calculated using the Black-Scholes option pricing model using the following assumptions – stock price of $0.64; exercise price of $0.64; expected life of 5 years; volatility of 79%; dividend rate of 0% and discount rate of 0.51%. During the year ended December 31, 2020, warrants to acquire 4,051,541 shares of common stock expired. As of December 31, 2020, the outstanding warrants havehad no intrinsic value.

 

F-20

During the year ended December 31, 2019, a total of 283,495 warrants were exercised, including 87,485 warrants that were exercised on a cashless basis, resulting in the issuance of 223,037 shares of our common stock. Aggregate proceeds to the Company were $365. During the year ended December 31, 2019, warrants to acquire 200,000 shares of common stock expired.

 

Additional information regarding warrants outstanding and exercisable as of December 31, 2020,2021, is as follows:

Schedule of Warrants Outstanding and Exercisable

   Warrants Outstanding  Warrants Exercisable 
Range of Exercise Price  Number of
Shares
Outstanding
  Weighted
Average
Exercise
Price
  Weighted
Average
Remaining
Contractual
Life (years)
  Number of
Shares
Exercisable
  Weighted
Average
Exercise
Price
 
$0.64 - $1.55   2,560,194  $1.17   2.92   2,560,194  $1.17 
$2.00 - $4.25   802,047   2.82   1.11   802,047   2.82 
     3,362,241  $1.56   2.49   3,362,241  $1.56 

   Warrants Outstanding  Warrants Exercisable 
Range of Exercise Price  Number of
Shares
Outstanding
  Weighted
Average
Exercise
Price
  Weighted
Average
Remaining
Contractual
Life (years)
  Number of
Shares
Exercisable
  Weighted
Average
Exercise
Price
 
$0.01 - $0.99   2,500,000  $0.53   4.52   2,500,000  $0.53 
$1.00 - $1.99   1,560,194   1.50   0.64   1,560,194   1.50 
$2.00 - $2.99   478,285   2.00   0.54   478,285   2.00 
     4,538,479  $1.02   2.77   4,538,479  $1.02 

 

14. 12. Income Taxes

 

AtFor the years ended December 31, 2021 and 2020, a reconciliation of the effective income tax rate to the U.S. statutory rate is as follows:

Schedule of Reconciliation of Effective Income Tax Rate to U.S. Statutory Rate

  December 31, 2021  December 31, 2020 
Federal statutory tax rate  (21)%  (21)%
State rate, net of federal benefit  (5)%  (5)%
   (26)%  (26)%
Effect of change in tax rate  -%  -%
Valuation allowance  26%  26%
Effective tax rate $-  $- 

As of December 31, 2021 and 2019,2020, significant components of the Company’s deferred tax assets and liabilities are as follows:

Schedule of Deferred Income Tax Assets

  December 31, 2021  December 31, 2020 
Deferred income tax asset:        
Net operating loss carryforwards $18,573  $15,641 
Disqualified corporate interest expense  1,078   857 
Stock-based compensation  1,764   1,260 
Accounts receivable allowances  26   61 
Inventory reserves  35   51 
Operating lease liability  145   179 
Reserve for asset impairment  58   58 
Gross deferred tax assets  21,679   18,107 
Valuation allowance  (21,490)  (17,903)
Total deferred tax assets  189   203 
Deferred tax liabilities:        
Operating lease right-of-use asset  (189)  (203)
Deferred finance costs  -   - 
Total deferred tax liabilities  (189)  (203)
Net deferred tax asset (liability) $-  $- 

At December 31, 2021 and 2020, the Company had available Federal and state net operating loss carryforwards (“NOL”s) to reduce future taxable income. For Federal purposes the amounts available were approximately $66,00063,000 and $58,00066,000, respectively. For state purposes approximately $42,00036,000 and $34,00042,000 was available at December 31, 20202021 and 2019,2020, respectively. The Federal carryforward for NOLs arising in years prior to 20182019 is approximately $33,00044,000, which expires on various dates through 20372038. NOLs for 2018, 2019, 2020 and 20202021 of approximately 33,00019,000, can be carried forward indefinitely, but are only able to offset 80% of taxable income in future years.years. The state carryforward expires on various dates through 2040.2041. Given the Company’s history of net operating losses, management has determined that it is more likely than not that the Company will not be able to realize the tax benefit of the carryforwards. Accordingly, the Company has not recognized a deferred tax asset for this benefit.

F-21

 

Due to restrictions imposed by Internal Revenue Code Section 382 regarding substantial changes in ownership of companies with loss carryforwards, the utilization of the Company’s NOL may be limited as a result of changes in stock ownership. NOLs incurred subsequent to the latest change in control are not subject to the limitation.

 

The Company recognizes tax benefits from uncertain tax positions only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position is measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement. As of December 31, 20202021 and 2019,2020, the Company did not have a liability for unrecognized tax benefits.

 

The Company recognizes as income tax expense, interest and penalties on uncertain tax provisions. As of December 31, 20202021 and 2019,2020, the Company has not accrued interest or penalties related to uncertain tax positions. Tax years 20162017 through 20202021 remain open to examination by the major taxing jurisdictions to which the Company is subject.

 

Upon the attainment of taxable income by the Company, management will assess the likelihood of realizing the tax benefit associated with the use of the NOLs and will recognize the appropriate deferred tax asset at that time.

 

F-21

Significant components of the Company’s deferred tax assets and liabilities are as follows:

Schedule of Deferred Income Tax Assets

  December 31, 2020  December 31, 2019 
Deferred income tax asset:        
Net operating loss carryforwards $15,641  $12,776 
Disqualified corporate interest expense  857   581 
Stock-based compensation  1,260   942 
Accounts receivable allowances  61   98 
Inventory reserves  51   168 
Operating lease liability  179   181 
Reserve for asset impairment  58   58 
Gross deferred tax assets  18,107   14,804 
Valuation allowance  (17,903)  (14,488)
Total deferred tax assets  203   316 
Deferred tax liabilities:        
Operating lease right-of-use asset  (203)  (190)
Deferred finance costs  -   (126)
Total deferred tax liabilities  (203)  (316)
Net deferred tax asset (liability) $-  $- 

 

Reconciliation of the effective income tax rate to the U.S. statutory rate is as follows:

Schedule of Reconciliation of Effective Income Tax Rate to U.S. Statutory Rate

  December 31, 2020  December 31, 2019 
Federal statutory tax rate  (21)%  (21)%
State rate, net of federal benefit  (5)%  (5)%
   (26)%  (26)%
Effect of change in tax rate  -%  -%
Valuation allowance  26%  26%
Effective tax rate $-  $- 

F-22

15. 13. Related Party Transactions

 

On December 31, 2018, the Company completed the sale of its Los Angeles manufacturing plant to California Custom Beverage, LLC (“CCB”), an entity owned by Christopher J. Reed, a related party, and CCB assumed the monthly payments on our lease obligation for the Los Angeles manufacturing plant. Our release from the obligation by the lessor, however, is dependent upon CCB’s deposit of $1,200 of security with the lessor. The deposit is secured by Mr. Reed’s pledge of common stock to the lessor and guaranteed personally by Mr. Reed and his wife. As of December 31, 2020,2021, $800 has been deposited with the lessor and Mr. Reed has placed approximately 363,000 pledged shares valued at $338131 that remain in escrow with the lessor.

 

Beginning in 2019, we are to receive a 5% royalty on CCB’s private label sales to existing customers for three years and a 5% referral fee on CCB’s private label sales to referred customers for three years. During the year ended December 31, 20202021 and 2019,2020, the Company recorded royalty revenue from CCB of $9872 and $12898, respectively.

 

At December 31, 2019,2020, the Company had royalty revenuean aggregate receivable balance from CCB of $128. In addition, at December 31, 2019, the Company has outstanding receivable from CCB of $228 consisting of inventory advances to CCB. The aggregate receivable from CCB at December 31, 2019 was $356682. During the year ended December 31, 2020,2021, the Company recorded royalty revenue receivable of $98,$72, and advanced inventory and equipmentexpenses of $381179, and reduced CCB receivable by $153 by offsetting CCB payable of $153, leaving an aggregate receivable balance of $682933 at December 31, 2020.2021.

 

At December 31, 20202021, and December 31, 2019,2020, the Company had accounts payable due to CCB of $557614 and $182557, respectively.

Any over-advance on the Company’s line of credit with Rosenthal was guaranteed by an irrevocable stand-by letter of credit in the amount of $1,500, issued by Daniel J. Doherty III and the Daniel J. Doherty, III 2002 Family Trust, affiliates of Raptor/Harbor Reeds SPV LLC (“Raptor”). On March 11, 2020, the Company entered into an amendment to the financing agreement, releasing that irrevocable standby letter of credit of $1,500 by Raptor with a $2,000 pledge of securities to Rosenthal by John J. Bello and Nancy E. Bello, as Co-Trustees of The John and Nancy Bello Revocable Living Trust. John J. Bello, current Chairman, significant shareholder and former Interim Chief Executive Officer of Reed’s, is a related party. As consideration for the collateral support, Mr. Bello received 400,000 shares of Reed’s restricted stock.

On November 24, 2021, the Bello trust provided additional collateral support securing a $2,500,000 over-advance under the Financing Agreement, and John J. Bello also provided a personal guarantee. The additional collateral was released on March 17, 2022 along with the personal guarantee. The initial pledged collateral was released March 30, 2022 with the pay-off of the Rosenthal facility.

 

Lindsay Martin, daughter of a director of the Company, was employed as Vice President of Marketing during the years ended December 31, 20202021 and 2019.2020. Ms. Martin was paid approximately $215181 and $161215, respectively, for her services during the years ended December 31, 20202021 and 2019,2020, respectively.

 

16. 14. Commitments and Contingencies

 

From time to time, we are a party to claims and legal proceedings arising in the ordinary course of business. Our management evaluates our exposure to these claims and proceedings individually and in the aggregate and provides for potential losses on such litigation if the amount of the loss is estimable and the loss is probable.

 

We believe that there are no material litigation matters at the current time. Although the results of such litigation matters and claims cannot be predicted with certainty, we believe that the final outcome of such claims and proceedings will not have a material adverse impact on our financial position, liquidity, or results of operations.

 

17. 15. Subsequent Events

 

On March 11, 2021,10, 2022, the Company entered into an amendmenta Securities Purchase Agreement with certain institutional and accredited investors pursuant to that certain Financing Agreement (see Note 6) dated October 4, 2018, as amended or supplemented with its senior secured lender, Rosenthal & Rosenthal, Inc. (“Rosenthal”) releasing that irrevocable standby letter of credit by Daniel J. Doherty, III and Daniel J. Doherty, III 2002 Family Trust inwhich the amount of $1.5 million, which served as financial collateral for certain obligations of Reed’s under the Rosenthal credit facility, with a $2 million dollar pledge of securitiesinvestors agreed to Rosenthal by John J. Bello and Nancy E. Bello, as Co-Trustees of The John and Nancy Bello Revocable Living Trust, under trust agreement dated December 3, 2012, evidenced by that certain Pledge Agreement to Rosenthal (the “Bello Pledge”).

purchase

John Bello, current Chairman and former Interim Chief Executive Officer of Reed’s, is a related party. He is also a greater than 5% beneficial owner of Reed’s common stock. As consideration for the Bello Pledge, Mr. Bello received 400,00018,594,571 shares of Reed’s restricted stock.the Company’s common stock and warrants to purchase 9,297,289

shares of common stock in a private placement. The Nasdaq Listing Qualifications Department notified the Company on December 2, 2020 that the bidwarrants have an exercise price of our common stock has closed at less than $10.2877 per share overfor a period of five years commencing six months from the previous 30 consecutive business days,closing date of March 11, 2022. The purchase price per share of common stock and as a result, did not comply with Listing Rule 5550(a)(2) (“Bid Price Rule”). On February 22, 2021, Nasdaq Listing Qualifications notifiedassociated warrant was $0.28 for certain investors and was $0.3502 for investors who are officers and directors of the Company that for 10 consecutive business days, from February 5, 2021 to February 19, 2021, the closing bid price of Reed’s common stock was $1.00 per share or greater. Accordingly, Reed’s regainedin compliance with Listing Rule 550(a)(2)the rules of the Nasdaq Stock Market. The net proceeds to the Company, after deducting placement agent fees and other offering expenses, was approximately $5.1 million. The officers and directors of the matter is now closed.Company purchased approximately $1.1 million of the securities in the offering. 

 

On January 26, 2021,March 21, 2022, the boardBoard of directorsDirectors of Reed’s, pursuant to a jointthe Company, upon recommendation from its governance committee, expanded the board from six to seven members and compensation committees, setappointed Mr. Leon M. Zaltzman to serve as director.

Mr. Zaltzman is the cash compensationfounder and managing member of its non-employee directors at $50,000 for fiscal 2021, payable quarterlyUnion Square Park Capital Management, LLC (“USPCM”), and is also the managing member of Union Square Park GP (“USPGP”). USPCM and USPGP serve as the investment manager and general partner to Union Square Park Partners, LP (“USPP Fund”), respectively. Foregoing entities hereinafter collectively referred to as the “Union Square Entities”.

USPP Fund participated in accordance with the company’s policies for non-employee director compensationCompany’s recent private placement of common stock and granted Restricted Stock Awards consisting ofit acquired 49,18010,714,286 shares of common stock and warrants to eachpurchase 5,357,143 shares of common stock for $3,000. Prior to the private placement, Mr. Zaltzman and the Union Square Entities beneficially owned approximately 7.79% of Reed’s common stock. After the private placement, Mr. Zaltzman and the Union Square Entities beneficially owned approximately 14.6% of Reed’s common stock.

On March 28, 2022, the Company entered into a financing agreement with Alterna Capital Solutions (“ACS”), for a line of credit to replace its non-employee directors.existing credit facility. The Restricted Stock Awards ACS line of credit is for a term of 3 years and provides for borrowings of up to $13,000. Borrowings are based upon eligible accounts receivable and inventory. The line of credit is secured by eligible accounts receivable and inventory of the Company. Inventory collateral is set to a maximum of 100% of eligible accounts receivable. An overadvance rider is in place which provides for up to $400 of additional borrowing beyond those amounts (the “Over Advance”).

Borrowings under the ACS financing agreement bear interest of prime plus 4.75% but not less than 8.0% on receivables. Borrowings based on inventory bear an interest of prime plus 5.25% but not less than 8.5%. The additional overadvance rider bears a rate of prime plus 12.75%, but not less than 16.00%. Additionally, the line of credit is subject to monthly monitoring fee of $1 with a minimum usage requirement on the credit facility. A loan balance of less than $1,500 will vestbear interest at a rate in four equal increments on a quarterly basis on eachline with account receivables advances plus the monthly monitoring fee of February $1 2021, May 1, 2021, August 1, 2021.

The Company incurred $503 of direct costs of the transaction, consisting primarily of broker, bank and November 1, 2021, in accordance withlegal fees. These costs have been capitalized and are being amortized over the company’s policies for non-employee director compensation.3-year life of the ACS agreement.

 

Subsequent to December 31, 2020,

On March 30, 2022, the Company issued 86,225 shares of common comprised of 6,000 shares issuedpaid in full its outstanding balance on the exercise of stock options, 61,475 shares of restricted stock issued to directors, and 18,750 shares of restricted stock issued to an executive on vesting.its credit facility with Rosenthal & Rosenthal, Inc.

F-23F-22

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

 

None.

 

Item 9A. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

Under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, we conducted an evaluation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Based on this evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective as of December 31, 20202021 to provide reasonable assurance that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosures.

 

Management’s Annual Report on Internal Control over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act). Our management, with the participation of our Chief Executive Officer and Chief Financial Officer and the oversight of our audit committee, has evaluated the effectiveness of our internal control over financial reporting as of December 31, 2020.2021. In assessing the effectiveness of our internal control over financial reporting, our management used the framework established in Internal Control Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on that evaluation, our management has concluded that our internal control over financial reporting was effective as of December 31, 2020.2021.

 

This Annual Report does not contain an attestation report of our independent registered public accounting firm related to internal control over financial reporting because the rules for smaller reporting companies provide an exemption from the attestation requirement.

 

Remediation of Previously Identified Material Weaknesses

As disclosed in Part II, Item 9A., “Controls and Procedures,” in our Annual Report on Form 10-K for fiscal year ended December 31, 2019, management identified the following control deficiencies during fiscal 2019 that constituted material weaknesses: (1) we did not have controls designed to assess the design and operation of internal controls pertaining to these outsourced information technology service providers over the period of reliance and (2) we did not maintain effective policies to ensure adequate segregation of duties within its accounting processes.

To remediate these previously identified material weaknesses, our management, with oversight from our audit committee, implemented a remediation plan, we designed and implemented controls related to the periodic monitoring and review of outsourced information technology service providers, and we implemented procedures and independent reconciliations of significant accounts to mitigate the lack of segregation of duties.

Based on the actions taken, management determined that our newly designed and enhanced controls were in place and operated effectively for a sufficient period of time to enable us to conclude that the material weaknesses were remediated as of December 31, 2020.

Changes in Internal Control over Financial Reporting

 

Other than as described above in the section “Remediation Efforts on Previously Identified Material Weakness,” thereThere were no other changes in our internal control over financial reporting during the quarterthree-month period ended December 31, 2020,2021, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

Inherent Limitations on Effectiveness of Controls

 

An effective internal control system, no matter how well designed, has inherent limitations, including the possibility of human error or overriding of controls, and, therefore, can provide only reasonable assurance with respect to reliable financial reporting. Because of its inherent limitations, our internal control over financial reporting may not prevent or detect all misstatements, including the possibility of human error, the circumvention or overriding of controls, or fraud. Effective internal controls can provide only reasonable assurance with respect to the preparation and fair presentation of financial statements.

 

Item 9B. Other Information

 

None.On March 28, 2022, the Company entered into a financing agreement with Alterna Capital Solutions (“ACS”), for a line of credit to replace its existing credit facility with Rosenthal & Rosenthal, Inc. The ACS line of credit is for a term of 3 years and provides for borrowings of up to $13,000. Borrowings are based upon eligible accounts receivable and inventory. The line of credit is secured by eligible accounts receivable and inventory of the Company. Inventory collateral is set to a maximum of 100% of eligible accounts receivable. An overadvance rider is in place which provides for up to $400 of additional borrowing beyond those amounts (the “Over Advance”).

Borrowings under the ACS financing agreement bear interest of prime plus 4.75% but not less than 8.0% on receivables. Borrowings based on inventory bear an interest of prime plus 5.25% but not less than 8.5%. The additional overadvance rider bears a rate of prime plus 12.75%, but not less than 16.00%. Additionally, the line of credit is subject to monthly monitoring fee of $1 with a minimum usage requirement on the credit facility. A loan balance of less than $1,500 will bear interest at a rate in line with account receivables advances plus the monthly monitoring fee of $1.

The Company incurred $503 of direct costs of the transaction, consisting primarily of broker, bank and legal fees. These costs have been capitalized and are being amortized over the 3-year life of the ACS agreement.

On March 30, 2022, the Company paid in full its outstanding balance on its credit facility with Rosenthal & Rosenthal, Inc.

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

Not applicable,

 

4235

 

PART III

 

Item 10. Directors, Executive Officers, and Corporate Governance.

 

General

 

Reed’s current directors have terms which will end at the next annual meeting of the stockholders orand until each of their successors areis elected and qualify, subject to their death, resignation or removal.qualified. The following table sets forth certain information with respect to our current directors and executive officers as of December 31, 2020:date of this Annual Report:

 

Name Position Age
Norman E. Snyder, Jr. Chief Executive Officer, Director 5960
Thomas J. Spisak Chief Financial Officer 5354
Neal Cohane Chief Sales Officer 59
Richard H. HubliVice President, Operations63
Christopher J. ReedChief Innovation Officer6260
John J. Bello Chairman of the Board 7475
Lewis Jaffe Director, Chairman of Governance and Compensations Committee, member of Audit and Operations and Compensation CommitteesCommittee 6364
James C. Bass Director, Chairman of the Audit Committee and member of Compensation Committee 6869
Scott R. GrossmanRhonda Kallman Director, Chairmanmember of the Compensation Committee and member of Audit and Governance Committees 4261
Louis Imbrogno, Jr. Director, member of the Audit Committee 7576
Leon M. ZaltmanDirector

52

 

Business Experience of Directors and Executive Officers

 

Norman E. Snyder, Jr. was appointed as Chief Executive Officer and director of Reed’s effective March 1, 2020. Prior to his promotion, Mr. Snyder served as Chief Operating Officer of Reed’s from September 2019 through February 29, 2020. Prior to joining Reed’s, Mr. Snyder served as President and Chief Executive Office for Avitae USA, LLC, an emerging premium new age beverage company that markets and sells a line of ready-to-drink caffeinated waters. Prior to Avitae, he served as the President and Chief Operating Officer for Adina For Life, Inc., President and Chief Executive Officer of High Falls Brewing Company, and Chief Financial Officer, and later Chief Operating Officer of South Beach Beverage Company, known as SoBe. In prior experience, Mr. Snyder served as Controller for National Football League Properties, Inc., and in various roles at PriceWaterhouseCoopers during an eight-year tenure. Mr. Snyder earned a B.S. in Accounting from the State University of New York at Albany.

 

Thomas J. Spisak has served as Chief Financial Officer of Reed’s since December 2019. Prior to joining Reed’s, Mr. Spisak provided financial leadership, including extensive expertise over a broad range of finance functions during his 26 year tenure in the North America region of Diageo, a multinational alcoholic beverage company with net sales over UK £12.9 billion (U.S. $16 billion). Mr. Spisak held numerous positions in multiple divisions of Diageo, most recently serving as Vice President of Finance and Controller of North America. Previously, he held positions of Vice President of Commercial Finance, Director of Business Performance and Senior Finance Director of Marketing and Innovation Decision Support, as well as other roles in finance. Prior to Diageo, Mr. Spisak served at International Masters Publishers, Inc., a private company with publishing activities in 35 countries. Mr. Spisak holds an MBA in International Business from Fairfield University and a Bachelor of Science in Finance from the University of Rhode Island.

 

Neal Cohane has served as Reed’s Chief Sales Officer since March of 2008 and previously as Vice President of Sales since August 2007. From March 2001 until August 2007, Mr. Cohane served in various senior-level sales and executive positions for PepsiCo, most recently as Senior National Accounts Manager, Eastern Division. In this capacity, Mr. Cohane was responsible for all business development and sales activities within the Eastern Division. From March 2001 until November 2002, Mr. Cohane served as Business Development Manager, Non-Carbonated Division within PepsiCo where he was responsible for leading the non-carbonated category build-out across the Northeast Territory. From 1998 to March 2001, Mr. Cohane spent three years at South Beach Beverage Company, most recently as Vice President of Sales, Eastern Region. From 1986 to 1998, Mr. Cohane spent approximately twelve years at Coca-Cola of New York where he held various senior-level sales and managerial positions, most recently as General Manager New York. Mr. Cohane holds a B.S. degree in Business Administration from Merrimack College in North Andover, Massachusetts.

 

Richard H. Hubli was appointed Vice President of Operations effective September 28, 2020. Mr. Hubli has nearly four decades of diversified experience in supply chain and operations management. From January 2015 to the present, he owned and operated Rockhouse Services, LLC, a consultancy focused on operations & supply chain improvement. From July 2014 to January 2015, he served as SVP of Operations for Harvest Hill Beverage Company. Prior, from August 2012 to July 2014, he served as VP of Operations for High Ridge Brands with end-to-end operations accountability of a copacker based supply chain plus new product delivery & quality. From March 2009 to July 2012, he served as VP of Operations of Kozy Shack Enterprises. From March 2008 to March 2009, Mr. Hubli was the VP of Operations for Fuze Beverages leading, directing S&OP; managing all operations/supply chain activities while integrating the business unit into Coca-Cola. From 2000 to 2007, he served as a VP of Operations Strategy Development at Cadbury Schweppes Americas Beverages where he created the long-term operations strategy. From 1991 to 2000, Mr. Hubli worked for the North American division of Colgate Palmolive initially as Director of Technology and later as Director of Supply Chain Development. In these roles he ran new product delivery across all business categories and spearheaded supply chain re-engineering initiatives. At Nestle Foods, where he worked from 1987 to 1991, he held the positions of Manager Coffee/Tea Industrial Engineering and Marketing Manager for the Nescafe brand. Mr. Hubli began his five-year tenure with PepsiCo R&D in 1982 as Program Manager and subsequently became Manager, Concentrate Operations leading copack production of aseptic juices for the Slice brand. He began his career as Logistics Analyst for Maxwell House Coffee, then a division of General Foods, in 1980. Mr. Hubli earned a BS in Industrial Engineering and an MBA, both in 1979 from the University of Rhode Island.

4336

Christopher J. Reed founded our company in 1987. Since inception, Mr. Reed has served in the roles of Chairman, President, and Chief Executive Officer, and is currently the company’s Chief Innovation Officer. Mr. Reed has been a non-independent Director since our incorporation in 1991. Mr. Reed also served as Chief Financial Officer during fiscal year 2007 until October 1, 2007 and again from April 17, 2008 to January 19, 2010. Mr. Reed remains a Director of the company with the election of John Bello as Chairman of the Board by fellow Board members. Mr. Reed has been responsible for our design and products, including the original product recipes, the proprietary brewing process and the packaging and marketing strategies. Mr. Reed received a B.S. in Chemical Engineering in 1980 from Rensselaer Polytechnic Institute in Troy, New York.

 

John J. Bello is Reed’s Chairman and sales and marketing expert. Since 2001, Mr. Bello has been the Managing Director of JoNa Ventures, a family venture fund. From 2004 to 2012 Mr. Bello also served as Principal and General Partner at Sherbrooke Capital, a venture capital group dedicated to investing in leading, early stage health and wellness companies. Mr. Bello is the founder and former CEO of South Beach Beverage Company, the maker of nutritionally enhanced teas and juices marketed under the brand name SoBe. The company was sold to PepsiCo in 2001 for $370 million and in the same year Ernst and Young named Mr. Bello National Entrepreneur of the Year in the consumer products category for his work with SoBe. Before founding SoBe, Mr. Bello spent fourteen years at National Football League Properties, the marketing arm of the NFL and served as its President from 1986 to 1993. As the President, Mr. Bello has been credited for building NFL Properties into a sports marketing leader and creating the model by which every major sports league now operates. Prior to working for the NFL, Mr. Bello served in marketing and strategic planning capacities at the Pepsi Cola Division of PepsiCo Inc. and in product management roles for General Foods Corporation on the Sanka and Maxwell House brands. As a board chair, Mr. Bello has also worked with IZZE in brand building, marketing and strategic planning capacities. That brand was also sold to PepsiCo.

 

Mr. Bello earned his BA from Tufts University, cum laude, and received his MBA from the Tuck School of business at Dartmouth College as an Edward Tuck Scholar. Mr. Bello is extensively involved in non-profit work and currently serves as a Tufts University Trustee and advisory board member (athletics) and the Veteran Heritage Project in Scottsdale, Arizona. Mr. Bello also serves on the board of Rockford Fosgate, a seller of OEM audio equipment, and is executive director of Eye Therapies which has licensed its technology to Bausch and Lomb, who markets a redness reduction eye drop under the Lumify brand name.

 

James C. Bass has served as a director since September 29, 2017, is Chairman of the Audit Committee and member of the Compensation Committee. Mr. Bass is retired from the position of Chief Financial Officer and Senior Vice President of Sony Interactive Entertainment America LLC, commonly referred to as the PlayStation business of Sony where he joined in 1995 as Vice President of Finance. Mr. Bass has more than thirty-five years of financial and international management experience and was responsible for all of Sony’s financial operations and controls including general accounting and financial reporting, planning, analysis and systems, treasury and risk management, internal audit, and federal, state and local income taxes. Prior experience includes holding several senior management positions encompassing fourteen years with Bristol-Myers Squibb Company, gaining international experience running operations in parts of Asia and Europe.

 

44

Mr. Bass also spent two years at Wang Laboratories as a Divisional Controller. He started his career in New York at the public accounting firm, Haskins and Sells, now Deloitte & Touche. Mr. Bass received a Bachelor of Business Administration degree in accounting and finance from Pace University, New York City. He is a Certified Public Accountant and a member of the American Institute of Certified Public Accountants.

 

Lewis Jaffe has served as a director since October 19, 2016, is Chairman of the Governance Committee and a member of the Audit and Compensation Committees. Since August 2014, Mr. Jaffe is an Executive-in-Residence and Clinical Faculty at the Fred Kiesner Center for Entrepreneurship, Loyola Marymount University. He is also a technology futurist, Executive Coach and Public Speaker. Since January 2010, Mr. Jaffe has served on the board of FitLife Brands Inc. (FTLF:OTCBB) and serves on its audit, compensation and governance committees. Since 2006 he has served on the board of directors of York Telecom, a private company, and serves on its compensation and governance committees. From 2006 to 2008 Mr. Jaffe was Interim Chief Executive Officer and President of Oxford Media, Inc. Mr. Jaffe has also served in executive management positions with Verso Technologies, Inc., Wireone Technologies, Inc., Picturetel Corporation, and he was also previously a Managing Director of Arthur Andersen. Mr. Jaffe was the co-founder of MovieMe Network. Mr. Jaffe also served on the Board of Directors of Benihana, Inc. as its lead independent director from 2004 to 2012.

 

37

Mr. Jaffe is a graduate of the Stanford Business School Executive Program, holds a Bachelor of Science from LaSalle University and holds a Masters Professional Director Certification from the American College of Corporate Directors, a public company director education and credentialing program.

 

Scott R. Grossman has served as a director since September 29, 2017, serves as Chairman of the Compensation Committee and is also a member of the Audit and Governance Committees. Mr. Grossman has nearly two decades of investing and advisory experience in both public and private companies undergoing significant change. Mr. Grossman is the founder and CEO of Vindico Capital LLC, a value-oriented investment firm that invests in public company transformations in partnership with management. Prior to Vindico, Mr. Grossman was a Senior Portfolio Manager at Magnetar Capital, a $13 billion multi-strategy alternative asset manager, which he first joined in 2006. Prior to Magnetar, Mr. Grossman worked at Soros Fund Management in its Private Equity division and Merrill Lynch in its investment banking group. In addition, Mr. Grossman is a non-operating partner and current Board Member at Zeitguide. Mr. Grossman received an MBA from the Stanford Graduate School of Business and a BA from Columbia University where he majored in economics.

Louis Imbrogno, Jr. has served as a director since August 7, 2019. He served a 40-year tenure at PepsiCo, bringing extensive expertise in beverage supply chain and management. At PepsiCo he served in a variety of field operating assignments and staff positions including the role of Senior Vice President of Worldwide Technical Operations. In this role he was responsible for Pepsi-Cola’s worldwide beverage quality, concentrate operations, research & development and contract manufacturing, reporting directly to the heads of Pepsi-Cola North America and PepsiCo Beverages International. Since Mr. Imbrogno’s retirement from PepsiCo, he has consulted for multiple companies including PepsiCo.

 

Rhonda Kallman has served as a director since December 30, 2021. Ms. Kallman is the founder of Boston Harbor Distillery, LLC, makers of craft whiskey, gin, rum, liqueurs, and other inventive spirits, and has served as its Chief Executive Officer since 2012. In 1984 she co-founded The Boston Beer Company (NYSE: SAM) and served as EVP, overseeing sales & marketing as well as the company’s human capital. Kallman was instrumental in paving the way for craft beer acceptance by making it available throughout the US while educating consumers on American craft beer superiority. In addition, as the pioneering woman in the beer industry, she was able to lead the way for other women to earn the respect and credibility they deserve.

Leon M. Zaltzman has served as a director since March 21, 2022. Mr. Zaltzman is the founder and managing member of Union Square Park Capital Management, LLC (“USPCM”), an SEC Registered Investment Adviser firm and is also the managing member of Union Square Park GP (“USPGP”). USPCM and USPGP serve as the investment manager and general partner to Union Square Park Partners, LP (“USPP Fund”), respectively. Foregoing entities hereinafter collectively referred to as the “Union Square Entities”. Prior to founding USPCM and USPGP in April 2015, Mr. Zaltzman worked at various major banks and investment firms for over twenty years. Mr. Zaltzman received an M.B.A. degree from Columbia Business School in 1997 and a B.S.B.A. degree from the University of Denver in 1992.

Legal Proceedings

In 2014, Louis Imbrogno Jr. served as Chief Executive Officer of Constar International, Inc. for a six-month period during a bankruptcy proceeding and subsequent sale in a court administered public auction. He was not an executive officer of the company prior to the initiation of the bankruptcy proceedings.

Except as described above, to the best of our knowledge, none of our executive officers or directors are parties to any material proceedings adverse to Reed’s, have any material interest adverse to Reed’s or have, during the past ten years been subject to legal or regulatory proceedings required to be disclosed hereunder.

Family Relationships

There are no family relationships between any of our executive officers and directors.

45

 

Corporate Governance

Audit Committee of the Board

The Audit Committee was formed in January 2007. The board has determined that each member of our Audit Committee is an “independent director” as defined by Rule 5605(a)(2) of The NASDAQ Stock Market Rules and that members of the Audit Committee are independent under the additional requirements of Rule 10A-3(b)(1) under the Securities Exchange Act of 1934 (the “Exchange Act”). The board has determined James C. Bass meets SEC requirements of an “audit committee financial expert” within the meaning of the Sarbanes Oxley Act of 2002, Section 407(b). In addition, the board determined that (i) none of the Audit Committee members have participated in the preparation of the financial statements of the company at any time during the past three years and (2) Audit Committee members are able to read and understand fundamental financial statements. Additionally, we intend to continue to have at least one member of the Audit Committee whose experience or background results in the individual’s financial sophistication. The Audit Committee charter is posted on our website at www.reedsinc.com.

 

4638

Code of Ethics

 

Our Chief Executive Officer and all senior financial officers, including the Chief Financial Officer, are bound by a Code of Ethics that complies with Item 406 of Regulation S-B of the Exchange Act. Our Code of Ethics is posted on our website at http://investor.reedsinc.com.

 

Compliance with Section 16(a) of the Exchange Act

 

Section 16(a) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) requires our directors and executive officers and beneficial holders of more than 10% of our common stock to file with the SEC initial reports of ownership and reports of changes in ownership of our equity securities.

 

To our knowledge, based solely upon a review of Forms 3 and 4 and amendments thereto furnished to Reed’s under 17 CFR 240.16a-3(e) during our fiscal year ended December 31, 20202021 the following individuals each filed one late Form 4 representing one transaction (unless otherwise noted): Thomas J. Spisak, Norman E. Snyder, Jr., John Bello, Neal Cohane.Bello(2). None of our officers or directors filed Form 5.

 

Stockholder Director Nomination Procedures

There have not been any material changes to the procedures by which stockholders may recommend nominees to the our board of directors.

 

Item 11. Executive Compensation

 

The following table summarizes all compensation for fiscal years 20202021 and 20192020 earned by our “Named Executive Officers” during the reported periods:

 

Name and Principal Position Year  Salary  Bonus  

Stock

Awards

(1)

  

All Other

Compensation

(2)

  Total 
Norman E. Snyder, Jr. 2019  $59,776   -   -  $62,610  $122,386 
Chief Executive Officer (Former Chief Operating Officer) 2020  $308,782  $157,500  $121,500  $14,353  $602,135 
                        
John J. Bello 2019          $127,200  $104,167  $231,367 
(Former Interim Chief Executive Officer, Chairman) (3) 2020          $177,758  $104,167  $281,925 
                        
Thomas J. Spisak 2019  $20,833  $-   -  $-  $20,833 
Chief Financial Officer 2020  $253,847  $67,500   -  $3,488  $324,835 
                        
Neal Cohane 2019  $210,000          $3,000  $213,000 
Chief Sales Officer 2020  $213,231  $66,150      $11,656  $291,037 

47

Name and Principal Position Year  Salary  Bonus  

Stock

Awards

(1)

  

All Other

Compensation

(2)

  Total 
Norman E. Snyder, Jr.  2020  $308,782  $157,500  $121,500  $14,353  $602,135 
Chief Executive Officer (Former Chief Operating Officer)  2021  $358,750  $-  $-  $14,092  $372,842 
                         
Thomas J. Spisak  2020  $253,847  $67,500   -  $3,488  $324,835 
Chief Financial Officer  2021  $256,250  $-   60,746  $10,638  $327,634 
                         
Neal Cohane  2020  $213,231  $66,150      $11,656  $291,037 
Chief Sales Officer  2021  $243,333  $-      $15,776  $259,110 

 

(1) The amounts represent the fair value for share-based payment awards issued during the year. The award is calculated on the date of grant in accordance with Financial Accounting Standards.

(2) Other compensation includes both cash payments and the estimated value of the use of company assets.

(3) Mr. Bello served as Interim Chief Executive Officer from September 30, 2019 through February 29, 2020. His director compensation was suspended during the period as his service as Interim Chief Executive Officer. Director compensation of $37,500 and consulting fees of $66,667. Mr. Bello was issued 200,000 RSAs as compensation for his services as Interim Chief Executive Officer on February 25, 2020 for his service from September 30, 2019 through February 29, 2020. Pro-rata portion of this award earned during 2019 is included in this table. Mr. Bello’s 2020 Director fees and compensation are also reported under the Director Compensation Table.

 

39

Employment Agreements

 

Norman E. Snyder, Jr.

 

The board appointed Mr. Snyder to the office of Chief Operating Officer, effective March 1, 2020. Mr. Snyder succeeded John J. Bello who served as Interim Chief Executive Officer from September 30, 2019 through February 29, 2020. The board granted Mr. Snyder a one-time bonus of 150,000 RSAs vesting March 1, 2020, subject to the conditions and limitations of Reed’s Second Amended and Restated 2017 Incentive Compensation Plan, in conjunction with his promotion. Pursuant his employment agreement, on February 25, 2020, he received an equity award of 446,000 stock options, one-half scheduled to vest in equal increments on an annual basis for four years and remainder to vest based on performance criteria to be determined by the board of directors (or compensation committee of the board). Mr. Snyder’s performance-based cash bonus was set at a target amount of 30% of base salary for the term of his service as Chief Operating Officer. The agreement provided for acceleration of equity grants triggered by a “change of control”, as defined in the agreement and contains confidentiality, invention assignment and non-solicitation covenants. Mr. Snyder is also eligible to participate in the company’s benefit plans available to its executive officers.

 

On June 24, 2020, we entered into an amended and restated employment agreement with Norman E. Snyder, Jr. reflecting his promotion to Chief Executive Officer on March 1, 2020. The term of the agreement continues through March 1, 2023 and will automatically renew for an additional one-year term, unless earlier terminated or unless notice of non-renewal is submitted by either party 90 days in advance. Pursuant to the agreement, Mr. Snyder’s base salary of $300,000 per year increased to $350,000 on September 30, 2020 based on satisfaction of certain objectives and to $360,500 on March 1, 2021. Mr. Snyder is also eligible to receive a performance-based cash bonus at a target amount of 50% of his base salary in effect. He is also eligible to participate in Reed’s other benefit plans available to its executive officers. The agreement provides for acceleration of equity grants triggered by a “change of control”, as defined in the agreement and contains customary, non-competition, confidentiality, invention assignment and non-solicitation covenants. Mr. Snyder is also entitled to six months’ severance benefits in the event of termination without cause by Reed’s or for good reason by Mr. Snyder, subject to execution of a release.

48

John J. Bello

On February 19, 2020 the board of directors granted John Bello 200,000 RSAs, vesting March 1, 2020, as compensation for his services as Interim Chief Executive from September 30, 2019 through February 29, 2020.

 

Thomas J. Spisak

 

We entered into an at-will employment agreement with Thomas J. Spisak to serve as the Chief Financial Officer of Reed’s, effective December 2, 2019. The agreement may be terminated by the Company or Mr. Spisak, with or without notice and with or without cause, pursuant to the terms of the agreement. Mr. Spisak’s base annual base salary was increased to $257,500 from $250,000 effective March 1, 2020. Mr. Spisak is also eligible to receive performance-based cash bonus at a target amount of 30% of his base salary. Pursuant to his employment agreement, Mr. Spisak received an initial equity award of 150,000 incentive stock options and 150,000 restricted stock awards on March 3, 2020, one-half of the award (75,000 options and 75,000 restricted stock awards) vesting in equal increments on an annual basis for four years and the remainder (75,000 options and 75,000 restricted stock awards) vesting based on performance criteria to be determined by the board of directors or compensation committee. Mr. Spisak is also eligible to participate in Reed’s other benefit plans available to its executive officers. The agreement contains customary confidentiality, non-competition and invention assignment covenants.

 

Current Salary Arrangements of Other Named Executive Officers

 

Neal Cohane receives an annual salary which increased from $210,000 to $250,000 on March 1, 2021 with a 30% bonus target, and he is eligible to participate in benefits offered by the company to its executive officers.

 

40

Richard H. Hubli receives an annual salary of $200,000 with a 30% bonus target, and he is eligible to participate in benefits offered by the company to its executive officers.

Christopher J. Reed receives an annual salary of $113,500.

Change-in-Control Provisions

General Policy

 

It is our general policy that awards that vest over a term greater one-year include provisions for acceleration upon a change-in-control.

 

Equity Compensation Plans

Our 2017 Plan provides the consequences of a change-in-control provisions may be set forth in individual award agreements. For purposes of the 2020 Plan, a “change in control” generally includes (a) the acquisition of more than 50% of the company’s common stock, (b) the acquisition within a twelve-month period of 30% or more of the Company’s common stock, (c) the replacement of a majority of the board of directors, within a twelve-month period, by directors whose election was not endorsed by the incumbent board, or (d) the acquisition of all or substantially all of the Company’s assets.

 

49

Our 2020 Plan, as amended, provides that the Compensation Committee of the board retains discretion under the 2020 Plan to determine the treatment of outstanding awards in connection with a change in control of the Company, subject to the terms of contractual agreements of executive officers. For example, the Compensation Committee may cause awards granted under the 2020 Plan to vest upon a change in control, may cancel awards in exchange for a payment of cash (or without a payment, in the case of stock options or SARs with an exercise price that exceeds fair market value), or may cause awards to be continued or substituted in connection with a change in control. For purposes of the 2020 Plan, a “change in control” generally includes (a) the acquisition of more than 50% of the company’s common stock, (b) the acquisition within a twelve-month period of 30% or more of the company’s common stock, (c) the replacement of a majority of the board of directors, within a twelve-month period, by directors whose election was not endorsed by the incumbent board of directors, or (d) the acquisition of all or substantially all of the company’s assets. The full definition of “change in control” is set out in the 2020 Plan.

General provisions of the 2017 Plan and 2020 Plan are subject to contractual modifications that may be set forth in executive employment agreements and award agreements.

 

Outstanding Equity Awards at Year-End

 

The following table sets forth information regarding unexercised options and equity incentive plan awards for each Named Executive Officer outstanding as of December 31, 2020:2021:

 

Name and Position Number of
Securities
Underlying
Unexercised
Options (#)
Exercisable
  Number of
Securities
Underlying
Unexercised
Options (#) Exercisable
  Equity Incentive Plan Awards:
Number of Securities
Underlying
Unexercised
Unearned
Options
  Option
Exercise
Price
  Option
Expiration
Date
 Number of Shares or Units of Stock That Have Not Vested (#)  

Market Value of Shares or Units of Stock That Have Not Vested ($)

  Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested (#)  Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested ($) 
Norman E. Snyder, Jr.                                  
(Chief Executive Officer, Former Chief Operating Officer)  110,324   167,250   162,362  $0.88  2/25/2030                
   25,000   -   -  $0.50  3/25/2030                
   55,291   93,750   98,288  $0.70  5/20/2030                
   90,675   403,000   302,250  $0.95  9/16/2030                
                                   
John Bello                                  
Former Interim Chief Executive Officer, Chairman  50,000   -   -  $3.74  9/30/2021  24,590  $14,508         
   50,000   -   -  $0.50  3/25/2030                
                                   

Thomas J. Spisak

(Chief Financial Officer)

  36,827   56,250   54,914  $0.89  3/2/2030  56,250  $33,188   54,914  $32,399 
   10,000   -   -  $0.50  3/25/2030                
   84,263   374,500   280,875  $0.95  9/16/2030                
                                   
Neal Cohane                                  
(Chief Sales Officer)  175,781   46,875   46,875  $1.60  3/28/2028                
   44,233   75,000   78,630  $0.70  5/20/2030                
   46,294   205,752   154,314  $0.95  9/16/2030                

Name and Position Number of
Securities
Underlying
Unexercised
Options (#)
Exercisable
  Number of
Securities
Underlying
Unexercised
Options (#) Exercisable
  Equity Incentive Plan Awards:
Number of Securities
Underlying
Unexercised
Unearned
Options
  Option
Exercise
Price
  Option
Expiration
Date
  Number of Shares or Units of Stock That Have Not Vested (#)  Market Value of Shares or Units of Stock That Have Not Vested ($)  Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested (#)  Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested ($) 
Norman E. Snyder, Jr.                                    
(Chief Executive Officer, Former Chief Operating Officer)  216,936   111,500   111,500  $0.88   2/25/2030                 
   25,000   -   -  $0.50   3/25/2030                 
   122,328   62,500   62,500  $0.70   5/20/2030                 
   292,174   302,250   201,500  $0.95   9/16/2030                 
                                     
                                     

Thomas J. Spisak

(Chief Financial Officer)

  72,992   37,500   37,500  $0.89   3/2/2030   37,500  $13,500   37,500  $13,500 
   10,000   -   -  $0.50   3/25/2030                 
   271,513   280,875   187,250  $0.95   9/16/2030                 
                                     
Neal Cohane                                    
(Chief Sales Officer)  269,531   -   -  $1.60   3/28/2028                 
   75,000   -   -  $0.50   3/25/2030                 
   97,862   52,138   50,000  $0.70   5/20/2030                 
   149,170   154,314   102,876  $0.95   9/16/2030                 

 

(A)These options will vest in 2021.
(B)These options vest 25% per year beginning in 2021.
(C)These options vest in accordance with performance criteria established by the board of directors.41

Director Compensation

 

The following table summarizes the compensation paid to our non-employee directors for the year ended December 31, 2020:2021:

 

Name Fees Earned or
Paid in Cash
  Stock Awards (1)  Option
Awards
  Non-Equity
Incentive Plan
Compensation
  All Other
Compensation
  Total  Fees Earned or
Paid in Cash
  Stock Awards (1)  Option
Awards
  Non-Equity
Incentive Plan
Compensation
  All Other
Compensation
  Total 
John J. Bello(2) $104,167  $177,758        -   -   -  $281,925  $104,167  $177,758           -             -                          -  $281,925 
Lewis Jaffe $37,500  $15,158   -        -        -  $52,658  $37,500  $15,158   -   -   -  $52,658 
Daniel J. Doherty, III (3) $37,500  $15,158   -   -   -  $52,658 
James C. Bass $37,500  $15,158   -   -   -  $52,658  $37,500  $15,158   -   -   -  $52,658 
Scott R. Grossman $37,500  $15,158   -   -   -  $52,658 
Scott R. Grossman (3) $37,500  $15,158   -   -   -  $52,658 
Louis Imbrogno, Jr. $37,500  $15,158   -   -   -  $52,658  $37,500  $15,158   -   -   -  $52,658 
Rhonda Kallman (4)                        

 

 (1)The amounts represent the fair value of restricted stock awards granted during the year. The award is calculated on the date of grant in accordance with Financial Accounting Standards, excluding any impact of assumed forfeiture rates.
 (2)Mr. Bello’s 2020 director fees and awards are also reported under the Executive Compensation Table.
(3)Daniel J. Doherty, IIIScott R. Grossman resigned from his position as director effective December 31, 2020.30, 2021.

50
 (4)Rhonda Kallman was elected to the board on December 30, 2021 at the Reed’s, Inc. 2021 Annual Stockholders Meeting.

 

Item 12. Security Ownership of Certain Beneficial Owners, Management and Related Stockholder Matters

 

The following table sets forth certain information regarding our shares of common stock beneficially owned as of March 22, 20212022 for (i) each Named Executive Officer and director, and (ii) all Named Executive officers and directors as a group and (iii) each stockholder known to be the beneficial owner of 5% or more of our outstanding shares of common stock. A person is considered to beneficially own any shares (i) over which such person, directly or indirectly, exercises sole or shared voting or investment power or (ii) of which such person has the right to acquire beneficial ownership at any time within 60 days through an exercise of stock options or warrants or otherwise. Unless otherwise indicated, voting and investment power relating to the shares shown in the table for our directors and executive officers is exercised solely by the beneficial owner or shared by the owner and the owner’s spouse or children.

 

For purposes of this table, a person or group of persons is deemed to have “beneficial ownership” of any shares of common stock that such person has the right to acquire within 60 days of March 22, 2021.2022. For purposes of computing the percentage of outstanding shares of our common stock held by each person or group of persons named above, any shares that such person or persons has the right to acquire within 60 days of March 22, 20212022 is deemed to be outstanding but is not deemed to be outstanding for the purpose of computing the percentage ownership of any other person. The inclusion herein of any shares listed as beneficially owned does not constitute an admission of beneficial ownership. Except as otherwise indicated below, the persons named in the table have sole voting and investment power with respect to all shares of common stock held by them. Unless otherwise indicated, the principal address of each listed executive officer and director is 201 Merritt 7 Corporate Park, Norwalk, Connecticut 06851.

 

Named Beneficial Owner

Directors and Named Executive Officers

 Number of Shares
Beneficially Owned
  Percentage of
Shares Beneficially
Owned (1)
 
John J. Bello (2)  5,466,895   6.3%
Norman E. Snyder, Jr. (3)  903,908   1.0%
Neal Cohane (4)  542,585   0.6%

James C. Bass (5)

  

451,947

   0.5%
Lewis Jaffe (6)  294,634   0.3%
Thomas J. Spisak (7)  284,584   0.3%
Scott R. Grossman (8)  221,529   0.3%
Louis Imbrogno (9)  205,151   0.1%
         
Directors and Named Executive Officers as a group (8 persons)  8,352,484   9.5%
5% or greater stockholders        
Raptor/ Harbor Reed SPV LLC (10)  6,619,600   7.4%
Union Square Park Partners  6,936,672   8.0%
Polar Asset Management Partners Inc  

5,315,917

   6.2

%

Named Beneficial Owner

Directors and Named Executive Officers

 Number of Shares
Beneficially Owned
  Percentage of
Shares Beneficially
Owned (1)
 
John J. Bello (2)  10,091,433   8.8%
Norman E. Snyder, Jr. (3)  1,614,606   1.4%
Neal Cohane (4)  792,840   0.7%
James C. Bass (5)  516,709   0.5%
Thomas J. Spisak (6)  497,138   0.4%
Louis Imbrogno (7)  427,217   0.4%
Lewis Jaffe (8)  399,568   4%
Leon M. Zaltzman (9)  

18,012,117

   14.6

%
Rhonda Kallman (10)  80,344   0.1%
         
Directors and Named Executive Officers as a group (9 persons)  32,718,263   25.8%
5% or greater stockholders        
Union Square Entities (11)  18,012,117   14.6%

42

 

* Less than 1%

(1) Based on 86,317,096112,842,146 shares outstanding as of December 31, 2020.March 22, 2022.

(2) Includes 100,00050,000 shares issuable upon exercise of currently-exercisable options, 24, 59080,344 RSAs from 20212022 Board Compensation, 400,000 shares of restricted common stock, and warrants of 133,201.1,500,000.

(3) Includes 256,290656,438 shares issuable upon exercise of currently-exercisable options.

(4) Includes 341,308591,563 shares issuable upon exercise of currently-exercisable options.

(5) Includes 80,000 shares issuable upon exercise of currently-exercisable options and 24,59080,344 RSAs from 20212022 Board Compensation.

(6) Includes 243,466 shares issuable upon exercise of currently-exercisable options.

(7) Includes 80,000 shares issuable upon exercise of currently-exercisable options and 24,59080,344 RSAs from 20212022 Board Compensation.

(7) Includes 167,917 shares issuable upon exercise of currently-exercisable options.Compensation

(8) Includes 80,000 shares issuable upon exercise of currently-exercisable options and 24,59080,344 RSAs from 20212022 Board Compensation.

(9) On March 21, 2022, the Board of Directors of the Company, upon recommendation from its governance committee, expanded the board from six to seven members and appointed Leon M. Zaltzman to serve as director. Mr. Zaltzman is voting and dispositive control over shares held by the Union Square Entities.

(10) Includes 69,950 shares issuable upon exercise of currently-exercisable options and 24,95080,344 RSAs from 20212022 Board Compensation

(10)(11) Principal address is 280 Congress Street, 12th Floor Boston, Massachusetts 02210. Includes 2,810,0001120 Avenue of the Americas, Suite 1512, New York, NY 10036. Mr. Zaltzman is the founder and managing member of Union Square Park Capital Management, LLC (“USPCM”), an SEC Registered Investment Adviser firm and is also the managing member of Union Square Park GP (“USPGP”). USPCM and USPGP serve as the investment manager and general partner to Union Square Park Partners, LP (“USPP Fund”), respectively. Foregoing entities hereinafter collectively referred to as the “Union Square Entities Mr. Zaltzman has voting and dispositive control over shares held by the Union Square Entities. Does not include 5,357,143 shares of common stock issuable upon exercise of currently-exercisable warrants.certain warrants, which may not be exercised until September 27, 2022 and are subject to a 19.99% beneficial ownership blocker.

Securities Authorized for Issuance under Equity Compensation Plans

On September 29, 2017, the 2017 Incentive Compensation Plan for 3,000,000 shares was approved by our shareholders. On December 13, 2018 the Amended and Restated 2017 Incentive Compensation Plan was approved by our shareholders increasing the number of shares issuable by 3,500,000 to 6,500,000. On December 16, 2019, the Second Amended and Restated 2017 Incentive Compensation Plan (“2017 Plan”) was approved by our shareholders, increasing the number of shares issuable by 1,000,000 to 7,500,000.

On December 21, 2020, the 2020 Equity Incentive Plan (“2020 Plan”) for 8,500,000 shares was approved by our shareholders. The 2020 Plan replaced the 2017 Plan, which will expirewould have expired by its terms on September 30, 2027. On December 30, 2021, the Amended and Restated 2020 Plan was adopted by our shareholders, increasing the 2020 Plan to 15,000,000 shares.

We have discontinued the 2017 Plan and all plans that preceded the 2017 Plan and will not issue any new awards under these prior plans, although awards granted under these plans will remain in effect.

The following table provides information, as of December 31, 2020,2021, with respect to equity securities authorized for issuance under compensation plans:

 Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants and Rights Weighted-Average Exercise Price of Outstanding Options, Warrants and Rights Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (excluding securities
reflected in
  

Number of Securities to be Issued Upon Exercise of Outstanding Options,

Warrants and Rights

 

Weighted-

Average Exercise Price of Outstanding Options,

Warrants and Rights

 Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (excluding securities
reflected in
 
Plan Category (a) (b) Column (a)  (a) (b) Column (a) 
              
Equity compensation plans approved by security holders  9,417,898  $1.19   3,874,048   10,522,995  $1.12   2,768,951 
Equity compensation plans not approved by security holders  -  $-   -   -  $-   - 
TOTAL  9,417,898  $1.19   3,874,048   10,522,995  $1.12   2,768,951 

 

5143

Item 13. Certain Relationships and Related Transactions, and Director Independence

 

Certain Relationships and Related Transactions

 

Our board of directors has adopted written policies and procedures for the review of any transaction, arrangement or relationship between Reed’s and one of our executive officers, directors, director nominees or 5% or greater stockholders (or their immediate family members), each of whom we refer to as a “related person,” in which such related person has a direct or indirect material interest.

 

If a related person proposes to enter into such a transaction, arrangement or relationship, defined as a “related party transaction,” the related party must report the proposed related party transaction to our Chief Financial Officer. The policy calls for the proposed related party transaction to be reviewed and, if deemed appropriate, approved by the Governance Committee. Our Governance Committee is comprised of John Bello, Lewis Jaffe and Scott R. Grossman.Rhonda Kallman. Mr. Jaffe serves as Chairman. The board of directors has determined allboth of the members of the Governance Committee are independent under the rules of the Nasdaq Stock Market, LLC. If practicable, the reporting, review and approval will occur prior to entry into the transaction. If advance review and approval is not practicable, the Governance Committee will review, and, in its discretion, may ratify the related party transaction. Any related party transactions that are ongoing in nature will be reviewed annually at a minimum. The related party transactions listed below were reviewed by the full board of directors. Prior to August 2005, we did not have independent directors on our board to review and approve related party transactions. The Governance Committee shall review future related party transactions.

The following includes a summary of transactions since the beginning of fiscal 20192021 or any currently proposed transaction, in which we were or are to be a participant and the amount involved exceeded or exceeds the lesser of $120,000 or one percent of the average of our total assets at year-end for the last two completed fiscal years and in which any related person had or will have a direct or indirect material interest (other than compensation described under “Executive Compensation”). We believe the terms obtained or consideration that we paid or received, as applicable, in connection with the transactions described below were comparable to or better than terms available or the amounts that would be paid or received, as applicable, in arm’s-length transactions.

 

Transactions with California Custom Beverage, LLC (“CCB”)

 

On December 31, 2018, after completion

As part of bidding process, Reed’s sold itsthe sale of our beverage manufacturing equipment and private label beverage business for a purchase price of $1.25 million pursuant to an asset purchase agreement of the same date with California Custom Beverage, LLC (“CCB”), anand entity owned by Christopher J. Reed, our founder and former Chairman, director and most recently, Chief Innovation Officer, and director of Reed’s. Mr. Reed obtained debt financing from a commercial bank, PMC Financial Services, LLC, in the amount of $1,050,000. In addition, in support of the transaction, a group of current Reed’s stockholders, including Chairman John J. Bello and certain institutional investors, purchased 350,000 shares of common stock of REED from Christopher J. Reed at $2.00 per share, in a private transaction exempt from the registration requirements of the Securities Act of 1933. The pricing was based on the higher of $2.00 per share or a 10% discount to the 5-day volume weighted average price ending December 28, 2018.

As part of the transaction, CCB assumed the monthly payments on our lease obligation for the Los Angeles manufacturing plant. Our release from the obligation by the lessor, however, iswas dependent upon CCB’s deposit of $1.2 million of security with the lessor. The deposit is secured by Mr. Reed’s pledge of common stock to the lessor and guaranteed personally by Mr. Reed and his wife. As of December 31, 2020,2021, $800 has been deposited with the lessor and Mr. Reed has placed approximately 363,000 pledged shares valued at $338$131 that remain pledged in in escrow in favor of lessor.

The plant equipment was sold to CCB on an “as-is, where is” basis. In addition, the partieswe also entered into a 3-year co-packing contract for the production of Reed’s beverages in glass bottles at prevailing West Coast market rates. Certain transitional services were provided by Reed’s to CCBWe are in the process of extending this agreement through the end of the year.

Furthermore, for 30 days. The transaction documents also contain customary protections for intellectual property, indemnification and non-competition provisions.

52

Beginning in 2019,a period of three years terminating December 31, 2021, we began receivingreceived a 5% royalty on CCB’s private label sales to existing customers for three years and a 5% referral fee on CCB’s private label sales to referred customers for three years.customers. During the year ended December 31, 2021 and 2020, the Company recorded royalty revenue from CCB of $98.$72 and $98, respectively.

44

At December 31, 2020, the Company had an aggregate receivable balance from CCB of $682. During the year ended December 31, 2019,2021, the Company recorded royalty revenue from CCBreceivable of $128.$72, and advanced expenses of $179, leaving an aggregate receivable balance of $933 at December 31, 2021.

 

At December 31, 2019, the Company had royalty revenue receivable from CCB of $128. In addition, at December 31, 2019, the Company has outstanding receivable from CCB of $228 consisting of inventory advances to CCB. The aggregate receivable from CCB at December 31, 2019 was $356. During the year ended December 31, 2020, the Company recorded royalty revenue receivable of $98, advanced inventory and equipment of $381, and reduced CCB receivable by $153 and reducing CCB payable of $153, leaving an aggregate receivable balance of $682 at December 31, 2020.

At December 31, 20202021, and December 31, 2019,2020, the Company had accounts payable due to CCB of $557$614 and $182,$856, respectively.

 

Settlement of Secured Convertible Subordinated Non-redeemable Note with Raptor/ Harbor Reeds SPV, LLC

On December 11, 2020, we entered into a Satisfaction, Settlement and Release Agreement (“Satisfaction Agreement”) with Raptor/ Harbor Reeds SPV, LLC (“Raptor”) satisfying all of our obligations to Raptor as our junior secured lender. Raptor is a related party. DanielCollateral Support Received from John J. Doherty III, a former director of Reed’s, is a principal and member of Raptor. The transaction was completed on December 15, 2020.

Prior to this transaction, our obligation under that certain Senior Secured Amended and Restated Subordinated Convertible Non-Redeemable Secured Note (“Subordinated Note”) dated October 4, 2018 in favor of Raptor, including accrued and unpaid interest through maturity on April 21, 2021, was approximately $5.5 million.

In full satisfaction of the Subordinated Note, including release of collateral, and termination of related junior lender documentation, we (a) paid Raptor $4,250,000 in cash, (b) issued to Raptor a 5-year warrant to purchase 1,000,000 shares of common stock, $0.0001 par value, of Reed’s (“Common Stock”) with an exercise price of $0.644 (“Satisfaction Warrant”), and (c) issued to Raptor 1,339,286 shares of Common Stock upon conversion of $750,000.00 of the Subordinated Note at the reduced per share conversion price of $0.56.

The Satisfaction Agreement includes a mutual release of liability. The Satisfaction Warrant contains customary protection for stock splits, dividends and reclassifications and provides certain rights in the event of a “Fundamental Transaction” as therein defined. Pursuant to a Registration Rights Agreement (“RRA”) dated December 11, 2020, the company also agreed to file a registration statement registering shares of Common Stock underlying the warrant for resale, provided however, sales under the registration statement may not commence until the 6th trading day after Reed’s files its Annual Report on Form 10-K for the period ending December 31, 2020 with the Securities Exchange Commission.

Reed’s senior lender, Rosenthal & Rosenthal Inc. (“Rosenthal”), a New York corporation consented to the settlement transaction subject to pay-down by Reed’s of senior credit line obligation to zero, in compliance with terms of existing financing documents, release of collateral securing the Subordinated Note and other customary requirements.

Amendment to Financing AgreementBello

 

On March 11, 2021, we entered into an amendment (“Amendment”) to that certain Financing Agreement dated October 4, 2018, as amended or supplemented with our senior secured lender, Rosenthal & Rosenthal, Inc. (“Rosenthal”) releasing and replacing that irrevocable standby letter of credit by Daniel J. Doherty, III and Daniel J. Doherty, III 2002 Family Trust in the amount of $1.5 million, (“LC”), which served as financial collateral for certain obligations of Reed’s under the Rosenthal credit facility, with a two million dollar ($2,000,000) pledge of securities to Rosenthal by John J. Bello and Nancy E. Bello, as Co-Trustees of THE JOHN AND NANCY BELLO REVOCABLE LIVING TRUST, under trust agreement dated December 3, 2012 (the “Bello Trust”), evidenced by that certain Pledge Agreement to Rosenthal, and as to which Rosenthal has a first and only perfected security interest by the Securities Account Control Agreement held by securities broker (“Bello Pledge”)broker).

53

On November 24, 2021, the Bello trust provided additional collateral support securing a $2,500,000 over-advance under the Financing Agreement, and John J. Bello also provided a personal guarantee. The additional collateral was released on March 17, 2022 along with the personal guarantee. The initial pledged collateral was released March 30, 2022 with the pay-off of the Rosenthal facility.

 

John J. Bello is the current Chairman, significant stockholder and former Interim Chief Executive Officer of Reed’s, is a related party. He is also a greater than 5% beneficial owner of Reed’s common stock.Reed’s. As consideration for the collateral support, Mr. Bello received 400,000 shares of Reed’s restricted stock.stock and a warrant to purchase up to 1,500,000 shares of common stock at an exercise price of $0.46 per share.

Leon M. Zaltzman and Union Square Entities.

 

On March 21, 2022, the Board of Directors of Reed’s, Inc., a Delaware corporation (“Reed’s), upon recommendation from its governance committee, expanded the board from six to seven members and appointed Leon M. Zaltzman (“Mr. Zaltzman”) to serve as director.

Mr. Zaltzman is the founder and managing member of Union Square Park Capital Management, LLC (“USPCM”), an SEC Registered Investment Adviser firm and is also the managing member of Union Square Park GP (“USPGP”). USPCM and USPGP serve as the investment manager and general partner to Union Square Park Partners, LP (“USPP Fund”), respectively. Foregoing entities hereinafter collectively referred to as the “Union Square Entities”.

USPP Fund participated in Reed’s recent private placement (the “private placement”) of common stock, $0.0001 par value (“common stock”), and warrants, which closed on March 11, 2022, in the aggregate principal amount of $3,000,000. It acquired 10,714,286 shares of common stock and warrants to purchase 5,357,143 shares of common stock in the private placement. Prior to the private placement, Mr. Zaltzman and the Union Square Entities beneficially owned approximately 7.79% of Reed’s common stock. After the private placement, Mr. Zaltzman and the Union Square Entities beneficially owned approximately 14.6% of Reed’s common stock. The common stock and shares of common stock underlying the warrants have the same registration rights granted to all investors in the private placement.

Warrants issued to USPP Fund are not exercisable until September 27, 2022 and carry a 19.99% beneficial ownership blocker. In conjunction with the private placement and USPP Fund’s role as lead investor, Reed’s and USPCM had an oral understanding pursuant to which Reed’s agreed to support the nomination of USPCM’s nominee, Leon M. Zaltzman, to the Reed’s board, upon qualification and recommendation from Reed’s governance committee. Except as set forth above, USPP Fund invested in the private placement pursuant to the same terms and conditions of the other purchasers in the private placement.

45

Other

 

Lindsay Martin, daughter of a director of the Company, was employed as Vice President of Marketing during the years ended December 31, 20202021 and 2019.2020. Ms. Martin was paid approximately $215$233 and $161,$215, respectively, for her services during the years ended December 31, 20202021 and 2019,2020, respectively.

Director Independence

As of the date of this Annual Report, our board has seven directors and the following four standing committees: an Audit Committee, a Compensation Committee, a Governance Committee and an Operations Committee. The board, upon recommendation from the Compensation Committee, determined through 2020, each of John J. Bello, Lewis Jaffe, James C. Bass, Scott R. GrossmanRhonda Kallman and Louis Imbrogno is an “independent director” as defined by Rule 5605(a)(2) of The NASDAQ Stock Market Rules (the “NASDAQ Rules”). Independence of board members is re-evaluated by the board annually. The board determined affirmatively that John J. Bello’s service as Interim Chief Executive Officer and the compensation received for such service would not interfere with his ability to exercise independent judgment as a director. Subsequently, in March of 2021, the board, upon recommendation from the Compensation Committee, determined that John J. Bello is no longer an “independent director” due to collateral support he now provides on behalf of the Company to the Company’s senior secured lender, Rosenthal & Rosenthal, Inc. We intend to maintain at least a majority of independent directors on our board in the future.

 

Item 14. Principal Accounting Fees and Services

 

Weinberg & Company, P.A. (“Weinberg”) was our independent registered public accounting firm for the years ended December 31, 20202021 and 2019.2020.

 

The following table shows the fees paid or accrued by us for the audit and other services provided by Weinberg for the years ended December 31, 20202021 and 2019:2020:

 

 2020  2019  2021  2020 
          
Audit Fees $161,597  $267,184  $186,089  $161,597 
Audit-Related Fees  -   -   -   - 
Tax Fees  36,169   63,561   45,184   36,169 
All Other Fees  93,548   83,670   38,896   93,548 
Total $291,314  $414,415  $270,169  $291,314 

 

As defined by the SEC, (i) “audit fees” are fees for professional services rendered by our principal accountant for the audit of our annual financial statements and review of financial statements included in our Form 10-K, or for services that are normally provided by the accountant in connection with statutory and regulatory filings or engagements for those fiscal years; (ii) “audit-related fees” are fees for assurance and related services by our principal accountant that are reasonably related to the performance of the audit or review of our financial statements and are not reported under “audit fees;” (iii) “tax fees” are fees for professional services rendered by our principal accountant for tax compliance, tax advice, and tax planning; and (iv) “all other fees” are fees for products and services provided by our principal accountant, other than the services reported under “audit fees,” “audit-related fees,” and “tax fees.”

 

Audit Fees

 

Weinberg provided services for the audits of our financial statements included in Annual Reports on Form 10-K and limited reviews of the financial statements included in Quarterly Reports on Form 10-Q.

 

Audit Related Fees

 

Weinberg did not provide any professional services which would be considered “audit related fees.”

 

46

Tax Fees

 

Weinberg prepared our 20192020 and 20182019 Federal and state income tax returns.

All Other Fees

 

Services provided by Weinberg with respect to the filing of various registration statements made throughout the year are considered “all other fees.”

 

Audit Committee Pre-Approval Policies and Procedures

 

Under the SEC’s rules, the Audit Committee is required to pre-approve the audit and non-audit services performed by the independent registered public accounting firm in order to ensure that they do not impair the auditors’ independence. The SEC’s rules specify the types of non-audit services that an independent auditor may not provide to its audit client and establish the Audit Committee’s responsibility for administration of the engagement of the independent registered public accounting firm.

 

Consistent with the SEC’s rules, the Audit Committee Charter requires that the Audit Committee review and pre-approve all audit services and permitted non-audit services provided by the independent registered public accounting firm to us or any of our subsidiaries. The Audit Committee may delegate pre-approval authority to a member of the Audit Committee and if it does, the decisions of that member must be presented to the full Audit Committee at its next scheduled meeting. Accordingly, 100% of audit services and non-audit services described in this Item 14 were pre-approved by the Audit Committee.

 

There were no hours expended on the principal accountant’s engagement to audit the registrant’s financial statements for the most recent fiscal year that were attributed to work performed by persons other than the principal accountant’s full-time, permanent employees.

 

5447

 

PART IV

 

Item 15. Exhibits and Financial Statements

 

(a) 1. Financial Statements

 

See Index to Financial Statements in Item 8 of this Annual Report on Form 10-K, which is incorporated herein by reference.

 

2. Financial Statement Schedules

 

All other financial statement schedules have been omitted because they are either not applicable or the required information is shown in the financial statements or notes thereto.

 

3. Exhibits

 

See the Exhibit Index, which follows the signature page of this Annual Report on Form 10-K, which is incorporated herein by reference.

 

(b) Exhibits

 

See Item 15(a) (3) above.

 

(c) Financial Statement Schedules

 

See Item 15(a) (2) above.

 

Item 16. Form 10K Summary

 

Not applicable.

 

5548

 

SIGNATURES

 

In accordance with Section 13 or 15(d) of the Exchange Act, the registrant caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: March 30, 2021April 15, 2022REED’S, INC.
 a Delaware corporation
   
 By:/s/ Norman E. Snyder, Jr.
  Norman E. Snyder, Jr.
  Chief Executive Officer

 

In accordance with the Exchange Act, this Report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

Signature Title Date
     
/s/ Norman E. Snyder, Jr. Chief Executive Officer, March 30, 2021April 15, 2022
Norman E. Snyder, Jr. (Principal Executive Officer), Director  
     
/s/ Thomas J. Spisak Chief Financial Officer March 30, 2021April 15, 2022
Thomas J. Spisak (Principal Financial Officer)  
     
/s/ John J. Bello Chairman of the Board March 30, 2021April 15, 2022
John J. Bello    
     
/s/ Christopher J. ReedLeon Michael Zaltzman Chief Innovation Officer, Director March 30, 2021April 15, 2022
Christopher J. ReedLeon Michael Zaltzman    
     
/s/ Lewis Jaffe Director March 30, 2021

April 15, 2022

Lewis Jaffe    
     
/s/ James C. Bass Director March 30, 2021

April 15, 2022

James C. Bass    
     
/s/ Scott R. GrossmanRhonda Kallman Director March 30, 2021

April 15, 2022

Scott R. GrossmanRhonda Kallman    
     
/s/ Louis Imbrogno, Jr. Director March 30, 2021

April 15, 2022

Louis Imbrogno, Jr.    

 

5649

 

EXHIBIT INDEX

 

Exhibit   Filed Incorporated by Reference   Filed Incorporated by Reference

No.

 Exhibit Title Herewith Form Exhibit File No. Date Filed Exhibit Title Herewith Form Exhibit File No. Date Filed
3 (i) Certificate of Incorporation of Reed’s Inc., as amended X         Certificate of Incorporation of Reed’s, Inc., as amended X        
3 (ii) Amended and Restated Bylaws of Reed’s, Inc.   10-KA 3.8 001-32501 04/08/2020 Amended and Restated Bylaws of Reed’s, Inc.   10-KA 3.8 001-32501 04/08/2020
4.1 Form of common stock certificate   SB-2 4.1 333-120451   Form of common stock certificate   SB-2 4.1 333-120451  
4.2 Form of series A preferred stock certificate   SB-2 4.2 333-120451   Form of series A preferred stock certificate   SB-2 4.2 333-120451  
4.3 Form of common stock purchase warrant issued to investors on June 2, 2016   8-K 4.1 001-32501 6/03/2016 Form of common stock purchase warrant issued to investors on June 2, 2016   8-K 4.1 001-32501 6/03/2016
4.4 Form of common stock purchase warrant issued to Maxim Group LLC on June 2, 2016   8-K 4.2 001-32501 6/03/2016 Form of common stock purchase warrant issued to Maxim Group LLC on June 2, 2016   8-K 4.2 001-32501 6/03/2016
4.5 Form of common stock purchase warrant issued to PMC Financial Services Group, LLC on November 9, 2015   10-Q 10.1 001-32501 5/11/2016 Form of common stock purchase warrant issued to PMC Financial Services Group, LLC on November 9, 2015   10-Q 10.1 001-32501 5/11/2016
4.6 Form of 2017-1 common stock purchase warrant   8-K 4.1 001-32501 4/24/2017 Form of 2017-1 common stock purchase warrant   8-K 4.1 001-32501 4/24/2017
4.7 Form of 2017-2 common stock purchase warrant   8-K 4.2 001-32501 4/24/2017 Form of 2017-2 common stock purchase warrant   8-K 4.2 001-32501 4/24/2017
4.8 Form of 2017-3 common stock purchase warrant   8-K 4.1 001-32501 7/14/2017 Form of 2017-3 common stock purchase warrant   8-K 4.1 001-32501 7/14/2017
4.9 Form of 2017-4 common stock purchase warrant   8-K 4.2 001-32501 7/14/2017 Form of 2017-4 common stock purchase warrant   8-K 4.2 001-32501 7/14/2017
4.10 Form of common stock purchase Warrant issued to Raptor/ Harbor Reed’s SPV on December 11, 2020 X         Form of common stock purchase Warrant issued to Raptor/ Harbor Reed’s SPV on December 11, 2020  

10-K

 

4.10

 
 

001-32501

 
 

3/30/2021

 
4.11 Form of Warrant (Union Square Park Partners, LP)   8-K 

4.1

 

001-32501

 

3/22/2022

4.12 Form of Warrant 2022 PIPE   8-K 4.1 001-32501 3/14/2022
4 (vi) Description of registrant’s common stock X         Description of registrant’s common stock X        
10.1 Satisfaction Settlement and Release Agreement by and between Reed’s, Inc. and Raptor/ Harbor Reeds SPV, dated December 11, 2020 X         Satisfaction Settlement and Release Agreement by and between Reed’s, Inc. and Raptor/ Harbor Reeds SPV, dated December 11, 2020  

10-K

 

10.1

 

001-32501 

 

3/20/2021

10.2 Registration Rights Agreement by and between Reed’s, Inc. and Raptor/ Harbor Reeds SPV, dated December 11, 2020 X         Registration Rights Agreement by and between Reed’s, Inc. and Raptor/ Harbor Reeds SPV, dated December 11, 2020  

10-K

 
 

10.2

 
 

001-32501

 
 

3/20/2021

10.3 Amendment dated March 11, 2021 to Financing Agreement dated October 4, 2018 by and between Reed’s Inc. and Rosenthal & Rosenthal, Inc. X         Amendment dated March 11, 2021 to Financing Agreement dated October 4, 2018 by and between Reed’s, Inc, and Rosenthal & Rosenthal, Inc.  

10-K

 
 

10.3

 
 

001-32501

 
 

3/20/2021

 
10.4 Registration Rights Agreement by and between Reed’s Inc. and purchasers signatory thereto dated May 26, 2016   8-K 10.3 001-32501 6/03/2016 Registration Rights Agreement by and between Reed’s, Inc., and purchasers signatory thereto dated May 26, 2016   8-K 10.3 001-32501 6/03/2016
10.5 Form of Registration Rights Agreement by and between Reed’s Inc. and Raptor/Harbor Reeds SPV LLC dated April 21, 2017   8-K 10.3 001-32501 4/24/2017 Form of Registration Rights Agreement by and between Reed’s, Inc. and Raptor/Harbor Reeds SPV LLC dated April 21, 2017   8-K 10.3 001-32501 4/24/2017
10.6* Reed’s, Inc. 2017 Incentive Compensation Plan   8-K 4.2 333-222741   Reed’s, Inc. 2017 Incentive Compensation Plan   S-8 4.2 333-222741 1/29/2018
10.7* Reed’s, Inc. 2020 Equity Incentive Plan   S-8 4.2 333-252140 1/15/2021 Reed’s, Inc. 2020 Equity Incentive Plan   S-8 4.2 333-252140 1/15/2021
10.8 Amendment dated December 23, 2020 to Financing Agreement dated October 4, 2018 between Reed’s, Inc. and Rosenthal & Rosenthal, Inc. X         Amendment dated December 23, 2020 to Financing Agreement dated October 4, 2018 between Reed’s, Inc. and Rosenthal & Rosenthal, Inc.  

10-K

 
 

10.8

 
 

001-32501

 

3/20/2021

 
10.9 Inventory Security Agreement by and between Reed’s Inc. and Rosenthal & Rosenthal Inc. dated October 4, 2018   10-Q 10.2 001-32501 11/14/2018 Inventory Security Agreement by and between Reed’s, Inc. and Rosenthal & Rosenthal Inc. dated October 4, 2018   10-Q 10.2 001-32501 11/14/2018
10.10 Intellectual Property Security Agreement by and between Reed’s, Inc. and Rosenthal & Rosenthal Inc. dated October 4, 2018   10-Q 10.3 001-32501 11/14/2018
10.11 Security Interest (short form) by Reed’s, Inc. in favor of Rosenthal & Rosenthal Inc. dated October 4, 2018   10-Q 10.4 001-32501 11/14/2018
10.12 Termination Agreement by and between Rosenthal & Rosenthal Inc. and Raptor/Harbor Reeds SPV LLC dated October 4, 2018 X        
10.13 Sublease Agreement by and between Reed’s, Inc., Merritt 7 Venture L.L.C., and GE Capital US Holdings, Inc., dated September 1, 2018   10-Q 10.7 001-32501 11/14/2018
10.14 Asset Purchase Agreement by and between Reed’s, Inc. and California Custom Beverage LLC dated December 31, 2018   8-K 10.1 001-32501 12/31/2018

 

5750

 

10.10 Intellectual Property Security Agreement by and between Reed’s, Inc. and Rosenthal & Rosenthal Inc. dated October 4, 2018   10-Q 10.3 001-32501 11/14/2018
10.11 Security Interest (short form) by Reed’s, Inc. in favor of Rosenthal & Rosenthal Inc. dated October 4, 2018   10-Q 10.4 001-32501 11/14/2018
10.12 Termination Agreement by and between Rosenthal & Rosenthal Inc. and Raptor/Harbor Reeds SPV LLC dated October 4, 2018  

10-K

 
 

10.12

 

001-32501

 
 

3/20/2021

 
10.13 Sublease Agreement by and between Reed’s, Inc., Merritt 7 Venture L.L.C., and GE Capital US Holdings, Inc., dated September 1, 2018   10-Q 10.7 001-32501 11/14/2018
10.14 Asset Purchase Agreement by and between Reed’s, Inc. and California Custom Beverage LLC dated December 31, 2018   8-K 10.1 001-32501 12/31/2018
10.15 Assignment and Assumption of Lease and Consent of Lessor by and between Reed’s, Inc. and California Custom Beverage LLC dated December 31, 2018   8-K 10.2 001-32501 12/31/2018 Assignment and Assumption of Lease and Consent of Lessor by and between Reed’s, Inc. and California Custom Beverage LLC dated December 31, 2018   8-K 10.2 001-32501 12/31/2018
10.16 Transition Services Agreement by and between Reed’s, Inc. and California Custom Beverage LLC dated December 31, 2018   8-K 10.4 001-32501 12/31/2018
10.17 Referral Agreement by and between Reed’s Inc. and California Custom Beverage LLC dated December 31, 2018   8-K 10.4 001-32501 12/31/2018
10.18 Form of Indemnification Agreement by and between Reed’s, Inc. and officers and directors   10-K 10.31 001-32501 4/01/2019 Form of Indemnification Agreement by and between Reed’s, Inc. and officers and directors   10-K 10.31 001-32501 4/01/2019
10.19* Executive Employment Agreement by and between Reed’s Inc. and Thomas J. Spisak dated December 2, 2019   10-KA 10.38 001-32501 4/08/2020 Executive Employment Agreement by and between Reed’s, Inc. and Thomas J. Spisak dated December 2, 2019   10-KA 10.38 001-32501 4/08/2020
10.20* Form of Non-Employee Director Nonstatutory Stock Option Agreement   8-K 10.1 001-32501   Form of Non-Employee Director Nonstatutory Stock Option Agreement   8-K 10.1 001-32501  
10.21* Form of Executive Incentive Stock Option Agreement   10-K   001-32501 8/10/2020 Form of Executive Incentive Stock Option Agreement   10-K   001-32501 8/10/2020
10.22* Amended and Restated Employment Agreement by and between Reed’s Inc. and Norman E. Snyder, Jr. dated June 24, 2020   10-Q 10.1 001-32501 8/10/2020 Amended and Restated Employment Agreement by and between Reed’s, Inc. and Norman E. Snyder, Jr. dated June 24, 2020   10-Q 10.1 001-32501 8/10/2020
10.23 Form of Reed’s, Inc. Promissory Note, in the principal amount of $769,816 in favor of City National Bank, dated April 20, 2020.   8-K 10.1 001-32501 5/01/2020 Form of Reed’s, Inc. Promissory Note, in the principal amount of $769,816 in favor of City National Bank, dated April 20, 2020.   8-K 10.1 001-32501 5/01/2020
10.24 Manufacturing and Distribution Agreement by and between Reed’s, Inc. and B C Marketing Concepts Inc., dba Full Sail Brewing Company dated October 11, 2019   10-Q 10.3 001-32501 11/13/2019 Manufacturing and Distribution Agreement by and between Reed’s, Inc. and B C Marketing Concepts Inc., dba Full Sail Brewing Company dated October 11, 2019   10-Q 10.3 001-32501 11/13/2019
10.25 Recipe Development Agreement Reed’s, Inc. and B C Marketing Concepts Inc., dba Full Sail Brewing Company dated October 11, 2019   10-Q 10.4 001-32501 11/13/2019 Recipe Development Agreement Reed’s, Inc. and B C Marketing Concepts Inc., dba Full Sail Brewing Company dated October 11, 2019   10-Q 10.4 001-32501 11/13/2019
10.26 Financing Agreement by and between Reed’s Inc. and Rosenthal & Rosenthal Inc. dated October 4, 2018   10-Q 10.1 001-32501 11/14/2018 Financing Agreement by and between Reed’s, Inc. and Rosenthal & Rosenthal Inc. dated October 4, 2018   10-Q 10.1 001-32501 11/14/2018
10.27 Form of Securities Purchase Agreement by and among Reed’s, Inc, and certain investors dated March 10, 2022   8-K 10.1 

001-32501

 0001-32501
10.28 Form of Registration Rights Agreement by and among Reed’s, Inc, and certain investors dated March 10, 2022   8-K 10.2 001-32501 0001-32501
10.29 Amendment dated December 23, 2020 to Financing Agreement dated October 4, 2018 between Reed’s, Inc. and Rosenthal & Rosenthal, Inc. 

X

        
10.30 Rosenthal & Rosenthal, Inc. Partial Release of Pledge Agreement dated March 17, 2022 

X

        
10.31 Ledgered ABL Agreement by and between Reed’s, Inc. and Alterna Capital Solutions, LLC dated March 28, 2022 X        
14.1 Code of Ethics   SB-2 14.1 333-157359   Code of Ethics   SB-2 14.1 333-157359  
21 Subsidiaries of Reed’s, Inc. X         Subsidiaries of Reed’s, Inc.  

10-K

 

21

 

0001-32501

 

3/30/2021

22(ii) Affiliate Guarantor X         Affiliate Guarantor X        
23.1 Consent of Weinberg & Co., PA X         Consent of Weinberg & Co., PA X        
31.1 Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, filed herewith. X        
31.2 Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, filed herewith. X        
32.1 Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 filed herewith. X        
32.2 Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 filed herewith. X        
101.INS XBRL Instance Document X        
101.SCH XBRL Taxonomy Extension Schema Document X        
101.CAL XBRL Taxonomy Extension Calculation Linkbase Document X        
101.DEF XBRL Taxonomy Extension Label Linkbase Document X        
101.LAB XBRL Taxonomy Extension Presentation Linkbase Document X        
101.PRE XBRL Taxonomy Extension Label Linkbase Document X        

51

31.1Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, filed herewith.X
31.2Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, filed herewith.X
32.1Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 filed herewith.X
32.2Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 filed herewith.X
101.INSInline XBRL Instance DocumentX
101.SCHInline XBRL Taxonomy Extension Schema DocumentX
101.CALInline XBRL Taxonomy Extension Calculation Linkbase DocumentX
101.DEFInline XBRL Taxonomy Extension Label Linkbase DocumentX
101.LABInline XBRL Taxonomy Extension Presentation Linkbase DocumentX
101.PREInline XBRL Taxonomy Extension Label Linkbase DocumentX
104Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

* Indicates a management contract or compensatory plan or arrangement.

5852